Publications 2024

Dinh PC, Monahan PO, Fosså SD, Sesso HD, Feldman DR, Dolan ME, Nevel K, Kincaid J, Vaughn DJ, Martin NE, Sanchez VA, Einhorn LH, Frisina R, Fung C, Kroenke K, Travis LB (2024)
Impact of pain and adverse health outcomes on long-term US testicular cancer survivors
J Natl Cancer Inst, 116 (3), 455-467
DOI 10.1093/jnci/djad236, PubMed 37966940

Fosså SD, Holck Storås A, Aas K, Børge Johannesen T, Maria Gjelsvik Y, Myklebust TÅ (2024)
Pretreatment Patient-reported Overall Health: A Prognostic Factor for Early Overall Mortality After Primary Curative Treatment of Prostate Cancer
Eur Urol Open Sci, 63, 62-70
DOI 10.1016/j.euros.2024.03.005, PubMed 38558766

Nilsson M, Aas K, Myklebust TÅ, Gjelsvik YM, Johannesen TB, Fosså SD (2024)
Adverse Health Outcomes 3 Years after Radical Prostatectomy Compared with Men in the General Population: A Study from the Cancer Registry of Norway
Clin Genitourin Cancer, 22 (6), 102219
DOI 10.1016/j.clgc.2024.102219, PubMed 39340952

Qvigstad LF, Eri LM, Lien MD, Fosså SD, Aas K, Berge V (2024)
Reduction of lower urinary tract symptoms in prostate cancer patients treated with robot assisted laparoscopic prostatectomy
Scand J Urol, 59, 121-125
DOI 10.2340/sju.v59.40070, PubMed 38888041

van der Perk MEM, Broer L, Yasui Y, Laven JSE, Robison LL, Tissing WJE, Versluys B, Bresters D, Kaspers GJL, Lambalk CB, Overbeek A, Loonen JJ, Beerendonk CCM, Byrne J, Berger C, Clemens E, van Dulmen-den Broeder E, Dirksen U, van der Pal HJ, de Vries ACH, Winther JF, Ranft A, Fosså SD, Grabow D, Muraca M et al. (2024)
Interindividual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors - a genome-wide association study: results from PanCareLIFE
Fertil Steril, 122 (3), 514-524
DOI 10.1016/j.fertnstert.2024.05.002, PubMed 38729340

Publications 2023

Albertsen PC, Bjerner LJ, Pasovic L, Müller S, Fosså S, Carlsson SV, Oldenburg J (2023)
Opportunistic prostate-specific antigen testing in Norwegian men: a public health challenge
BJU Int, 133 (1), 104-111
DOI 10.1111/bju.16211, PubMed 37869764

Bjerner J, Bratt O, Aas K, Albertsen PC, Fosså SD, Kvåle R, Lilja H, Müller C, Müller S, Stensvold A, Thomas O, Røe OD, Vickers A, Walz J, Carlsson SV, Oldenburg J (2023)
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
Eur Urol, 86 (1), 20-26
DOI 10.1016/j.eururo.2023.04.028, PubMed 37169639

Dahl AA, Bentzen AG, Fosså SD, Hess SL, Kiserud CE (2023)
A study of modifiable factors associated with health-related quality of life in long-term cervical cancer survivors
Acta Obstet Gynecol Scand, 102 (2), 218-225
DOI 10.1111/aogs.14490, PubMed 36683549

Fosså SD, Haugnes HS, Dahl AA, Kiserud CE, Fosså A, Skalleberg J, Myklebust TÅ (2023)
Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective
Ann Oncol, 34 (12), 1165-1174
DOI 10.1016/j.annonc.2023.09.3101, PubMed 37739265

Hjelle LV, Sælen M, Aarsæther E, Knutsen T, Andersen S, Bentzen AG, Richardsen E, Wilsgaard T, Fosså SD, Haugnes HS (2023)
The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy
Eur Urol Open Sci, 53, 6-15
DOI 10.1016/j.euros.2023.04.005, PubMed 37441342

Møller CT, Tafjord G, Blindheim A, Berge V, Fosså S, Andreassen BK (2023)
Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway
Scand J Urol, 58, 101-108
DOI 10.2340/sju.v58.5923, PubMed 37953521

Otrebski Nilsson M, Aas K, Myklebust TÅ, Gjelsvik YM, Haug ES, Fosså SD, Johannesen TB (2023)
Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?
Scand J Urol, 58, 133-140
DOI 10.2340/sju.v58.14730, PubMed 38116675

Sanchez VA, Shuey MM, Dinh PC, Monahan PO, Fosså SD, Sesso HD, Dolan ME, Einhorn LH, Vaughn DJ, Martin NE, Feldman DR, Kroenke K, Fung C, Frisina RD, Travis LB (2023)
Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy
J Clin Oncol, 41 (12), 2211-2226
DOI 10.1200/JCO.22.01456, PubMed 36626694

Storås AH, Tsuruda K, Fosså SD, Andreassen BK (2023)
Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort study
Acta Oncol, 62 (12), 1716-1722
DOI 10.1080/0284186X.2023.2257876, PubMed 37725527

Sælen MG, Hjelle LV, Aarsæther E, Knutsen T, Andersen S, Bentzen AG, Richardsen E, Fosså SD, Haugnes HS (2023)
Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy
Acta Oncol, 62 (6), 657-665
DOI 10.1080/0284186X.2023.2224051, PubMed 37353983

Thorsen L, Courneya KS, Steene-Johannessen J, Gran JM, Haugnes HS, Negaard HFS, Kiserud CE, Fosså SD (2023)
Association of physical activity with overall mortality among long-term testicular cancer survivors: A longitudinal study
Int J Cancer, 153 (8), 1512-1519
DOI 10.1002/ijc.34625, PubMed 37334652

Wedde TB, Smaastuen MC, Vatne K, Schulz-Jaavall MB, Fosså SD, Lilleby WL (2023)
External beam radiotherapy of prostate cancer with or without high dose-rate brachytherapy: the Norwegian experience with long-term urinary and bowel adverse effects
Scand J Urol, 58, 68-75
DOI 10.2340/sju.v58.9571, PubMed 37644904

Publications 2022

Ardeshirrouhanifard S, Fossa SD, Huddart R, Monahan PO, Fung C, Song Y, Dolan ME, Feldman DR, Hamilton RJ, Vaughn D, Martin NE, Kollmannsberger C, Dinh P, Einhorn L, Frisina RD, Travis LB (2022)
Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments
Ear Hear, 43 (3), 794-807
DOI 10.1097/AUD.0000000000001172, PubMed 35067571

Dahl AA, Fosså SD (2022)
High Neuroticism Is Related to More Overall Functional Problems and Lower Function Scores in Men Who Had Surgery for Non-Relapsing Prostate Cancer
Curr Oncol, 29 (8), 5823-5832
DOI 10.3390/curroncol29080459, PubMed 36005197

Dahl AA, Kiserud CE, Fosså SD, Loge JH, Reinertsen KV, Ruud E, Lie HC (2022)
A study of high neuroticism in long-term survivors of childhood, adolescence, and young adult cancers
Sci Rep, 12 (1), 12325
DOI 10.1038/s41598-022-15697-3, PubMed 35853946

Fosså SD, Dahl AA, Johannesen TB, Gjelsvik YM, Storås AH, Myklebust TÅ (2022)
Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population
Clin Transl Radiat Oncol, 37, 78-84
DOI 10.1016/j.ctro.2022.08.003, PubMed 36093341

Fosså SD, Dahl AA, Thorsen L, Hellesnes R, Kiserud CE, Tandstad T, Brydøy M, Haugnes HS, Myklebust TÅ (2022)
Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors
J Clin Oncol, 40 (23), 2588-2599
DOI 10.1200/JCO.21.02105, PubMed 35380874

Monsen KV, Fosså SD, Myklebust TÅ, Smeland S, Dahl AA, Stensvold A (2022)
Long-term satisfaction with curative treatment and follow-up in prostate cancer survivors
Acta Oncol, 61 (3), 357-362
DOI 10.1080/0284186X.2021.2006775, PubMed 35103559

Møller CT, Fosså SD, Tafjord G, Babigumira R, Berge V, Andreassen BK (2022)
Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment
Scand J Urol, 56 (3), 214-220
DOI 10.1080/21681805.2022.2056633, PubMed 35506475

Møller CT, Støer NC, Blindheim A, Berge V, Tafjord G, Fosså SD, Andreassen BK (2022)
Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study
BMC Cancer, 22 (1), 1301
DOI 10.1186/s12885-022-10394-w, PubMed 36510166

Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T (2022)
Re: Thyroid hypofunction in aging testicular cancer survivors by Nome et al
Acta Oncol, 61 (3), 385
DOI 10.1080/0284186X.2021.2023214, PubMed 35037554

Storås AH, Andreassen BK, Fosså SD (2022)
Characterization of long-term survivors of primary metastatic prostate cancer patients in Norway
Acta Oncol, 61 (5), 615-618
DOI 10.1080/0284186X.2022.2051204, PubMed 35300560

Publications 2021

ArdeshirRouhaniFard S, Dinh PC, Monahan PO, Fossa SD, Huddart R, Fung C, Song Y, Feldman DR, Hamilton RJ, Vaughn DJ, Martin NE, Kollmannsberger C, Einhorn L, Kroenke K, Travis LB (2021)
Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study
Cancer Epidemiol Biomarkers Prev, 30 (6), 1129-1138
DOI 10.1158/1055-9965.EPI-20-1762, PubMed 33849970

Bjerring AW, Fosså SD, Haugnes HS, Nome R, Stokke TM, Haugaa KH, Kiserud CE, Edvardsen T, Sarvari SI (2021)
The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up
Eur Heart J Cardiovasc Imaging, 22 (4), 443-450
DOI 10.1093/ehjci/jeaa289, PubMed 33152065

Blindheim AJ, Fosså SD, Babigumira R, Andreassen BK (2021)
The use of reTURB in T1 bladder cancer: a Norwegian population-based study
Scand J Urol, 55 (4), 268-274
DOI 10.1080/21681805.2021.1917652, PubMed 33998957

Dahl AA, Kiserud CE, Fosså SD, Loge JH, Reinertsen KV, Ruud E, Lie HC (2021)
A Controlled Study of Major Depressive Episodes in Long-Term Childhood, Adolescence, and Young Adult Cancer Survivors (The NOR-CAYACS Study)
Cancers (Basel), 13 (22)
DOI 10.3390/cancers13225800, PubMed 34830953

Hellesnes R, Myklebust TÅ, Fosså SD, Bremnes RM, Karlsdottir Á, Kvammen Ø, Tandstad T, Wilsgaard T, Negaard HFS, Haugnes HS (2021)
Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort
J Clin Oncol, 39 (32), 3561-3573
DOI 10.1200/JCO.21.00637, PubMed 34388002

Hopland OA, Fosså SD, Ottosson F, Brennhovd B, Svindland A, Hole KH, Hernes E, Eri LM, Diep LM, Berge V (2021)
Robotic salvage pelvic lymph node dissection for locoregional recurrence after radical prostatectomy: a single institution experience
Scand J Urol, 55 (4), 287-292
DOI 10.1080/21681805.2021.1946135, PubMed 34196594

Jakobsen J, Veierød MB, Grimsrud TK, Fosså SD, Hammarström B, Kjærheim K (2021)
Early detection of prostate cancer in firefighters: a register-based study of prognostic factors and survival
Occup Environ Med, 79 (3), 200-206
DOI 10.1136/oemed-2021-107622, PubMed 34510005

Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T (2021)
Thyroid hypofunction in aging testicular cancer survivors
Acta Oncol, 60 (11), 1452-1458
DOI 10.1080/0284186X.2021.1958004, PubMed 34351829

Skalleberg J, Myhrum M, Småstuen MC, Osnes TA, Fosså SD, Bunne M (2021)
Speech perception 30 years after cisplatin-based chemotherapy in adults: limited clinical relevance of long-term ototoxicity?
Acta Oncol, 60 (4), 426-433
DOI 10.1080/0284186X.2021.1887514, PubMed 33617403

Storås AH, Fosså SD, Ursin G, Andreassen BK (2021)
Survival trends for patients with primary metastatic prostate cancer before and after the introduction of new antitumor drugs
Prostate Cancer Prostatic Dis, 26 (1), 53-58
DOI 10.1038/s41391-021-00445-x, PubMed 34493838

Thorsen L, Bøhn SH, Lie HC, Fosså SD, Kiserud CE (2021)
Needs for information about lifestyle and rehabilitation in long-term young adult cancer survivors
Support Care Cancer, 30 (1), 521-533
DOI 10.1007/s00520-021-06418-z, PubMed 34333716

van den Berg MH, van Dijk M, Byrne J, Berger C, Dirksen U, Winther JF, Fossa SD, Grabow D, Grandage VL, Haupt R, van den Heuvel-Eibrink MM, Kaiser M, Kepak T, van der Kooi ALF, Kremer LCM, Kruseova J, Lambalk CB, van Leeuwen FE, Leiper A, Modan-Moses D, Spix C, Twisk JWR, Ronckers CM, Kaatsch P, van Dulmen-den Broeder E et al. (2021)
Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE)
Hum Reprod, 36 (6), 1561-1573
DOI 10.1093/humrep/deab035, PubMed 33744927

van der Kooi ALF, van Dijk M, Broer L, van den Berg MH, Laven JSE, van Leeuwen FE, Lambalk CB, Overbeek A, Loonen JJ, van der Pal HJ, Tissing WJ, Versluys B, Bresters D, Beerendonk CCM, Ronckers CR, van der Heiden-van der Loo M, Kaspers GL, de Vries ACH, Robison LL, Hudson MM, Chemaitilly W, Byrne J, Berger C, Clemens E, Dirksen U et al. (2021)
Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function
Hum Reprod, 36 (4), 1120-1133
DOI 10.1093/humrep/deaa342, PubMed 33582778

van der Perk MEM, Broer L, Yasui Y, Robison LL, Hudson MM, Laven JSE, van der Pal HJ, Tissing WJE, Versluys B, Bresters D, Kaspers GJL, de Vries ACH, Lambalk CB, Overbeek A, Loonen JJ, Beerendonk CCM, Byrne J, Berger C, Clemens E, Dirksen U, Winther JF, Fosså SD, Grabow D, Muraca M, Kaiser M et al. (2021)
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study
Cancers (Basel), 13 (18)
DOI 10.3390/cancers13184598, PubMed 34572825

Aas K, Berge V, Myklebust TÅ, Fosså SD (2021)
Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens
Eur Urol Open Sci, 26, 55-63
DOI 10.1016/j.euros.2021.01.011, PubMed 34337508

Publications 2020

Aksnessæther BY, Myklebust TÅ, Solberg A, Klepp OH, Skovlund E, Hoff SR, Fosså SD, Widmark A, Lund JÅ (2020)
In Reply to Sari et al
Int J Radiat Oncol Biol Phys, 107 (2), 388-389
DOI 10.1016/j.ijrobp.2020.02.027, PubMed 32112877

Blindheim A, Fosså S, Babigumira R, Myklebust TÅ, Haug E, Arum CJ, Andreassen BK (2020)
T1 bladder cancer in Norway: treatment and survival
Scand J Urol, 54 (5), 370-375
DOI 10.1080/21681805.2020.1803401, PubMed 32783590

Bøhn SH, Lie HC, Reinertsen KV, Fosså SD, Haugnes HS, Kiserud CE, Loge JH, Wisløff T, Thorsen L (2020)
Lifestyle among long-term survivors of cancers in young adulthood
Support Care Cancer, 29 (1), 289-300
DOI 10.1007/s00520-020-05445-6, PubMed 32358776

Dahl AA, Bentzen AG, Fosså SD, Hess SL, Steen R, Kiserud CE (2020)
Long-term cervical cancer survivors on disability pension: a subgroup in need of attention from health care providers
J Cancer Surviv, 14 (4), 578-585
DOI 10.1007/s11764-020-00877-9, PubMed 32279150

Dahl AA, Bentzen AG, Fosså SD, Hess SL, Steen R, Vistad I, Kiserud CE (2020)
Sexual Inactivity During the Last 4 Weeks in Long-Term Cervical Cancer Survivors: Prevalence and Associated Factors
J Sex Med, 17 (7), 1359-1369
DOI 10.1016/j.jsxm.2020.03.010, PubMed 32336554

Dahl AA, Brennhovd B, Fosså SD, Axcrona K (2020)
A cross-sectional study of current work ability after radical prostatectomy
BMC Urol, 20 (1), 9
DOI 10.1186/s12894-020-0579-9, PubMed 32005115

Dahl AA, Fosså SD, Brennhovd B, Axcrona K (2020)
The EPIC-26 domain scores after radical prostatectomy are associated with the personality trait of neuroticism
Int Urol Nephrol, 53 (4), 691-698
DOI 10.1007/s11255-020-02688-4, PubMed 33118115

Dybvik E, Furnes O, Havelin LI, Fosså SD, Trovik C, Lie SA (2020)
A prospective study on cancer risk after total hip replacements for 41,402 patients linked to the Cancer registry of Norway
BMC Musculoskelet Disord, 21 (1), 599
DOI 10.1186/s12891-020-03605-7, PubMed 32900364

Fosså SD, Dahl AA, Myklebust TÅ, Kiserud CE, Nome R, Klepp OH, Brydøy M, Haugnes HS (2020)
Risk of positive selection bias in longitudinal surveys among cancer survivors: Lessons learnt from the national Norwegian Testicular Cancer Survivor Study
Cancer Epidemiol, 67, 101744
DOI 10.1016/j.canep.2020.101744, PubMed 32652337

Fosså SD, Aas K, Müller C, Jerm MB, Tandstad T, Lilleby W, Kvåle R, Gulbrandsen J, Haug E, Myklebust TA (2020)
Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survival
Radiother Oncol, 155, 33-41
DOI 10.1016/j.radonc.2020.10.022, PubMed 33096165

Gullestad HP, Haugen G, Fosså SD (2020)
Late arm and shoulder problems after axillary therapeutic lymph node dissection in patients with melanoma
J Plast Surg Hand Surg, 55 (2), 127-131
DOI 10.1080/2000656X.2020.1842746, PubMed 33176535

Hellesnes R, Myklebust TÅ, Bremnes RM, Karlsdottir Á, Kvammen Ø, Negaard HFS, Tandstad T, Wilsgaard T, Fosså SD, Haugnes HS (2020)
Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study
J Clin Oncol, 39 (4), 308-318
DOI 10.1200/JCO.20.02713, PubMed 33356420

Kerns SL, Fung C, Fossa SD, Dinh PC, Monahan P, Sesso HD, Frisina RD, Feldman DR, Hamilton RJ, Vaughn D, Martin N, Huddart R, Kollmannsberger C, Sahasrabudhe D, Ardeshir-Rouhani-Fard S, Einhorn L, Travis LB (2020)
Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors
JNCI Cancer Spectr, 4 (4), pkaa022
DOI 10.1093/jncics/pkaa022, PubMed 32704617

Mellblom AV, Kiserud CE, Rueegg CS, Ruud E, Loge JH, Fosså SD, Lie HC (2020)
Self-reported late effects and long-term follow-up care among 1889 long-term Norwegian Childhood, Adolescent, and Young Adult Cancer Survivors (the NOR-CAYACS study)
Support Care Cancer, 29 (6), 2947-2957
DOI 10.1007/s00520-020-05790-6, PubMed 33011832

Milano MT, Dinh PC, Yang H, Zaid MA, Fossa SD, Feldman DR, Monahan PO, Travis LB, Fung C (2020)
Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors
JNCI Cancer Spectr, 4 (3), pkaa017
DOI 10.1093/jncics/pkaa017, PubMed 32455335

Nome RV, Cvancarova Småstuen M, Bjøro T, Kiserud CE, Fosså SD (2020)
Longitudinal kidney function outcome in aging testicular cancer survivors
Acta Oncol, 59 (4), 467-474
DOI 10.1080/0284186X.2020.1724328, PubMed 32043400

Ryalen PC, Stensrud MJ, Fosså S, Røysland K (2020)
Causal inference in continuous time: an example on prostate cancer therapy
Biostatistics, 21 (1), 172-185
DOI 10.1093/biostatistics/kxy036, PubMed 30124773

Skalleberg J, Småstuen MC, Oldenburg J, Osnes T, Fosså SD, Bunne M (2020)
The Relationship Between Cisplatin-related and Age-related Hearing Loss During an Extended Follow-up
Laryngoscope, 130 (9), E515-E521
DOI 10.1002/lary.28543, PubMed 32065408

Stewart R, Fosså SD, Hotopf M, Mykletun A (2020)
Extent of disease at first cancer presentation and previous anxiety and depressive symptoms: the HUNT study
Br J Psychiatry, 217 (2), 427-433
DOI 10.1192/bjp.2019.211, PubMed 31587671

Thorsen L, Haugnes HS, Fosså SD, Brydøy M, Tandstad T, Wisløff T, Gjerset GM, Edvardsen E, Larsen KO, Sandset PM, Henriksson CE, Raastad T, Negaard HFS (2020)
Thromboembolic events after high-intensity training during cisplatin-based chemotherapy for testicular cancer: Case reports and review of the literature
Int J Cancer, 147 (11), 3189-3198
DOI 10.1002/ijc.33151, PubMed 32525564

Vatne Monsen K, Fosså SD, Dahl AA, Myklebust TÅ, Smeland S, Stensvold A (2020)
Prostatectomy with or without post-operative radiotherapy: long-term adverse effects and quality of life
Scand J Urol, 55 (1), 9-16
DOI 10.1080/21681805.2020.1854343, PubMed 33349097

Aas K, Dorothea Fosså S, Åge Myklebust T, Møller B, Kvåle R, Vlatkovic L, Berge V (2020)
Increased curative treatment is associated with decreased prostate cancer-specific and overall mortality in senior adults with high-risk prostate cancer; results from a national registry-based cohort study
Cancer Med, 9 (18), 6646-6657
DOI 10.1002/cam4.3297, PubMed 32750229

Publications 2019

Abu Zaid M, Dinh PC, Monahan PO, Fung C, El-Charif O, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Sesso HD, Huddart R, Mushiroda T, Kubo M, Dolan ME, Einhorn LH, Fossa SD, Travis LB, Platinum Study Group (2019)
Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors
J Natl Compr Canc Netw, 17 (5), 459-468
DOI 10.6004/jnccn.2018.7109, PubMed 31085753

Agrawal V, Dinh PC, Fung C, Monahan PO, Althouse SK, Norton K, Cary C, Einhorn L, Fossa SD, Adra N, Travis LB (2019)
Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management
JNCI Cancer Spectr, 4 (2), pkz079
DOI 10.1093/jncics/pkz079, PubMed 32190815

Aksnessæther BY, Myklebust TÅ, Solberg A, Klepp OH, Skovlund E, Hoff SR, Fosså SD, Widmark A, Lund JÅ (2019)
Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial
Int J Radiat Oncol Biol Phys, 106 (4), 706-714
DOI 10.1016/j.ijrobp.2019.11.027, PubMed 31786279

Bucher-Johannessen C, Page CM, Haugen TB, Wojewodzic MW, Fosså SD, Grotmol T, Haugnes HS, Rounge TB (2019)
Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome
Clin Epigenetics, 11 (1), 179
DOI 10.1186/s13148-019-0764-4, PubMed 31796056

Bøhn SH, Thorsen L, Kiserud CE, Fosså SD, Lie HC, Loge JH, Wisløff T, Haugnes HS, Reinertsen KV (2019)
Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood
Acta Oncol, 58 (5), 753-762
DOI 10.1080/0284186X.2018.1557344, PubMed 30696351

Dahl AA, Fosså SD, Lie HC, Loge JH, Reinertsen KV, Ruud E, Kiserud CE (2019)
Employment Status and Work Ability in Long-Term Young Adult Cancer Survivors
J Adolesc Young Adult Oncol, 8 (3), 304-311
DOI 10.1089/jayao.2018.0109, PubMed 30900929

El Charif O, Mapes B, Trendowski MR, Wheeler HE, Wing C, Dinh PC, Frisina RD, Feldman DR, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Gamazon ER, Cox NJ, Huddart R, Ardeshir-Rouhani-Fard S, Monahan P, Fossa SD, Einhorn LH, Travis LB, Dolan ME (2019)
Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms
Clin Cancer Res, 25 (13), 4104-4116
DOI 10.1158/1078-0432.CCR-18-3179, PubMed 30952644

Fosså SD, Beyer B, Dahl AA, Aas K, Eri LM, Kvan E, Falk RS, Graefen M, Huland H, Berge V (2019)
Improved patient-reported functional outcomes after nerve-sparing radical prostatectomy by using NeuroSAFE technique
Scand J Urol, 53 (6), 385-391
DOI 10.1080/21681805.2019.1693625, PubMed 31797716

Fung C, Dinh PC, Fossa SD, Travis LB (2019)
Testicular Cancer Survivorship
J Natl Compr Canc Netw, 17 (12), 1557-1568
DOI 10.6004/jnccn.2019.7369, PubMed 31805527

Gjerset GM, Kiserud CE, Loge JH, Fosså SD, Wisløff T, Gudbergsson SB, Oldervoll LM, Thorsen L (2019)
Changes in fatigue, health-related quality of life and physical activity after a one-week educational program for cancer survivors
Acta Oncol, 58 (5), 682-689
DOI 10.1080/0284186X.2018.1562210, PubMed 30862228

Hellesnes R, Kvammen Ø, Myklebust TÅ, Bremnes RM, Karlsdottir Á, Negaard HFS, Tandstad T, Wilsgaard T, Fosså SD, Haugnes HS (2019)
Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era
Int J Cancer, 147 (1), 21-32
DOI 10.1002/ijc.32704, PubMed 31597192

Kvammen Ø, Myklebust TÅ, Solberg A, Møller B, Klepp OH, Fosså SD, Tandstad T (2019)
Causes of inferior relative survival after testicular germ cell tumor diagnosed 1953-2015: A population-based prospective cohort study
PLoS One, 14 (12), e0225942
DOI 10.1371/journal.pone.0225942, PubMed 31851716

Kvåle R, Myklebust TÅ, Fosså SD, Aas K, Ekanger C, Helle SI, Honoré A, Møller B (2019)
Impact of positive surgical margins on secondary treatment, palliative radiotherapy and prostate cancer-specific mortality. A population-based study of 13 198 patients
Prostate, 79 (16), 1852-1860
DOI 10.1002/pros.23911, PubMed 31566779

Lie HC, Rueegg CS, Fosså SD, Loge JH, Ruud E, Kiserud CE (2019)
Limited evidence of non-response bias despite modest response rate in a nationwide survey of long-term cancer survivors-results from the NOR-CAYACS study
J Cancer Surviv, 13 (3), 353-363
DOI 10.1007/s11764-019-00757-x, PubMed 30993649

Storås AH, Sanda MG, Garin O, Chang P, Patil D, Crociani C, Suarez JF, Cvancarova M, Loge JH, Fosså SD (2019)
A prospective study of patient reported urinary incontinence among American, Norwegian and Spanish men 1 year after prostatectomy
Asian J Urol, 7 (2), 161-169
DOI 10.1016/j.ajur.2019.08.001, PubMed 32257809

Trendowski MR, El-Charif O, Ratain MJ, Monahan P, Mu Z, Wheeler HE, Dinh PC, Feldman DR, Ardeshir-Rouhani-Fard S, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Hannigan R, Strathmann F, Einhorn LH, Fossa SD, Travis LB, Dolan ME (2019)
Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy
Clin Cancer Res, 25 (19), 5913-5924
DOI 10.1158/1078-0432.CCR-19-0113, PubMed 31296530

Publications 2018

Ávila M, Patel L, López S, Cortés-Sanabria L, Garin O, Pont À, Ferrer F, Boladeras A, Zamora V, Fosså S, Storås AH, Sanda M, Serra-Sutton V, Ferrer M (2018)
Patient-reported outcomes after treatment for clinically localized prostate cancer: A systematic review and meta-analysis
Cancer Treat Rev, 66, 23-44
DOI 10.1016/j.ctrv.2018.03.005, PubMed 29673922

Byrne J, Grabow D, Campbell H, O'Brien K, Bielack S, Am Zehnhoff-Dinnesen A, Calaminus G, Kremer L, Langer T, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E, Baust K, Bautz A, Beck JD, Berger C, Binder H, Borgmann-Staudt A, Broer L, Cario H, Casagranda L, Clemens E, Deuster D, de Vries A, Dirksen U, Winther JF et al. (2018)
PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents
Eur J Cancer, 103, 227-237
DOI 10.1016/j.ejca.2018.08.007, PubMed 30273888

Bøhn SH, Fosså SD, Wisløff T, Thorsen L (2018)
Physical activity and associations with treatment-induced adverse effects among prostate cancer patients
Support Care Cancer, 27 (3), 1001-1011
DOI 10.1007/s00520-018-4389-5, PubMed 30094728

Feldman DR, Ardeshir-Rouhani-Fard S, Monahan P, Sesso HD, Fung C, Williams AM, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Zaid MA, Lipshultz SE, Einhorn LH, Oeffinger KC, Travis LB, Fossa SD, Platinum Study Group (2018)
Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score
Clin Genitourin Cancer, 16 (4), e761-e769
DOI 10.1016/j.clgc.2018.01.011, PubMed 29534941

Fossa SD, Fung C, Dahl AA (2018)
Late adverse outcomes after treatment of testicular cancer. German version
Onkologe, 24 (10), 802-808
DOI 10.1007/s00761-018-0462-4

Fossa SD, Fung C, Dahl AA (2018)
Late adverse outcomes after treatment of testicular cancer
Onkologe, 24 2, S104-S109
DOI 10.1007/s00761-018-0442-8

Fung C, Dinh P, Ardeshir-Rouhani-Fard S, Schaffer K, Fossa SD, Travis LB (2018)
Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors
Adv Urol, 2018, 8671832
DOI 10.1155/2018/8671832, PubMed 29670654

Haugnes HS, Stenklev NC, Brydøy M, Dahl O, Wilsgaard T, Laukli E, Fosså SD (2018)
Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study
Acta Oncol, 57 (8), 1075-1083
DOI 10.1080/0284186X.2018.1433323, PubMed 29384420

Hjelle LV, Gundersen POM, Hellesnes R, Sprauten M, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Oldenburg J, Bremnes RM, Haugnes HS (2018)
Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
Acta Oncol, 57 (10), 1392-1400
DOI 10.1080/0284186X.2018.1473641, PubMed 29775128

Honecker F, Aparicio J, Berney D, Beyer J, Bokemeyer C, Cathomas R, Clarke N, Cohn-Cedermark G, Daugaard G, Dieckmann KP, Fizazi K, Fosså S, Germa-Lluch JR, Giannatempo P, Gietema JA, Gillessen S, Haugnes HS, Heidenreich A, Hemminki K, Huddart R, Jewett MAS, Joly F, Lauritsen J, Lorch A, Necchi A et al. (2018)
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Ann Oncol, 29 (8), 1658-1686
DOI 10.1093/annonc/mdy217, PubMed 30113631

Jacobsen EL, Bye A, Aass N, Fosså SD, Grotmol KS, Kaasa S, Loge JH, Moum T, Hjermstad MJ (2018)
Correction to: Norwegian reference values for the Short-Form Health Survey 36: development over time
Qual Life Res, 27 (5), 1213-1215
DOI 10.1007/s11136-017-1708-0, PubMed 29168123

Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid MI, Williams AM, Stump TE, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger C, Sahasrabudhe DM, Cook R, Fossa SD, Einhorn LH, Travis LB, Platinum Study Group (2018)
Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study
J Clin Oncol, 36 (15), 1505-1512
DOI 10.1200/JCO.2017.77.0735, PubMed 29617189

Kiserud CE, Dahl AA, Fosså SD (2018)
Cancer Survivorship in Adults
Recent Results Cancer Res, 210, 123-143
DOI 10.1007/978-3-319-64310-6_8, PubMed 28924683

Solheim O, Skalleberg J, Warncke T, Ørstavik K, Tropé C, Fosså SD (2018)
Long-term neurotoxicity and Raynaud's phenomenon in patients treated with cisplatin-based chemotherapy for malignant ovarian germ cell tumor
Acta Obstet Gynecol Scand, 98 (2), 240-249
DOI 10.1111/aogs.13477, PubMed 30289161

van den Berg M, van Dijk M, Byrne J, Campbell H, Berger C, Borgmann-Staudt A, Calaminus G, Dirksen U, Winther JF, Fossa SD, Grabow D, Grandage VL, van den Heuvel-Eibrink MM, Kaiser M, Kepak T, Kremer LC, Kruseova J, Kuehni CE, Lambalk CB, van Leeuwen FE, Leiper A, Modan-Moses D, Morsellino V, Spix C, Kaatsch P et al. (2018)
Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE)
JMIR Res Protoc, 7 (9), e10824
DOI 10.2196/10824, PubMed 30215599

van der Kooi ALF, Clemens E, Broer L, Zolk O, Byrne J, Campbell H, van den Berg M, Berger C, Calaminus G, Dirksen U, Winther JF, Fosså SD, Grabow D, Haupt R, Kaiser M, Kepak T, Kremer L, Kruseova J, Modan-Moses D, Ranft A, Spix C, Kaatsch P, Laven JSE, van Dulmen-den Broeder E, Uitterlinden AG et al. (2018)
Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol
BMC Cancer, 18 (1), 930
DOI 10.1186/s12885-018-4834-3, PubMed 30257669

Wedde TB, Småstuen MC, Brabrand S, Fosså SD, Kaasa S, Tafjord G, Russnes KM, Hellebust TP, Lilleby W (2018)
Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort
Radiother Oncol, 132, 211-217
DOI 10.1016/j.radonc.2018.10.013, PubMed 30389241

Zaid MA, Gathirua-Mwangi WG, Fung C, Monahan PO, El-Charif O, Williams AM, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse SK, Ardeshir-Rouhani-Fard S, Dinh PC, Sesso HD, Einhorn LH, Fossa SD, Travis LB, Platinum Study Group (2018)
Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors
J Natl Compr Canc Netw, 16 (3), 257-265
DOI 10.6004/jnccn.2017.7046, PubMed 29523664

Aas K, Fosså SD, Kvåle R, Møller B, Myklebust TÅ, Vlatkovic L, Müller S, Berge V (2018)
Is time from diagnosis to radical prostatectomy associated with oncological outcomes?
World J Urol, 37 (8), 1571-1580
DOI 10.1007/s00345-018-2570-6, PubMed 30483947

Publications 2017

Axcrona K, Nilsson R, Brennhovd B, Sørebø Ø, Fosså SD, Dahl AA (2017)
Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations
BMC Urol, 17 (1), 111
DOI 10.1186/s12894-017-0302-7, PubMed 29197360

Chen H, Ewing CM, Zheng S, Grindedaal EM, Cooney KA, Wiley K, Djurovic S, Andreassen OA, Axcrona K, Mills IG, Xu J, Maehle L, Fosså SD, Isaacs WB (2017)
Genetic factors influencing prostate cancer risk in Norwegian men
Prostate, 78 (3), 186-192
DOI 10.1002/pros.23453, PubMed 29181843

Dolan ME, El Charif O, Wheeler HE, Gamazon ER, Ardeshir-Rouhani-Fard S, Monahan P, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Kim J, Fossa SD, Hertz DL, Mushiroda T, Kubo M, Einhorn LH, Cox NJ, Travis LB, Platinum Study Group (2017)
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer
Clin Cancer Res, 23 (19), 5757-5768
DOI 10.1158/1078-0432.CCR-16-3224, PubMed 28611204

Fosså SD (2017)
[Not Available]
Tidsskr Nor Laegeforen, 137 (4), 259-260
DOI 10.4045/tidsskr.17.0046, PubMed 28225224

Fung C, Sesso HD, Williams AM, Kerns SL, Monahan P, Abu Zaid M, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Kollmannsberger CK, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Lipshultz SE, Einhorn LH, Fossa SD, Travis LB, Platinum Study Group (2017)
Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy
J Clin Oncol, 35 (11), 1211-1222
DOI 10.1200/JCO.2016.70.3108, PubMed 28240972

Gilbert ES, Curtis RE, Hauptmann M, Kleinerman RA, Lynch CF, Stovall M, Smith SA, Weathers R, Andersson M, Dores GM, Fraumeni JF, Fossa SD, Hall P, Hodgson DC, Holowaty EJ, Joensuu H, Johannesen TB, Langmark F, Kaijser M, Pukkala E, Rajaraman P, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Aleman BM et al. (2017)
Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects
Radiat Res, 187 (2), 186-195
DOI 10.1667/RR14453.1, PubMed 28118119

Gjerset GM, Loge JH, Kiserud CE, Fosså SD, Gudbergsson SB, Oldervoll LM, Wisløff T, Thorsen L (2017)
Perceived needs for different components in a rehabilitation program among cancer survivors with chronic fatigue compared to survivors without chronic fatigue
Acta Oncol, 56 (2), 245-253
DOI 10.1080/0284186X.2016.1266091, PubMed 28075207

Grov EK, Fosså SD, Dahl AA (2017)
A controlled study of the influence of comorbidity on activities of daily living in elderly cancer survivors (the HUNT-3 survey)
J Geriatr Oncol, 8 (5), 328-335
DOI 10.1016/j.jgo.2017.05.007, PubMed 28629695

Holm HV, Dahl AA, Klepp OH, Fossa SD (2017)
Useful and gentle about the Munchhaus syndrome
Tidsskr. Nor. Laegeforen., 137 (14-15), 976

Holm HV, Dahl AA, Klepp OH, Fosså SD (2017)
Modern treatment of metastatic prostate cancer
Tidsskr Nor Laegeforen, 137 (11), 803-805
DOI 10.4045/tidsskr.16.0265, PubMed 28597635

Holm HV, Dahl AA, Klepp OH, Fosså SD (2017)
[Not Available]
Tidsskr Nor Laegeforen, 137 (14-15)
DOI 10.4045/tidsskr.17.0579, PubMed 28828789

Jacobsen EL, Bye A, Aass N, Fosså SD, Grotmol KS, Kaasa S, Loge JH, Moum T, Hjermstad MJ (2017)
Norwegian reference values for the Short-Form Health Survey 36: development over time
Qual Life Res, 27 (5), 1201-1212
DOI 10.1007/s11136-017-1684-4, PubMed 28808829

Johannsdottir IMR, Hamre H, Fosså SD, Loge JH, Drolsum L, Lund MB, Nordsletten L, Kiserud C (2017)
Adverse Health Outcomes and Associations with Self-Reported General Health in Childhood Lymphoma Survivors
J Adolesc Young Adult Oncol, 6 (3), 470-476
DOI 10.1089/jayao.2017.0018, PubMed 28837384

Lie HC, Mellblom AV, Brekke M, Finset A, Fosså SD, Kiserud CE, Ruud E, Loge JH (2017)
Experiences with late effects-related care and preferences for long-term follow-up care among adult survivors of childhood lymphoma
Support Care Cancer, 25 (8), 2445-2454
DOI 10.1007/s00520-017-3651-6, PubMed 28236146

Nome RV, Bjøro T, Paus E, Bjerner J, Fosså SD, Steen R, Nustad K, Bolstad N (2017)
Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumors
Clin Biochem, 52, 73-79
DOI 10.1016/j.clinbiochem.2017.11.016, PubMed 29198759

Parker CC, Coleman RE, Sartor O, Vogelzang NJ, Bottomley D, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Bruland ØS et al. (2017)
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial
Eur Urol, 73 (3), 427-435
DOI 10.1016/j.eururo.2017.06.021, PubMed 28705540

Seland M, Smeland KB, Bjøro T, Falk RS, Fosså SD, Gjesdal CG, Godang K, Holte H, Svartberg J, Syversen U, Bollerslev J, Kiserud CE (2017)
Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation
Acta Oncol, 56 (4), 590-598
DOI 10.1080/0284186X.2016.1267870, PubMed 28077016

Skalleberg J, Solheim O, Fosså SD, Småstuen MC, Osnes T, Gundersen POM, Bunne M (2017)
Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer
Gynecol Oncol, 145 (1), 148-153
DOI 10.1016/j.ygyno.2017.02.006, PubMed 28202195

Thorsen L, Kirkegaard C, Loge JH, Kiserud CE, Johansen ML, Gjerset GM, Edvardsen E, Hamre H, Ikdahl T, Fosså SD (2017)
Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer
BMC Res Notes, 10 (1), 214
DOI 10.1186/s13104-017-2531-y, PubMed 28619116

van Leeuwen M, Kieffer JM, Efficace F, Fosså SD, Bolla M, Collette L, Colombel M, De Giorgi U, Holzner B, van de Poll-Franse LV, van Poppel H, White J, de Wit R, Osanto S, Aaronson NK, European Organisation for Research and Treatment of Cancer Quality of Life Group, Genito-Urinary Cancers Group and Radiation Oncology Group, and the NCRN Testis Clinical Studies Group (2017)
International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer
Health Qual Life Outcomes, 15 (1), 97
DOI 10.1186/s12955-017-0670-4, PubMed 28490338

Vatne K, Stensvold A, Myklebust TÅ, Møller B, Svindland A, Kvåle R, Fosså SD (2017)
Pre- and post-prostatectomy variables associated with pelvic post-operative radiotherapy in prostate cancer patients: a national registry-based study
Acta Oncol, 56 (10), 1295-1301
DOI 10.1080/0284186X.2017.1314006, PubMed 28422584

Aas K, Axcrona K, Kvåle R, Møller B, Myklebust TÅ, Axcrona U, Berge V, Fosså SD (2017)
Ten-year Mortality in Men With Nonmetastatic Prostate Cancer in Norway
Urology, 110, 140-147
DOI 10.1016/j.urology.2017.07.048, PubMed 28823634

Publications 2016

Cameron MG, Kersten C, Vistad I, van Helvoirt R, Weyde K, Undseth C, Mjaaland I, Skovlund E, Fosså SD, Guren MG (2016)
Palliative pelvic radiotherapy for symptomatic rectal cancer - a prospective multicenter study
Acta Oncol, 55 (12), 1400-1407
DOI 10.1080/0284186X.2016.1191666, PubMed 27332723

Christiansen JR, Massey R, Dalen H, Kanellopoulos A, Hamre H, Fosså SD, Ruud E, Kiserud CE, Aakhus S (2016)
Utility of Global Longitudinal Strain by Echocardiography to Detect Left Ventricular Dysfunction in Long-Term Adult Survivors of Childhood Lymphoma and Acute Lymphoblastic Leukemia
Am J Cardiol, 118 (3), 446-52
DOI 10.1016/j.amjcard.2016.05.021, PubMed 27296561

Christiansen JR, Massey R, Dalen H, Kanellopoulos A, Hamre H, Ruud E, Kiserud CE, Fosså SD, Aakhus S (2016)
Right ventricular function in long-term adult survivors of childhood lymphoma and acute lymphoblastic leukaemia
Eur Heart J Cardiovasc Imaging, 17 (7), 735-41
DOI 10.1093/ehjci/jew018, PubMed 26917232

Dahl AA, Østby-Deglum M, Oldenburg J, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD (2016)
Aspects of posttraumatic stress disorder in long-term testicular cancer survivors: cross-sectional and longitudinal findings
J Cancer Surviv, 10 (5), 842-9
DOI 10.1007/s11764-016-0529-4, PubMed 26920871

Fosså SD, Bengtsson T, Borre M, Ahlgren G, Rannikko A, Dahl AA (2016)
Reduction of quality of life in prostate cancer patients: experience among 6200 men in the Nordic countries
Scand J Urol, 50 (5), 330-7
DOI 10.1080/21681805.2016.1201859, PubMed 27398736

Fosså SD, Storås AH, Steinsvik EA, Myklebust TA, Eri LM, Loge JH, Dahl AA (2016)
Psychometric testing of the Norwegian version of the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26)
Scand J Urol, 50 (4), 280-5
DOI 10.3109/21681805.2016.1163617, PubMed 27049891

Fosså SD, Wiklund F, Klepp O, Angelsen A, Solberg A, Damber JE, Hoyer M, Widmark A, The Scandinavian Prostate Cancer Group-7 Investigators (2016)
Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7
Eur Urol, 70 (4), 684-691
DOI 10.1016/j.eururo.2016.03.021, PubMed 27025586

Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, Monahan PO, Feldman DR, Hamilton R, Vaughn DJ, Beard CJ, Budnick A, Johnson EM, Ardeshir-Rouhani-Fard S, Einhorn LH, Lipshultz SE, Dolan ME, Travis LB (2016)
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer
J Clin Oncol, 34 (23), 2712-20
DOI 10.1200/JCO.2016.66.8822, PubMed 27354478

Fung C, Fossa SD, Milano MT, Sahasrabudhe DM, Peterson DR, Travis LB (2016)
Reply to S. Alanee et al
J Clin Oncol, 34 (11), 1285-6
DOI 10.1200/JCO.2015.65.7015, PubMed 26858338

Hauptmann M, Børge Johannesen T, Gilbert ES, Stovall M, van Leeuwen FE, Rajaraman P, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Morton LM et al. (2016)
Increased pancreatic cancer risk following radiotherapy for testicular cancer
Br J Cancer, 115 (7), 901-8
DOI 10.1038/bjc.2016.272, PubMed 27599043

Hjelle LV, Bremnes RM, Gundersen POM, Sprauten M, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Oldenburg J, Haugnes HS (2016)
Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors
Urol Oncol, 34 (11), 487.e13-487.e20
DOI 10.1016/j.urolonc.2016.06.012, PubMed 27523611

Jeppesen E, Bjelland I, Fosså SD, Loge JH, Dahl AA (2016)
Health-related quality of life in teenagers with a parent with cancer
Eur J Oncol Nurs, 22, 46-53
DOI 10.1016/j.ejon.2016.03.004, PubMed 27179892

Johannsdottir IM, Karlstad Ø, Loge JH, Fosså SD, Kiserud C, Skurtveit S (2016)
Prescriptions of Antidepressants to Survivors of Cancer in Childhood, Adolescence, and Young Adulthood: A Population-Based Study
J Adolesc Young Adult Oncol, 6 (1), 120-126
DOI 10.1089/jayao.2016.0041, PubMed 27841952

Kvammen Ø, Myklebust TÅ, Solberg A, Møller B, Klepp OH, Fosså SD, Tandstad T (2016)
Long-term Relative Survival after Diagnosis of Testicular Germ Cell Tumor
Cancer Epidemiol Biomarkers Prev, 25 (5), 773-9
DOI 10.1158/1055-9965.EPI-15-1153, PubMed 26908435

Nilsen TS, Thorsen L, Kirkegaard C, Ugelstad I, Fosså SD, Raastad T (2016)
The effect of strength training on muscle cellular stress in prostate cancer patients on ADT
Endocr Connect, 5 (2), 74-82
DOI 10.1530/EC-15-0120, PubMed 27169606

Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjøro T, Laake P, Taskén KA, Svindland A, Eri LM, Brennhovd B, Carlsen MH, Fosså SD, Smeland SS, Karlsen AS, Blomhoff R (2016)
Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA
Clin Nutr, 36 (3), 672-679
DOI 10.1016/j.clnu.2016.06.014, PubMed 27406859

Strathmann FG, Travis LB, Ardeshirrouhanifard S, Fossa SD, Moody S, Clarke D, Law CL (2016)
Residual Platinum Concentrations in Post-Cancer Chemotherapy and Healthy Control Populations Using an Automated, 96-Well Plate Method and Inductively Coupled Plasma Mass Spectrometry
J Appl Lab Med, 1 (2), 143-151
DOI 10.1373/jalm.2016.020081, PubMed 33626787

Wheeler HE, Gamazon ER, Frisina RD, Perez-Cervantes C, El Charif O, Mapes B, Fossa SD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Kollmannsberger C, Kim J, Mushiroda T, Kubo M, Ardeshir-Rouhani-Fard S, Einhorn LH, Cox NJ, Dolan ME, Travis LB (2016)
Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity
Clin Cancer Res, 23 (13), 3325-3333
DOI 10.1158/1078-0432.CCR-16-2809, PubMed 28039263

Publications 2015

Brabrand S, Johannessen B, Axcrona U, Kraggerud SM, Berg KG, Bakken AC, Bruun J, Fosså SD, Lothe RA, Lehne G, Skotheim RI (2015)
Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages
Neoplasia, 17 (2), 167-74
DOI 10.1016/j.neo.2014.12.005, PubMed 25748235

Cameron MG, Kersten C, Vistad I, van Helvoirt R, Weyde K, Undseth C, Mjaaland I, Skovlund E, Fosså SD, Guren MG (2015)
Palliative pelvic radiotherapy for symptomatic incurable prostate cancer – A prospective multicenter study
Radiother Oncol, 115 (3), 314-20
DOI 10.1016/j.radonc.2015.05.021, PubMed 26091575

Dahl S, Cvancarova M, Dahl AA, Fosså SD (2015)
Work ability in prostate cancer survivors after radical prostatectomy
Scand J Urol, 50 (2), 116-22
DOI 10.3109/21681805.2015.1100674, PubMed 26609896

Fosså SD, Dahl AA (2015)
Global Quality of Life After Curative Treatment for Prostate Cancer: What Matters? A Study Among Members of the Norwegian Prostate Cancer Patient Association
Clin Genitourin Cancer, 13 (6), 518-24
DOI 10.1016/j.clgc.2015.07.004, PubMed 26303590

Fosså SD, Dahl AA, Langhammer A, Weedon-Fekjær H (2015)
Cancer patients' participation in population-based health surveys: findings from the HUNT studies
BMC Res Notes, 8, 649
DOI 10.1186/s13104-015-1635-5, PubMed 26541408

Fung C, Fossa SD, Milano MT, Sahasrabudhe DM, Peterson DR, Travis LB (2015)
Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study
J Clin Oncol, 33 (28), 3105-15
DOI 10.1200/JCO.2014.60.3654, PubMed 26240226

Fung C, Fossa SD, Williams A, Travis LB (2015)
Long-term Morbidity of Testicular Cancer Treatment
Urol Clin North Am, 42 (3), 393-408
DOI 10.1016/j.ucl.2015.05.002, PubMed 26216826

Gjerset GM, Loge JH, Gudbergsson SB, Bye A, Fosså SD, Oldervoll LM, Kiserud CE, Demark-Wahnefried W, Thorsen L (2015)
Lifestyles of cancer survivors attending an inpatient educational program-a cross-sectional study
Support Care Cancer, 24 (4), 1527-36
DOI 10.1007/s00520-015-2936-x, PubMed 26370221

Hjelle LV, Gundersen PO, Oldenburg J, Brydøy M, Tandstad T, Wilsgaard T, Fosså SD, Bremnes RM, Haugnes HS (2015)
Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study
Anticancer Res, 35 (3), 1619-25
PubMed 25750319

Kanellopoulos A, Andersson S, Zeller B, Tamnes CK, Fjell AM, Walhovd KB, Westlye LT, Fosså SD, Ruud E (2015)
Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only
Pediatr Blood Cancer, 63 (1), 133-8
DOI 10.1002/pbc.25690, PubMed 26312396

Kristiansen W, Karlsson R, Rounge TB, Whitington T, Andreassen BK, Magnusson PK, Fosså SD, Adami HO, Turnbull C, Haugen TB, Grotmol T, Wiklund F (2015)
Two new loci and gene sets related to sex determination and cancer progression are associated with susceptibility to testicular germ cell tumor
Hum Mol Genet, 24 (14), 4138-46
DOI 10.1093/hmg/ddv129, PubMed 25877299

Lie HC, Loge JH, Fosså SD, Hamre HM, Hess SL, Mellblom AV, Ruud E, Finset A (2015)
Providing information about late effects after childhood cancer: lymphoma survivors' preferences for what, how and when
Patient Educ Couns, 98 (5), 604-11
DOI 10.1016/j.pec.2015.01.016, PubMed 25704291

Löffeler S, Weedon-Fekjaer H, Wang-Hansen MS, Sebakk K, Hamre H, Haug ES, Fosså SD (2015)
"Natural course" of disease in patients with metastatic castrate-resistant prostate cancer: Survival and prognostic factors without life-prolonging treatment
Scand J Urol, 49 (6), 440-445
DOI 10.3109/21681805.2015.1059881, PubMed 26139461

Murbraech K, Solheim O, Aulie HM, Fossa SD, Aakhus S (2015)
The impact of cisplatinum-based chemotherapy on ventricular function and cardiovascular risk factors in female survivors after malignant germ cell cancer
ESC Heart Fail, 2 (3), 142-149
DOI 10.1002/ehf2.12048, PubMed 28834675

Nilsen TS, Raastad T, Skovlund E, Courneya KS, Langberg CW, Lilleby W, Fosså SD, Thorsen L (2015)
Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy
Acta Oncol, 54 (10), 1805-13
DOI 10.3109/0284186X.2015.1037008, PubMed 25927504

Nilsen TS, Thorsen L, Fosså SD, Wiig M, Kirkegaard C, Skovlund E, Benestad HB, Raastad T (2015)
Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapy
Scand J Med Sci Sports, 26 (9), 1026-35
DOI 10.1111/sms.12543, PubMed 26282343

Seland M, Bjøro T, Furre T, Schreiner T, Bollerslev J, Fosså SD, Loge JH, Holte H, Kiserud CE (2015)
Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region
J Cancer Surviv, 9 (4), 630-40
DOI 10.1007/s11764-015-0439-x, PubMed 25750158

Seland M, Holte H, Bjøro T, Schreiner T, Bollerslev J, Loge JH, Fosså SD, Kiserud CE (2015)
Chronic fatigue is prevalent and associated with hormonal dysfunction in long-term non-Hodgkin lymphoma survivors treated with radiotherapy to the head and neck region
Leuk Lymphoma, 56 (12), 3306-14
DOI 10.3109/10428194.2015.1036258, PubMed 25827172

Sprauten M, Haugnes HS, Brydøy M, Kiserud C, Tandstad T, Bjøro T, Bjerner J, Cvancarova M, Fosså SD, Oldenburg J (2015)
Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors
Ann Oncol, 26 (10), 2133-40
DOI 10.1093/annonc/mdv328, PubMed 26265167

Storås AH, Sanda MG, Boronat OG, Chang P, Patil D, Crociani C, Suarez JF, Cvancarova M, Loge JH, Fosså SD (2015)
Erectile Dysfunction and Sexual Problems Two to Three Years After Prostatectomy Among American, Norwegian, and Spanish Patients
Clin Genitourin Cancer, 14 (3), e265-73
DOI 10.1016/j.clgc.2015.10.009, PubMed 26778476

Tjessem KH, Bosse G, Fosså K, Reinertsen KV, Fosså SD, Johansen S, Fosså A (2015)
Coronary calcium score in 12-year breast cancer survivors after adjuvant radiotherapy with low to moderate heart exposure - Relationship to cardiac radiation dose and cardiovascular risk factors
Radiother Oncol, 114 (3), 328-34
DOI 10.1016/j.radonc.2015.01.006, PubMed 25600105

Wilberg P, Kanellopoulos A, Ruud E, Hjermstad MJ, Fosså SD, Herlofson BB (2015)
Dental abnormalities after chemotherapy in long-term survivors of childhood acute lymphoblastic leukemia 7-40 years after diagnosis
Support Care Cancer, 24 (4), 1497-506
DOI 10.1007/s00520-015-2940-1, PubMed 26361760

Østby-Deglum M, Brennhovd B, Axcrona K, Fosså SD, Dahl AA (2015)
A comparative study of erectile function and use of erectile aids in high-risk prostate cancer patients after robot-assisted laparoscopic prostatectomy
Scand J Urol, 49 (6), 433-439
DOI 10.3109/21681805.2015.1042038, PubMed 26116048

Publications 2014

Aschim EL, Oldenburg J, Kristiansen W, Giwercman A, Witczak O, Fosså SD, Haugen TB (2014)
Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones
Hum Reprod, 29 (12), 2844-51
DOI 10.1093/humrep/deu274, PubMed 25336703

Christiansen JR, Hamre H, Massey R, Dalen H, Beitnes JO, Fosså SD, Kiserud CE, Aakhus S (2014)
Left ventricular function in long-term survivors of childhood lymphoma
Am J Cardiol, 114 (3), 483-90
DOI 10.1016/j.amjcard.2014.04.055, PubMed 24948492

Dahl S, Loge JH, Berge V, Dahl AA, Cvancarova M, Fosså SD (2014)
Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery
J Cancer Surviv, 9 (2), 172-9
DOI 10.1007/s11764-014-0399-6, PubMed 25216609

Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Fraumeni JF, Aleman BM, Morton LM, Gilbert ES (2014)
Pancreatic cancer risk after treatment of Hodgkin lymphoma
Ann Oncol, 25 (10), 2073-2079
DOI 10.1093/annonc/mdu287, PubMed 25185241

Dybvik E, Furnes O, Fosså SD, Trovik C, Lie SA (2014)
Pelvic irradiation does not increase the risk of hip replacement in patients with gynecological cancer. A cohort study based on 8,507 patients
Acta Orthop, 85 (6), 652-6
DOI 10.3109/17453674.2014.963784, PubMed 25238432

Fitzpatrick JM, Bellmunt J, Fizazi K, Heidenreich A, Sternberg CN, Tombal B, Alcaraz A, Bahl A, Bracarda S, Di Lorenzo G, Efstathiou E, Finn SP, Fosså S, Gillessen S, Kellokumpu-Lehtinen PL, Lecouvet FE, Oudard S, de Reijke TM, Robson CN, De Santis M, Seruga B, de Wit R (2014)
Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel
Eur J Cancer, 50 (9), 1617-27
DOI 10.1016/j.ejca.2014.03.010, PubMed 24703899

Fossa SD (2014)
Treatment and 5-Year Survival in Patients With Nonmetastatic Prostate Cancer: The Norwegian Experience REPLY
Urology, 83 (1), 153
DOI 10.1016/j.urology.2013.08.086

Fosså SD, Hess SL, Paus E, Borgen E (2014)
Circulating tumor cells in patients with metastatic castration resistant prostate cancer: exploratory findings at a tertiary referral hospital
Res Rep Urol, 6, 121-6
DOI 10.2147/RRU.S68477, PubMed 25328865

Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB (2014)
Reply to G. Gandaglia et al
J Clin Oncol, 32 (11), 1167-9
DOI 10.1200/JCO.2013.54.6168, PubMed 24590643

Hauglann B, Benth JS, Fosså SD, Tveit KM, Dahl AA (2014)
A controlled cohort study of long-term income in colorectal cancer patients
Support Care Cancer, 22 (10), 2821-30
DOI 10.1007/s00520-014-2258-4, PubMed 24821364

Hauptmann M, Fossa SD, Stovall M, van Leeuwen FE, Johannesen TB, Rajaraman P, Gilbert ES, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW et al. (2014)
Increased stomach cancer risk following radiotherapy for testicular cancer
Br J Cancer, 112 (1), 44-51
DOI 10.1038/bjc.2014.552, PubMed 25349972

Heidenreich A, Bracarda S, Mason M, Ozen H, Sengelov L, Van Oort I, Papandreou C, Fossa S, Hitier S, Climent MA, European investigators (2014)
Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: results of the European compassionate-use programme
Eur J Cancer, 50 (6), 1090-9
DOI 10.1016/j.ejca.2014.01.006, PubMed 24485664

Holm HV, Fosså SD, Hedlund H, Schultz A, Dahl AA (2014)
How should continence and incontinence after radical prostatectomy be evaluated? A prospective study of patient ratings and changes with time
J Urol, 192 (4), 1155-61
DOI 10.1016/j.juro.2014.03.113, PubMed 24727062

Holm HV, Fosså SD, Hedlund H, Schultz A, Dahl AA (2014)
Severe postprostatectomy incontinence: Is there an association between preoperative urodynamic findings and outcome of incontinence surgery?
Scand J Urol, 49 (3), 250-9
DOI 10.3109/21681805.2014.980845, PubMed 25428752

Jeppesen E, Bjelland I, Fosså SD, Loge JH, Sørebø O, Dahl AA (2014)
Does a parental history of cancer moderate the associations between impaired health status in parents and psychosocial problems in teenagers: a HUNT study
Cancer Med, 3 (4), 919-26
DOI 10.1002/cam4.245, PubMed 24723456

Johansen S, Fosså K, Nesvold IL, Malinen E, Fosså SD (2014)
Arm and shoulder morbidity following surgery and radiotherapy for breast cancer
Acta Oncol, 53 (4), 521-9
DOI 10.3109/0284186X.2014.880512, PubMed 24495044

Kiserud CE, Dahl AA, Loge JH, Fosså SD (2014)
Cancer survivorship in adults
Recent Results Cancer Res, 197, 103-20
DOI 10.1007/978-3-642-40187-9_8, PubMed 24305772

Kiserud CE, Seland M, Holte H, Fosså A, Fosså SD, Bollerslev J, Bjøro T, Loge JH (2014)
Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism
Acta Oncol, 54 (1), 49-59
DOI 10.3109/0284186X.2014.948057, PubMed 25140862

Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, Hall P, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Lamart S, Simon SL, Fraumeni JF et al. (2014)
Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma
Haematologica, 99 (10), e193-6
DOI 10.3324/haematol.2014.108258, PubMed 25271315

Nome R, Hernes E, Bogsrud TV, Bjøro T, Fosså SD (2014)
Changes in prostate-specific antigen, markers of bone metabolism and bone scans after treatment with radium-223
Scand J Urol, 49 (3), 211-7
DOI 10.3109/21681805.2014.982169, PubMed 25515952

Oldenburg J, Aparicio J, Beyer J, Cohn-Cedermark G, Cullen M, Gilligan T, De Giorgi U, De Santis M, de Wit R, Fosså SD, Germà-Lluch JR, Gillessen S, Haugnes HS, Honecker F, Horwich A, Lorch A, Ondruš D, Rosti G, Stephenson AJ, Tandstad T (2014)
Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
Ann Oncol, 26 (5), 833-838
DOI 10.1093/annonc/mdu514, PubMed 25378299

Sartor O, Coleman R, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Widmark A, Johannessen DC, Hoskin P, James ND, Solberg A, Syndikus I, Vogelzang NJ, O'Bryan-Tear CG, Shan M, Bruland ØS, Parker C (2014)
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
Lancet Oncol, 15 (7), 738-46
DOI 10.1016/S1470-2045(14)70183-4, PubMed 24836273

Solheim O, Gershenson DM, Tropé CG, Rokkones E, Sun CC, Weedon-Fekjaer H, Fosså SD (2014)
Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010)
Eur J Cancer, 50 (11), 1942-50
DOI 10.1016/j.ejca.2014.03.288, PubMed 24857045

Solheim O, Tropé CG, Rokkones E, Kærn J, Paulsen T, Salvesen HB, Hagen B, Vereide AB, Fosså SD (2014)
Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era"
Gynecol Oncol, 136 (2), 224-9
DOI 10.1016/j.ygyno.2014.12.010, PubMed 25511159

Sprauten M, Brydøy M, Haugnes HS, Cvancarova M, Bjøro T, Bjerner J, Fosså SD, Oldenburg J (2014)
Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors
J Clin Oncol, 32 (6), 571-8
DOI 10.1200/JCO.2013.51.2715, PubMed 24419125

Sternberg CN, Skoneczna I, Kerst JM, Albers P, Fossa SD, Agerbaek M, Dumez H, de Santis M, Théodore C, Leahy MG, Chester JD, Verbaeys A, Daugaard G, Wood L, Witjes JA, de Wit R, Geoffrois L, Sengelov L, Thalmann G, Charpentier D, Rolland F, Mignot L, Sundar S, Symonds P, Graham J et al. (2014)
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
Lancet Oncol, 16 (1), 76-86
DOI 10.1016/S1470-2045(14)71160-X, PubMed 25498218

Storås AH, Sanda MG, Ferrer M, Loge JH, Dahl AA, Steinsvik EA, Guedea F, Cvancarova M, Fosså SD (2014)
Localized prostate cancer in Norway, the United States, and Spain: between-country differences of variables before treatment among patients eligible for curative treatment
Clin Genitourin Cancer, 12 (4), e117-25
DOI 10.1016/j.clgc.2013.12.007, PubMed 24524968

Travis LB, Fossa SD, Sesso HD, Frisina RD, Herrmann DN, Beard CJ, Feldman DR, Pagliaro LC, Miller RC, Vaughn DJ, Einhorn LH, Cox NJ, Dolan ME, Platinum Study Group (2014)
Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics
J Natl Cancer Inst, 106 (5)
DOI 10.1093/jnci/dju044, PubMed 24623533

van Leeuwen M, Efficace F, Fosså SD, Bolla M, De Giorgi U, de Wit R, Holzner B, van de Poll-Franse LV, van Poppel H, White J, Collette L, Osanto S, Aaronson NK, European Organisation for Research and Treatment of Cancer Quality of Life Group, Genito-Urinary Cancers Group, Radiation Oncology Group (2014)
Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities
Eur J Cancer, 50 (11), 1957-63
DOI 10.1016/j.ejca.2014.04.018, PubMed 24820932

Publications 2013

Andreassen KE, Kristiansen W, Karlsson R, Aschim EL, Dahl O, Fosså SD, Adami HO, Wiklund F, Haugen TB, Grotmol T (2013)
Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor
Hum Reprod, 28 (7), 1995-2002
DOI 10.1093/humrep/det127, PubMed 23639623

Bjerkehagen B, Småstuen MC, Hall KS, Skjeldal S, Bruland ØS, Smeland S, Johannesen TB, Fosså SD (2013)
Incidence and mortality of second sarcomas - a population-based study
Eur J Cancer, 49 (15), 3292-302
DOI 10.1016/j.ejca.2013.05.017, PubMed 23787025

Brennhovd B, Axcrona K, Fosså SD, Giercksky KE, Vlatkovic L, Dahl AA (2013)
Robot-assisted radical prostatectomy of clinical high-risk patients with prostate cancer: a controlled study of operative and short-term postoperative events
Scand J Urol, 47 (6), 449-55
DOI 10.3109/21681805.2013.780257, PubMed 24328733

Cameron MG, Kersten C, Guren MG, Fosså SD, Vistad I (2013)
Palliative pelvic radiotherapy of symptomatic incurable prostate cancer - a systematic review
Radiother Oncol, 110 (1), 55-60
DOI 10.1016/j.radonc.2013.08.008, PubMed 24044801

Cameron MG, Kersten C, Vistad I, Fosså S, Guren MG (2013)
Palliative pelvic radiotherapy of symptomatic incurable rectal cancer - a systematic review
Acta Oncol, 53 (2), 164-73
DOI 10.3109/0284186X.2013.837582, PubMed 24195692

Chung CC, Kanetsky PA, Wang Z, Hildebrandt MA, Koster R, Skotheim RI, Kratz CP, Turnbull C, Cortessis VK, Bakken AC, Bishop DT, Cook MB, Erickson RL, Fosså SD, Jacobs KB, Korde LA, Kraggerud SM, Lothe RA, Loud JT, Rahman N, Skinner EC, Thomas DC, Wu X, Yeager M, Schumacher FR et al. (2013)
Meta-analysis identifies four new loci associated with testicular germ cell tumor
Nat Genet, 45 (6), 680-5
DOI 10.1038/ng.2634, PubMed 23666239

Dahl S, Steinsvik EA, Dahl AA, Loge JH, Cvancarova M, Fosså SD (2013)
Return to work and sick leave after radical prostatectomy: a prospective clinical study
Acta Oncol, 53 (6), 744-51
DOI 10.3109/0284186X.2013.844357, PubMed 24195691

Edvardsen H, Landmark-Høyvik H, Reinertsen KV, Zhao X, Grenaker-Alnæs GI, Nebdal D, Syvänen AC, Rødningen O, Alsner J, Overgaard J, Borresen-Dale AL, Fosså SD, Kristensen VN (2013)
SNP in TXNRD2 associated with radiation-induced fibrosis: a study of genetic variation in reactive oxygen species metabolism and signaling
Int J Radiat Oncol Biol Phys, 86 (4), 791-9
DOI 10.1016/j.ijrobp.2013.02.025, PubMed 23597419

Fosså SD, Nilssen Y, Kvåle R, Hernes E, Axcrona K, Møller B (2013)
Treatment and 5-year survival in patients with nonmetastatic prostate cancer: the Norwegian experience
Urology, 83 (1), 146-52
DOI 10.1016/j.urology.2013.08.081, PubMed 24238563

Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB (2013)
Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study
J Clin Oncol, 31 (30), 3807-14
DOI 10.1200/JCO.2013.50.3409, PubMed 24043737

Grytli HH, Fagerland MW, Fosså SD, Taskén KA (2013)
Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease
Eur Urol, 65 (3), 635-41
DOI 10.1016/j.eururo.2013.01.007, PubMed 23351721

Grytli HH, Fagerland MW, Fosså SD, Taskén KA (2013)
Reply to Chris R. Cardwell, Samy Suissa and Liam J. Murray's letter to the editor re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007
Eur Urol, 64 (1), e11-2
DOI 10.1016/j.eururo.2013.03.045, PubMed 23602404

Hamre H, Zeller B, Kanellopoulos A, Kiserud CE, Aakhus S, Lund MB, Loge JH, Fossa SD, Ruud E (2013)
High Prevalence of Chronic Fatigue in Adult Long-Term Survivors of Acute Lymphoblastic Leukemia and Lymphoma During Childhood and Adolescence
J. Adolesc. Young Adult Oncol., 2 (1), 2-9
DOI 10.1089/jayao.2012.0015

Hamre H, Zeller B, Kanellopoulos A, Ruud E, Fosså SD, Loge JH, Aukrust P, Halvorsen B, Mollnes TE, Kiserud CE (2013)
Serum cytokines and chronic fatigue in adults surviving after childhood leukemia and lymphoma
Brain Behav Immun, 30, 80-7
DOI 10.1016/j.bbi.2013.01.006, PubMed 23333795

Hauglann BK, Saltytė Benth J, Fosså SD, Tveit KM, Dahl AA (2013)
A controlled cohort study of sickness absence and disability pension in colorectal cancer survivors
Acta Oncol, 53 (6), 735-43
DOI 10.3109/0284186X.2013.844354, PubMed 24345277

Holm HV, Fosså SD, Hedlund H, Dahl AA (2013)
Study of generic quality of life in patients operated on for post-prostatectomy incontinence
Int J Urol, 20 (9), 889-95
DOI 10.1111/iju.12077, PubMed 23418855

Horwich A, Fossa SD, Huddart R, Dearnaley DP, Stenning S, Aresu M, Bliss JM, Hall E (2013)
Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma
Br J Cancer, 110 (1), 256-63
DOI 10.1038/bjc.2013.551, PubMed 24263066

Jeppesen E, Bjelland I, Fosså SD, Loge JH, Dahl AA (2013)
Psychosocial problems of teenagers who have a parent with cancer: a population-based case-control study (young-HUNT study)
J Clin Oncol, 31 (32), 4099-104
DOI 10.1200/JCO.2013.50.7061, PubMed 24101041

Johansen S, Tjessem KH, Fosså K, Bosse G, Danielsen T, Malinen E, Fosså SD (2013)
Dose Distribution in the Heart and Cardiac Chambers Following 4-field Radiation Therapy of Breast Cancer: a Retrospective Study
Breast Cancer (Auckl), 7, 41-9
DOI 10.4137/BCBCR.S11118, PubMed 23589693

Kanellopoulos A, Hamre HM, Dahl AA, Fosså SD, Ruud E (2013)
Factors associated with poor quality of life in survivors of childhood acute lymphoblastic leukemia and lymphoma
Pediatr Blood Cancer, 60 (5), 849-55
DOI 10.1002/pbc.24375, PubMed 23335116

Karlsson R, Andreassen KE, Kristiansen W, Aschim EL, Bremnes RM, Dahl O, Fosså SD, Klepp O, Langberg CW, Solberg A, Tretli S, Magnusson PK, Adami HO, Haugen TB, Grotmol T, Wiklund F (2013)
Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4
Hum Mol Genet, 22 (16), 3373-80
DOI 10.1093/hmg/ddt188, PubMed 23640991

Morton LM, Dores GM, Curtis RE, Lynch CF, Stovall M, Hall P, Gilbert ES, Hodgson DC, Storm HH, Johannesen TB, Smith SA, Weathers RE, Andersson M, Fossa SD, Hauptmann M, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Pukkala E, Vaalavirta L, van den Belt-Dusebout AW, Fraumeni JF, Travis LB et al. (2013)
Stomach cancer risk after treatment for hodgkin lymphoma
J Clin Oncol, 31 (27), 3369-77
DOI 10.1200/JCO.2013.50.6832, PubMed 23980092

Oldenburg J, Fosså SD (2013)
Testicular cancer in 2013: towards personalized medicine--are we there yet?
Nat Rev Urol, 11 (2), 68-9
DOI 10.1038/nrurol.2013.298, PubMed 24366345

Oldenburg J, Fosså SD, Nuver J, Heidenreich A, Schmoll HJ, Bokemeyer C, Horwich A, Beyer J, Kataja V, ESMO Guidelines Working Group (2013)
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Ann Oncol, 24 Suppl 6, vi125-32
DOI 10.1093/annonc/mdt304, PubMed 24078656

Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Coleman R, Vogelzang NJ, O'Bryan-Tear CG et al. (2013)
Alpha emitter radium-223 and survival in metastatic prostate cancer
N Engl J Med, 369 (3), 213-23
DOI 10.1056/NEJMoa1213755, PubMed 23863050

Rowland JH, Kent EE, Forsythe LP, Loge JH, Hjorth L, Glaser A, Mattioli V, Fosså SD (2013)
Cancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other?
Cancer, 119 Suppl 11 (0 11), 2094-108
DOI 10.1002/cncr.28060, PubMed 23695922

Schumacher FR, Wang Z, Skotheim RI, Koster R, Chung CC, Hildebrandt MA, Kratz CP, Bakken AC, Bishop DT, Cook MB, Erickson RL, Fosså SD, Greene MH, Jacobs KB, Kanetsky PA, Kolonel LN, Loud JT, Korde LA, Le Marchand L, Lewinger JP, Lothe RA, Pike MC, Rahman N, Rubertone MV, Schwartz SM et al. (2013)
Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23
Hum Mol Genet, 22 (13), 2748-53
DOI 10.1093/hmg/ddt109, PubMed 23462292

Solheim O, Kærn J, Tropé CG, Rokkones E, Dahl AA, Nesland JM, Fosså SD (2013)
Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009)
Gynecol Oncol, 131 (2), 330-5
DOI 10.1016/j.ygyno.2013.08.028, PubMed 24001518

Stensheim H, Klungsøyr K, Skjaerven R, Grotmol T, Fosså SD (2013)
Birth outcomes among offspring of adult cancer survivors: a population-based study
Int J Cancer, 133 (11), 2696-705
DOI 10.1002/ijc.28292, PubMed 23729011

Tjessem KH, Johansen S, Malinen E, Reinertsen KV, Danielsen T, Fosså SD, Fosså A (2013)
Long-term cardiac mortality after hypofractionated radiation therapy in breast cancer
Int J Radiat Oncol Biol Phys, 87 (2), 337-43
DOI 10.1016/j.ijrobp.2013.05.038, PubMed 23886416

Wethal T, Nedregaard B, Andersen R, Fosså A, Lund MB, Günther A, Kvaløy S, Fosså SD, Kjekshus J (2013)
Atherosclerotic lesions in lymphoma survivors treated with radiotherapy
Radiother Oncol, 110 (3), 448-54
DOI 10.1016/j.radonc.2013.10.029, PubMed 24231235

Wæhre H, Vlatkovic L, Cvancarova M, Paus E, Fosså SD, Danielsen HE (2013)
Fifteen-year mortality after radical prostatectomy: which factors are available for patient counselling?
Scand J Urol, 48 (2), 123-30
DOI 10.3109/21681805.2013.817483, PubMed 23885810

Publications 2012

Arvold ND, Catalano PJ, Sweeney CJ, Hoffman KE, Nguyen PL, Balboni TA, Fosså SD, Travis LB, Beard CJ (2012)
Barriers to the implementation of surveillance for stage I testicular seminoma
Int J Radiat Oncol Biol Phys, 84 (2), 383-9
DOI 10.1016/j.ijrobp.2011.11.064, PubMed 22349043

Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, Cathomas R, Cavallin-Stahl E, Clarke NW, Claßen J, Cohn-Cedermark G, Dahl AA, Daugaard G, De Giorgi U, De Santis M, De Wit M, De Wit R, Dieckmann KP, Fenner M, Fizazi K, Flechon A, Fossa SD, Germá Lluch JR, Gietema JA, Gillessen S et al. (2012)
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
Ann Oncol, 24 (4), 878-88
DOI 10.1093/annonc/mds579, PubMed 23152360

Brabrand S, Fosså SD, Cvancarova M, Axcrona U, Lehne G (2012)
Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer
J Clin Oncol, 30 (32), 4004-10
DOI 10.1200/JCO.2011.40.8914, PubMed 23071246

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Bjøro T, Wentzel-Larsen T, Dahl O, Norwegian Urology Cancer Group (NUCG) III study group (2012)
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer
Br J Cancer, 107 (11), 1833-9
DOI 10.1038/bjc.2012.471, PubMed 23169336

Cvancarova M, Aagnes B, Fosså SD, Lambert PC, Møller B, Bray F (2012)
Proportion cured models applied to 23 cancer sites in Norway
Int J Cancer, 132 (7), 1700-10
DOI 10.1002/ijc.27802, PubMed 22927104

Daneshmand S, Albers P, Fosså SD, Heidenreich A, Kollmannsberger C, Krege S, Nichols C, Oldenburg J, Wood L (2012)
Contemporary management of postchemotherapy testis cancer
Eur Urol, 62 (5), 867-76
DOI 10.1016/j.eururo.2012.08.014, PubMed 22938868

Fung C, Fossa SD, Beard CJ, Travis LB (2012)
Second malignant neoplasms in testicular cancer survivors
J Natl Compr Canc Netw, 10 (4), 545-56
DOI 10.6004/jnccn.2012.0052, PubMed 22491051

Grytli HH, Fagerland MW, Fosså SD, Taskén KA, Håheim LL (2012)
Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy
Prostate, 73 (3), 250-60
DOI 10.1002/pros.22564, PubMed 22821802

Hauglann B, Benth JŠ, Fosså SD, Dahl AA (2012)
A cohort study of permanently reduced work ability in breast cancer patients
J Cancer Surviv, 6 (3), 345-56
DOI 10.1007/s11764-012-0215-0, PubMed 22457217

Haugnes HS, Bosl GJ, Boer H, Gietema JA, Brydøy M, Oldenburg J, Dahl AA, Bremnes RM, Fosså SD (2012)
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up
J Clin Oncol, 30 (30), 3752-63
DOI 10.1200/JCO.2012.43.4431, PubMed 23008318

Kristiansen W, Andreassen KE, Karlsson R, Aschim EL, Bremnes RM, Dahl O, Fosså SD, Klepp O, Langberg CW, Solberg A, Tretli S, Adami HO, Wiklund F, Grotmol T, Haugen TB (2012)
Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population
Hum Reprod, 27 (5), 1525-35
DOI 10.1093/humrep/des075, PubMed 22402210

Kristiansen W, Aschim EL, Andersen JM, Witczak O, Fosså SD, Haugen TB (2012)
Variations in testosterone pathway genes and susceptibility to testicular cancer in Norwegian men
Int J Androl, 35 (6), 819-827
DOI 10.1111/j.1365-2605.2012.01297.x, PubMed 22882535

Kyrdalen AE, Dahl AA, Hernes E, Småstuen MC, Fosså SD (2012)
A national study of adverse effects and global quality of life among candidates for curative treatment for prostate cancer
BJU Int, 111 (2), 221-32
DOI 10.1111/j.1464-410X.2012.11198.x, PubMed 22672151

Meulenbeld HJ, van Werkhoven ED, Coenen JL, Creemers GJ, Loosveld OJ, de Jong PC, Ten Tije AJ, Fosså SD, Polee M, Gerritsen W, Dalesio O, de Wit R (2012)
Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)
Eur J Cancer, 48 (16), 2993-3000
DOI 10.1016/j.ejca.2012.05.014, PubMed 22677260

Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, Holowaty EJ, Lynch CF, Curtis RE, Smith SA, Kleinerman RA, Kaijser M, Storm HH, Pukkala E, Weathers RE, Linet MS, Rajaraman P, Fraumeni JF, Brown LM, van Leeuwen FE, Fossa SD, Johannesen TB, Langmark F et al. (2012)
Risk of treatment-related esophageal cancer among breast cancer survivors
Ann Oncol, 23 (12), 3081-3091
DOI 10.1093/annonc/mds144, PubMed 22745217

Ruud E, Kanellopoulos A, Zeller B, Widing E, Tjønnfjord GE, Fosså SD (2012)
Patient knowledge of late effects of acute lymphoblastic leukaemia
Tidsskr Nor Laegeforen, 132 (18), 2052-5
DOI 10.4045/tidsskr.12.0153, PubMed 23038194

Sorensen T, Dahl AA, Fossa SD, Holmen J, Lien L, Danbolt LJ (2012)
Is 'Seeking God's Help' Associated with Life Satisfaction and Disease-specific Quality of Life in Cancer Patients? The HUNT Study
Arch. Psychol. Relig., 34 (2), 191-213
DOI 10.1163/15736121-12341237

Steinsvik EA, Axcrona K, Angelsen A, Beisland C, Dahl A, Eri LM, Haug ES, Svindland A, Fosså S (2012)
Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study
Scand J Urol, 47 (2), 92-100
DOI 10.3109/00365599.2012.707684, PubMed 22860630

Stensvold A, Dahl AA, Brennhovd B, Småstuen MC, Fosså SD, Lilleby W, Steinsvik A, Axcrona K, Smeland S (2012)
Bother problems in prostate cancer patients after curative treatment
Urol Oncol, 31 (7), 1067-78
DOI 10.1016/j.urolonc.2011.12.020, PubMed 22341412

Thorsen L, Nilsen TS, Raastad T, Courneya KS, Skovlund E, Fosså SD (2012)
A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design
BMC Cancer, 12, 123
DOI 10.1186/1471-2407-12-123, PubMed 22458865

Torp S, Nielsen RA, Fosså SD, Gudbergsson SB, Dahl AA (2012)
Change in employment status of 5-year cancer survivors
Eur J Public Health, 23 (1), 116-22
DOI 10.1093/eurpub/ckr192, PubMed 22227027

Torp S, Nielsen RA, Gudbergsson SB, Fosså SD, Dahl AA (2012)
Sick leave patterns among 5-year cancer survivors: a registry-based retrospective cohort study
J Cancer Surviv, 6 (3), 315-23
DOI 10.1007/s11764-012-0228-8, PubMed 22706884

Publications 2011

Abouassaly R, Fossa SD, Giwercman A, Kollmannsberger C, Motzer RJ, Schmoll HJ, Sternberg CN (2011)
Sequelae of treatment in long-term survivors of testis cancer
Eur Urol, 60 (3), 516-26
DOI 10.1016/j.eururo.2011.05.055, PubMed 21684072

Andreassen KE, Grotmol T, Cvancarova MS, Johannesen TB, Fosså SD (2011)
Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953-2007)
Int J Cancer, 129 (12), 2867-74
DOI 10.1002/ijc.25943, PubMed 21626506

Bjerkehagen B, Småstuen MC, Hall KS, Skjeldal S, Smeland S, Fosså SD (2011)
Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival?
Br J Cancer, 106 (2), 297-306
DOI 10.1038/bjc.2011.559, PubMed 22173669

Cameron MG, Kersten C, van Helvoirt R, Rohde G, Fosså SD, Vistad I (2011)
Patient reported outcomes of symptoms and quality of life among cancer patients treated with palliative pelvic radiation: a pilot study
BMC Res Notes, 4, 252
DOI 10.1186/1756-0500-4-252, PubMed 21777440

Dahl AA, Gudbergsson SB, Dørum A, Fosså SD, Liavaag AH, Sørebø Ø (2011)
"The impact of cancer scale" version 1: psychometric testing of the Norwegian translation in a heterogeneous sample of cancer survivors
Qual Life Res, 21 (8), 1459-70
DOI 10.1007/s11136-011-0053-y, PubMed 22045155

Dahl AA, Nesvold IL, Reinertsen KV, Fosså SD (2011)
Arm/shoulder problems and insomnia symptoms in breast cancer survivors: cross-sectional, controlled and longitudinal observations
Sleep Med, 12 (6), 584-90
DOI 10.1016/j.sleep.2011.01.011, PubMed 21645872

Fosså SD, Cvancarova M, Chen L, Allan AL, Oldenburg J, Peterson DR, Travis LB (2011)
Adverse prognostic factors for testicular cancer-specific survival: a population-based study of 27,948 patients
J Clin Oncol, 29 (8), 963-70
DOI 10.1200/JCO.2010.32.3204, PubMed 21300926

Fosså SD, Hamre HM (2011)
[Childhood cancer and fertility]
Tidsskr Nor Laegeforen, 131 (15), 1412
DOI 10.4045/tidsskr.11.0778, PubMed 21844933

Gjerset GM, Fosså SD, Courneya KS, Skovlund E, Jacobsen AB, Thorsen L (2011)
Interest and preferences for exercise counselling and programming among Norwegian cancer survivors
Eur J Cancer Care (Engl), 20 (1), 96-105
DOI 10.1111/j.1365-2354.2009.01161.x, PubMed 20345456

Gjerset GM, Fosså SD, Dahl AA, Loge JH, Ensby T, Thorsen L (2011)
Effects of a 1-week inpatient course including information, physical activity, and group sessions for prostate cancer patients
J Cancer Educ, 26 (4), 754-60
DOI 10.1007/s13187-011-0245-8, PubMed 21626449

Grov EK, Fosså SD, Dahl AA (2011)
Morbidity, life style and psychosocial situation in cancer survivors aged 60-69 years: results from the Nord-Trøndelag health study (the HUNT-II study)
BMC Cancer, 11, 34
DOI 10.1186/1471-2407-11-34, PubMed 21266091

Hamre H, Kiserud CE, Ruud E, Thorsby PM, Fosså SD (2011)
Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study
Pediatr Blood Cancer, 59 (2), 271-7
DOI 10.1002/pbc.23363, PubMed 22021108

Hess SL, Jóhannsdóttir IM, Hamre H, Kiserud CE, Loge JH, Fosså SD (2011)
Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects
Acta Oncol, 50 (5), 653-9
DOI 10.3109/0284186X.2010.550934, PubMed 21261507

Johansen S, Reinertsen KV, Knutstad K, Olsen DR, Fosså SD (2011)
Dose distribution in the thyroid gland following radiation therapy of breast cancer--a retrospective study
Radiat Oncol, 6, 68
DOI 10.1186/1748-717X-6-68, PubMed 21651829

Kristiansen W, Haugen TB, Witczak O, Andersen JM, Fosså SD, Aschim EL (2011)
CYP1A1, CYP3A5 and CYP3A7 polymorphisms and testicular cancer susceptibility
Int J Androl, 34 (1), 77-83
DOI 10.1111/j.1365-2605.2010.01057.x, PubMed 20345875

Mead GM, Fossa SD, Oliver RT, Joffe JK, Huddart RA, Roberts JT, Pollock P, Gabe R, Stenning SP, MRC/EORTC seminoma trial collaborators (2011)
Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up
J Natl Cancer Inst, 103 (3), 241-9
DOI 10.1093/jnci/djq525, PubMed 21212385

Oldenburg J, Lorch A, Fosså SD (2011)
Late relapse of germ cell tumors
Hematol Oncol Clin North Am, 25 (3), 615-26, x
DOI 10.1016/j.hoc.2011.03.006, PubMed 21570613

Orre IJ, Reinertsen KV, Aukrust P, Dahl AA, Fosså SD, Ueland T, Murison R (2011)
Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors
J Psychosom Res, 71 (3), 136-41
DOI 10.1016/j.jpsychores.2011.04.003, PubMed 21843747

Reinertsen KV, Grenaker Alnæs GI, Landmark-Høyvik H, Loge JH, Wist E, Kristensen VN, Fosså SD, Edvardsen H (2011)
Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway
Brain Behav Immun, 25 (7), 1376-83
DOI 10.1016/j.bbi.2011.04.001, PubMed 21496483

Skaali T, Fosså SD, Andersson S, Cvancarova M, Langberg CW, Lehne G, Dahl AA (2011)
Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress
J Psychosom Res, 70 (5), 403-10
DOI 10.1016/j.jpsychores.2010.12.004, PubMed 21511070

Skaali T, Fosså SD, Dahl AA (2011)
A prospective study of cognitive complaints in patients with testicular cancer
Clin Genitourin Cancer, 9 (1), 6-13
DOI 10.1016/j.clgc.2011.04.002, PubMed 21729683

Sprauten M, Darrah TH, Peterson DR, Campbell ME, Hannigan RE, Cvancarova M, Beard C, Haugnes HS, Fosså SD, Oldenburg J, Travis LB (2011)
Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer
J Clin Oncol, 30 (3), 300-7
DOI 10.1200/JCO.2011.37.4025, PubMed 22184390

Steinsvik EA, Axcrona K, Dahl AA, Eri LM, Stensvold A, Fosså SD (2011)
Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother
BJU Int, 109 (9), 1366-74
DOI 10.1111/j.1464-410X.2011.10598.x, PubMed 21999333

Stensheim H, Cvancarova M, Møller B, Fosså SD (2011)
Pregnancy after adolescent and adult cancer: a population-based matched cohort study
Int J Cancer, 129 (5), 1225-36
DOI 10.1002/ijc.26045, PubMed 21387311

Stensvold A, Dahl AA, Brennhovd B, Cvancarova M, Fosså SD, Lilleby W, Axcrona K, Smeland S (2011)
Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones
Prostate, 72 (6), 668-76
DOI 10.1002/pros.21470, PubMed 21809351

Thorsen L, Gjerset GM, Loge JH, Kiserud CE, Skovlund E, Fløtten T, Fosså SD (2011)
Cancer patients' needs for rehabilitation services
Acta Oncol, 50 (2), 212-22
DOI 10.3109/0284186X.2010.531050, PubMed 21231783

Torp S, Gudbergsson SB, Dahl AA, Fosså SD, Fløtten T (2011)
Social support at work and work changes among cancer survivors in Norway
Scand J Public Health, 39 (6 Suppl), 33-42
DOI 10.1177/1403494810395827, PubMed 21382846

Tsai HR, Gjesdal O, Wethal T, Haugaa KH, Fosså A, Fosså SD, Edvardsen T (2011)
Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy
Am J Cardiol, 107 (3), 472-7
DOI 10.1016/j.amjcard.2010.09.048, PubMed 21257017

Vistad I, Cvancarova M, Kristensen GB, Fosså SD (2011)
A study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer
J Cancer Surviv, 5 (2), 208-16
DOI 10.1007/s11764-011-0172-z, PubMed 21259075

Warde P, Huddart R, Bolton D, Heidenreich A, Gilligan T, Fossa S (2011)
Management of localized seminoma, stage I-II: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009
Urology, 78 (4 Suppl), S435-43
DOI 10.1016/j.urology.2011.02.031, PubMed 21986223

Zaikova O, Fosså SD, Bruland OS, Giercksky KE, Sandstad B, Skjeldal S (2011)
Radiotherapy or surgery for spine metastases?
Acta Orthop, 82 (3), 365-71
DOI 10.3109/17453674.2011.566142, PubMed 21434789

Publications 2010

Brabrand S, Fosså SD, Cvancarova M, Lehne G (2010)
Androgen substitution with testosterone undecanoate in survivors of bilateral testicular cancer requires individually-adjusted injection intervals
BJU Int, 107 (7), 1080-7
DOI 10.1111/j.1464-410X.2010.09649.x, PubMed 20825398

Bruheim K, Tveit KM, Skovlund E, Balteskard L, Carlsen E, Fosså SD, Guren MG (2010)
Sexual function in females after radiotherapy for rectal cancer
Acta Oncol, 49 (6), 826-32
DOI 10.3109/0284186X.2010.486411, PubMed 20615170

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O, Norwegian Urology Cancer Group III study group (2010)
Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy
Eur Urol, 58 (1), 134-40
DOI 10.1016/j.eururo.2010.03.041, PubMed 20395037

Dahl CF, Haugnes HS, Bremnes R, Dahl O, Fosså SD, Klepp O, Wist E, Dahl AA (2010)
A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors
J Cancer Surviv, 4 (3), 256-65
DOI 10.1007/s11764-010-0133-y, PubMed 20574815

Falk Dahl CA, Reinertsen KV, Nesvold IL, Fosså SD, Dahl AA (2010)
A study of body image in long-term breast cancer survivors
Cancer, 116 (15), 3549-57
DOI 10.1002/cncr.25251, PubMed 20564138

Fu YP, Edvardsen H, Kaushiva A, Arhancet JP, Howe TM, Kohaar I, Porter-Gill P, Shah A, Landmark-Høyvik H, Fosså SD, Ambs S, Naume B, Børresen-Dale AL, Kristensen VN, Prokunina-Olsson L (2010)
NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations
Mol Cancer, 9, 113
DOI 10.1186/1476-4598-9-113, PubMed 20482849

Gjerset GM, Fosså SD, Courneya KS, Skovlund E, Thorsen L (2010)
Exercise behavior in cancer survivors and associated factors
J Cancer Surviv, 5 (1), 35-43
DOI 10.1007/s11764-010-0148-4, PubMed 20890674

Grov EK, Fosså SD, Dahl AA (2010)
Activity of daily living problems in older cancer survivors: a population-based controlled study
Health Soc Care Community, 18 (4), 396-406
DOI 10.1111/j.1365-2524.2010.00912.x, PubMed 20491969

Grov EK, Fosså SD, Dahl AA (2010)
Insomnia in elderly cancer survivors--a population-based controlled study of associations with lifestyle, morbidity, and psychosocial factors. Results from the Health Survey of North-Trøndelag County (HUNT-2). Insomnia in elderly cancer survivors
Support Care Cancer, 19 (9), 1319-26
DOI 10.1007/s00520-010-0948-0, PubMed 20632038

Grov EK, Fosså SD, Dahl AA (2010)
Short-term and long-term elderly cancer survivors: a population-based comparative and controlled study of morbidity, psychosocial situation, and lifestyle
Eur J Oncol Nurs, 15 (3), 213-20
DOI 10.1016/j.ejon.2010.06.011, PubMed 20674499

Gudbergsson SB, Fosså SD, Dahl AA (2010)
Are there sex differences in the work ability of cancer survivors? Norwegian experiences from the NOCWO study
Support Care Cancer, 19 (3), 323-31
DOI 10.1007/s00520-010-0820-2, PubMed 20135150

Gudbergsson SB, Torp S, Fløtten T, Fosså SD, Nielsen R, Dahl AA (2010)
A comparative study of cancer patients with short and long sick-leave after primary treatment
Acta Oncol, 50 (3), 381-9
DOI 10.3109/0284186X.2010.500298, PubMed 20843177

Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, Wilsgaard T, Bremnes RM, Fosså SD (2010)
Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study
J Clin Oncol, 28 (30), 4649-57
DOI 10.1200/JCO.2010.29.9362, PubMed 20855830

Kiserud CE, Loge JH, Fosså A, Holte H, Cvancarova M, Fosså SD (2010)
Mortality is persistently increased in Hodgkin's lymphoma survivors
Eur J Cancer, 46 (9), 1632-9
DOI 10.1016/j.ejca.2010.02.010, PubMed 20219350

Kvåle R, Møller B, Angelsen A, Dahl O, Fosså SD, Halvorsen OJ, Hoem L, Solberg A, Wahlqvist R, Bray F (2010)
Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007
Cancer Epidemiol, 34 (4), 359-67
DOI 10.1016/j.canep.2010.04.017, PubMed 20627840

Kyrdalen AE, Dahl AA, Hernes E, Cvancarova M, Fosså SD (2010)
Fatigue in hormone-naïve prostate cancer patients treated with radical prostatectomy or definitive radiotherapy
Prostate Cancer Prostatic Dis, 13 (2), 144-50
DOI 10.1038/pcan.2009.61, PubMed 20101260

Kyrdalen AE, Dahl AA, Hernes E, Hem E, Fosså SD (2010)
Fatigue in prostate cancer survivors treated with definitive radiotherapy and LHRH analogs
Prostate, 70 (13), 1480-9
DOI 10.1002/pros.21183, PubMed 20687221

Landmark-Høyvik H, Dumeaux V, Reinertsen KV, Edvardsen H, Fosså SD, Børresen-Dale AL (2010)
Blood gene expression profiling of breast cancer survivors experiencing fibrosis
Int J Radiat Oncol Biol Phys, 79 (3), 875-83
DOI 10.1016/j.ijrobp.2010.09.052, PubMed 21129856

Landmark-Høyvik H, Reinertsen KV, Loge JH, Kristensen VN, Dumeaux V, Fosså SD, Børresen-Dale AL, Edvardsen H (2010)
The genetics and epigenetics of fatigue
PM R, 2 (5), 456-65
DOI 10.1016/j.pmrj.2010.04.003, PubMed 20656628

Nesvold IL, Fosså SD, Holm I, Naume B, Dahl AA (2010)
Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life
Acta Oncol, 49 (3), 347-53
DOI 10.3109/02841860903302905, PubMed 19842790

Nesvold IL, Reinertsen KV, Fosså SD, Dahl AA (2010)
The relation between arm/shoulder problems and quality of life in breast cancer survivors: a cross-sectional and longitudinal study
J Cancer Surviv, 5 (1), 62-72
DOI 10.1007/s11764-010-0156-4, PubMed 20972640

Reinertsen KV, Cvancarova M, Loge JH, Edvardsen H, Wist E, Fosså SD (2010)
Predictors and course of chronic fatigue in long-term breast cancer survivors
J Cancer Surviv, 4 (4), 405-14
DOI 10.1007/s11764-010-0145-7, PubMed 20862614

Revheim ME, Winge-Main AK, Hagen G, Fjeld JG, Fosså SD, Lilleby W (2010)
Combined positron emission tomography/computed tomography in sunitinib therapy assessment of patients with metastatic renal cell carcinoma
Clin Oncol (R Coll Radiol), 23 (5), 339-43
DOI 10.1016/j.clon.2010.11.006, PubMed 21134733

Rutskij R, Gaarden T, Bremnes R, Dahl O, Finset A, Fossa SD, Klepp O, Sorebo O, Wist E, Dahl AA (2010)
A study of coping in long-term testicular cancer survivors
Psychol Health Med, 15 (2), 146-58
DOI 10.1080/13548501003623955, PubMed 20391232

Skaali T, Fosså SD, Andersson S, Cvancarova M, Langberg CW, Lehne G, Dahl AA (2010)
A prospective study of neuropsychological functioning in testicular cancer patients
Ann Oncol, 22 (5), 1062-1070
DOI 10.1093/annonc/mdq553, PubMed 21048038

Skaali T, Fosså SD, Andersson S, Langberg CW, Lehne G, Dahl AA (2010)
Is psychological distress in men recently diagnosed with testicular cancer associated with their neuropsychological test performance?
Psychooncology, 20 (4), 369-77
DOI 10.1002/pon.1737, PubMed 20878832

Steinsvik EA, Fosså SD, Axcrona K, Fransson P, Widmark A, Dahl AA (2010)
Do perceptions of adverse events differ between patients and physicians? Findings from a randomized, controlled trial of radical treatment for prostate cancer
J Urol, 184 (2), 525-31
DOI 10.1016/j.juro.2010.04.009, PubMed 20620412

Stensvold A, Dahl AA, Fosså SD, Axcrona K, Lilleby W, Brennhovd B, Smeland S (2010)
Clinicians' use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center
Acta Oncol, 50 (3), 408-14
DOI 10.3109/0284186X.2010.492236, PubMed 20586661

Travis LB, Beard C, Allan JM, Dahl AA, Feldman DR, Oldenburg J, Daugaard G, Kelly JL, Dolan ME, Hannigan R, Constine LS, Oeffinger KC, Okunieff P, Armstrong G, Wiljer D, Miller RC, Gietema JA, van Leeuwen FE, Williams JP, Nichols CR, Einhorn LH, Fossa SD (2010)
Testicular cancer survivorship: research strategies and recommendations
J Natl Cancer Inst, 102 (15), 1114-30
DOI 10.1093/jnci/djq216, PubMed 20585105

Wethal T, Haugnes HS, Kjekshus J, Småstuen MC, Ueland T, Aukrust P, Fosså SD (2010)
C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?
Eur J Cancer, 46 (18), 3425-33
DOI 10.1016/j.ejca.2010.08.004, PubMed 20832295

Zaikova O, Fosså SD, Kongsgaard U, Kvaløy S, Giercksky KE, Skjeldal S (2010)
Pain after palliative radiotherapy for spine metastases
Clin Oncol (R Coll Radiol), 22 (10), 828-36
DOI 10.1016/j.clon.2010.03.008, PubMed 20363110

Publications 2009

Aksnes LH, Bauer HC, Dahl AA, Fosså SD, Hjorth L, Jebsen N, Lernedal H, Hall KS (2009)
Health status at long-term follow-up in patients treated for extremity localized Ewing Sarcoma or osteosarcoma: a Scandinavian sarcoma group study
Pediatr Blood Cancer, 53 (1), 84-9
DOI 10.1002/pbc.22027, PubMed 19343771

Andersen R, Wethal T, Günther A, Fosså A, Edvardsen T, Fosså SD, Kjekshus J (2009)
Relation of coronary artery calcium score to premature coronary artery disease in survivors >15 years of Hodgkin's lymphoma
Am J Cardiol, 105 (2), 149-52
DOI 10.1016/j.amjcard.2009.09.005, PubMed 20102909

Berg A, Dahl AA, Bruland ØS, Bjøro T, Aanensen MS, Fosså SD (2009)
Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes
Prostate Cancer Prostatic Dis, 12 (3), 269-76
DOI 10.1038/pcan.2009.8, PubMed 19290019

Bjerner J, Biernat D, Fosså SD, Bjøro T (2009)
Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project
Scand J Clin Lab Invest, 69 (8), 873-9.e1-11
DOI 10.3109/00365510903380886, PubMed 19929279

Bruheim K, Guren MG, Dahl AA, Skovlund E, Balteskard L, Carlsen E, Fosså SD, Tveit KM (2009)
Sexual function in males after radiotherapy for rectal cancer
Int J Radiat Oncol Biol Phys, 76 (4), 1012-7
DOI 10.1016/j.ijrobp.2009.03.075, PubMed 19880263

Brydøy M, Oldenburg J, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Hauge ER, Dahl O, Fosså SD (2009)
Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors
J Natl Cancer Inst, 101 (24), 1682-95
DOI 10.1093/jnci/djp413, PubMed 19940282

Chaturvedi AK, Kleinerman RA, Hildesheim A, Gilbert ES, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fossa SD, Joensuu H, Travis LB, Engels EA (2009)
Nonsmoking: A Surrogate Factor in Primary Lung Cancer in Survivors of Cervical Adenocarcinoma? Reply
J. Clin. Oncol., 27 (18), 3066-3067
DOI 10.1200/JCO.2009.22.5706

Cvancarova M, Samuelsen SO, Fossa SD (2009)
Reproduction Rates After Cytotoxic Therapy Reply
J. Clin. Oncol., 27 (27), E120
DOI 10.1200/JCO.2009.23.5895

Dybvik E, Furnes O, Fosså SD, Trovik C, Lie SA (2009)
Long-term risk of receiving a total hip replacement in cancer patients
Cancer Epidemiol, 33 (3-4), 235-41
DOI 10.1016/j.canep.2009.06.009, PubMed 19744907

Fosså SD, Egey A, Haukaas SA, Angelsen A, Klepp O, Berge V, Axcrona K, Lilleby W (2009)
[Incorrect about hormone treatment in prostatic cancer]
Tidsskr Nor Laegeforen, 129 (5), 429
DOI 10.4045/tidsskr.08.0649, PubMed 19247406

Fosså SD, Loge JH, Dahl AA (2009)
Kreftoverlevere: ny kunnskap og nye muligheter i et langtidsperspektiv
Gyldendal akademisk, Oslo, 247 s.
BIBSYS 091809436, ISBN 978-82-05-39204-5

Fosså SD, Oldenburg J, Dahl AA (2009)
Short- and long-term morbidity after treatment for testicular cancer
BJU Int, 104 (9 Pt B), 1418-22
DOI 10.1111/j.1464-410X.2009.08869.x, PubMed 19840023

Fransson P, Lund JA, Damber JE, Klepp O, Wiklund F, Fosså S, Widmark A, Scandinavian Prostate Cancer Group Study 7, Swedish Association for Urological Oncology 3 (2009)
Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial
Lancet Oncol, 10 (4), 370-80
DOI 10.1016/S1470-2045(09)70027-0, PubMed 19286422

Grov EK, Fosså SD, Bremnes RM, Dahl O, Klepp O, Wist E, Dahl AA (2009)
The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors
Acta Oncol, 48 (6), 842-9
DOI 10.1080/02841860902795232, PubMed 19412812

Grov EK, Fosså SD, Dahl AA (2009)
Is somatic comorbidity associated with more somatic symptoms, mental distress, or unhealthy lifestyle in elderly cancer survivors?
J Cancer Surviv, 3 (2), 109-16
DOI 10.1007/s11764-009-0081-6, PubMed 19241174

Gudbergsson SB, Fosså SD, Lindbohm ML, Dahl AA (2009)
Received and needed social support at the workplace in Norwegian and Finnish stage 1 breast cancer survivors: a study from the Nordic Study Group of Cancer and Work (NOCWO)
Acta Oncol, 48 (1), 67-75
DOI 10.1080/02841860802314704, PubMed 18759139

Haugnes HS, Aass N, Fosså SD, Dahl O, Brydøy M, Aasebø U, Wilsgaard T, Bremnes RM (2009)
Pulmonary function in long-term survivors of testicular cancer
J Clin Oncol, 27 (17), 2779-86
DOI 10.1200/JCO.2008.18.5181, PubMed 19414680

Hernes E, Kyrdalen A, Kvåle R, Hem E, Klepp O, Axcrona K, Fosså SD (2009)
Initial management of prostate cancer: first year experience with the Norwegian National Prostate Cancer Registry
BJU Int, 105 (6), 805-11; discussion 811
DOI 10.1111/j.1464-410X.2009.08834.x, PubMed 19735258

Kiserud CE, Fosså A, Bjøro T, Holte H, Cvancarova M, Fosså SD (2009)
Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy
Br J Cancer, 100 (3), 455-63
DOI 10.1038/sj.bjc.6604892, PubMed 19156143

Kiserud CE, Schover LR, Dahl AA, Fosså A, Bjøro T, Loge JH, Holte H, Yuan Y, Fosså SD (2009)
Do male lymphoma survivors have impaired sexual function?
J Clin Oncol, 27 (35), 6019-26
DOI 10.1200/JCO.2009.23.2280, PubMed 19858388

Kraggerud SM, Oldenburg J, Alnaes GI, Berg M, Kristensen VN, Fossa SD, Lothe RA (2009)
Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology
Pharmacogenet Genomics, 19 (10), 751-9
DOI 10.1097/FPC.0b013e3283304253, PubMed 19741569

Landmark-Høyvik H, Reinertsen KV, Loge JH, Fosså SD, Børresen-Dale AL, Dumeaux V (2009)
Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors
Pharmacogenomics J, 9 (5), 333-40
DOI 10.1038/tpj.2009.27, PubMed 19546881

Liavaag AH, Dørum A, Fosså SD, Tropé C, Dahl AA (2009)
Morbidity associated with "self-rated health" in epithelial ovarian cancer survivors
BMC Cancer, 9, 2
DOI 10.1186/1471-2407-9-2, PubMed 19121203

Mai PL, Chen BE, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Bodrogi I, Geczi L, Olah E, Heimdal K, Fosså SD, Nathanson KL, Korde L, Easton DF, Dudakia D, Huddart R, Stratton MR, Bishop DT, Rapley EA, Greene MH (2009)
Younger age-at-diagnosis for familial malignant testicular germ cell tumor
Fam Cancer, 8 (4), 451-6
DOI 10.1007/s10689-009-9264-6, PubMed 19609727

Mai PL, Friedlander M, Tucker K, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Bonaïti-Pellié C, Heidenreich A, Albers P, Bodrogi I, Geczi L, Olah E, Daly PA, Guilford P, Fosså SD, Heimdal K, Liubchenko L, Tjulandin SA, Stoll H, Weber W, Easton DF, Dudakia D et al. (2009)
The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred
Urol Oncol, 28 (5), 492-9
DOI 10.1016/j.urolonc.2008.10.004, PubMed 19162511

Michelsen TM, Dørum A, Tropé CG, Fosså SD, Dahl AA (2009)
Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer
Int J Gynecol Cancer, 19 (6), 1029-36
DOI 10.1111/IGC.0b013e3181a83cd5, PubMed 19820364

Oldenburg J, Fosså SD (2009)
[Long-term toxicity after therapy for testicular cancer with special focus on sexual disorders]
Urologe A, 48 (4), 372-6
DOI 10.1007/s00120-009-1945-0, PubMed 19234684

Oldenburg J, Fosså SD (2009)
Exploration of platinum-induced neuropathy should be based on both objective and subjective examinations
Acta Oncol, 48 (6), 804-6
DOI 10.1080/02841860902984729, PubMed 19484592

Oldenburg J, Fosså SD (2009)
Late relapse of nonseminomatous germ cell tumours
BJU Int, 104 (9 Pt B), 1413-7
DOI 10.1111/j.1464-410X.2009.08868.x, PubMed 19840022

Oldenburg J, Wahlqvist R, Fosså SD (2009)
Late relapse of germ cell tumors
World J Urol, 27 (4), 493-500
DOI 10.1007/s00345-009-0411-3, PubMed 19373473

Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P, Fosså SD (2009)
Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue
Brain Behav Immun, 23 (6), 868-74
DOI 10.1016/j.bbi.2009.04.003, PubMed 19362138

Reidunsdatter RJ, Lund JA, Fransson P, Widmark A, Fosså SD, Kaasa S (2009)
Validation of the intestinal part of the prostate cancer questionnaire "QUFW94": psychometric properties, responsiveness, and content validity
Int J Radiat Oncol Biol Phys, 77 (3), 793-804
DOI 10.1016/j.ijrobp.2009.05.057, PubMed 19879063

Reinertsen KV, Cvancarova M, Wist E, Bjøro T, Dahl AA, Danielsen T, Fosså SD (2009)
Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample
Int J Radiat Oncol Biol Phys, 75 (3), 764-70
DOI 10.1016/j.ijrobp.2008.11.037, PubMed 19286332

Skaali T, Fosså SD, Bremnes R, Dahl O, Haaland CF, Hauge ER, Klepp O, Oldenburg J, Wist E, Dahl AA (2009)
Fear of recurrence in long-term testicular cancer survivors
Psychooncology, 18 (6), 580-8
DOI 10.1002/pon.1437, PubMed 18855944

Stensheim H, Miller B, van Dijk T, Fossa SD (2009)
Cancer During Pregnancy: The Time Has Come for a Prospective Program Reply
J. Clin. Oncol., 27 (13), 2299
DOI 10.1200/JCO.2009.21.8255

Stensheim H, Moller B, van Dijk T, Fossa SD (2009)
Cutaneous Melanoma During Pregnancy: Is the Controversy Over? Reply
J. Clin. Oncol., 27 (19), E13-E14
DOI 10.1200/JCO.2009.22.3594

Wethal T, Lund MB, Edvardsen T, Fosså SD, Pripp AH, Holte H, Kjekshus J, Fosså A (2009)
Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study
Br J Cancer, 101 (4), 575-81
DOI 10.1038/sj.bjc.6605191, PubMed 19623176

Zaikova O, Giercksky KE, Fosså SD, Kvaløy S, Johannesen TB, Skjeldal S (2009)
A population-based study of spinal metastatic disease in South-East Norway
Clin Oncol (R Coll Radiol), 21 (10), 753-9
DOI 10.1016/j.clon.2009.09.023, PubMed 19850454

Publications 2008

Arriagada R, Averbeck D, Dahl AA, Darby S, Fosså S, Friberg S, Polgár C, de Vathaire F (2008)
OECI Workshop on late side-effects of cancer treatments
Eur J Cancer, 45 (3), 354-9
DOI 10.1016/j.ejca.2008.10.005, PubMed 19081244

Berg Gudbergsson S, Fosså SD, Dahl AA (2008)
Is cancer survivorship associated with reduced work engagement? A NOCWO Study
J Cancer Surviv, 2 (3), 159-68
DOI 10.1007/s11764-008-0059-9, PubMed 18654861

Berg A, Bruland ØS, Fosså SD, Nesland JM, Berner A, Schirmer C, Lilleby W (2008)
Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer
Prostate, 68 (15), 1607-14
DOI 10.1002/pros.20826, PubMed 18655095

Bjerkehagen B, Smeland S, Walberg L, Skjeldal S, Hall KS, Nesland JM, Småstuen MC, Fosså SD, Saeter G (2008)
Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital
Acta Oncol, 47 (8), 1475-82
DOI 10.1080/02841860802047387, PubMed 18607853

Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fossa SD, Joensuu H, Boice JD, Kleinerman RA, Travis LB (2008)
Re: Second cancers among 104760 survivors of cervical cancer: Evaluation of long-term risk - Reply
J. Natl. Cancer Inst., 100 (8), 600-601
DOI 10.1093/jnci/djn086

Chaturvedi AK, Kleinerman RA, Hildesheim A, Gilbert ES, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fossa SD, Joensuu H, Travis LB, Engels EA (2008)
Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix
J Clin Oncol, 27 (6), 967-73
DOI 10.1200/JCO.2008.18.4549, PubMed 19114696

Cvancarova M, Samuelsen SO, Magelssen H, Fosså SD (2008)
Reproduction rates after cancer treatment: experience from the Norwegian radium hospital
J Clin Oncol, 27 (3), 334-43
DOI 10.1200/JCO.2007.15.3130, PubMed 19075285

Di Lorenzo G, Figg WD, Fossa SD, Mirone V, Autorino R, Longo N, Imbimbo C, Perdonà S, Giordano A, Giuliano M, Labianca R, De Placido S (2008)
Combination of bevacizumab and docetaxel in docetaxel-pretreated hormone-refractory prostate cancer: a phase 2 study
Eur Urol, 54 (5), 1089-94
DOI 10.1016/j.eururo.2008.01.082, PubMed 18276061

Fosså SD (2008)
A randomized phase II trial comparing weekly taxotere plus prednisolone versus prednisolone alone in androgen-independent prostate cancer
Front Radiat Ther Oncol, 41, 108-116
DOI 10.1159/000139885, PubMed 18544992

Fosså SD, Dahl AA (2008)
Fertility and sexuality in young cancer survivors who have adult-onset malignancies
Hematol Oncol Clin North Am, 22 (2), 291-303, vii
DOI 10.1016/j.hoc.2008.01.002, PubMed 18395151

Fosså SD, Dahl AA, Smeland S, Thorsen L, Loge JH (2008)
[Rehabilitation after cancer]
Tidsskr Nor Laegeforen, 128 (22), 2615-6
PubMed 19023358

Fosså SD, Kvaløy J, Kvaløy S, Loge JH, Dahl AA (2008)
[Courses for cancer patients--15 years' experience at The Montebello Centre in Norway]
Tidsskr Nor Laegeforen, 128 (22), 2554-7
PubMed 19023349

Fosså SD, Loge JH, Dahl AA (2008)
Long-term survivorship after cancer: how far have we come?
Ann Oncol, 19 Suppl 5, v25-9
DOI 10.1093/annonc/mdn305, PubMed 18611895

Gudbergsson SB, Fosså SD, Dahl AA, NOCWO (2008)
A study of work changes due to cancer in tumor-free primary-treated cancer patients. A NOCWO study
Support Care Cancer, 16 (10), 1163-71
DOI 10.1007/s00520-008-0407-3, PubMed 18256856

Haugnes HS, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Wilsgaard T, Bremnes RM (2008)
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors
J Cancer Surviv, 2 (3), 128-37
DOI 10.1007/s11764-008-0054-1, PubMed 18792787

Hernes E, Johansson LA, Fosså SD, Pedersen AG, Glattre E (2008)
High prostate cancer mortality in Norway evaluated by automated classification of medical entities
Eur J Cancer Prev, 17 (4), 331-5
DOI 10.1097/CEJ.0b013e3282f5220d, PubMed 18562957

Howard R, Gilbert E, Lynch CF, Hall P, Storm H, Holowaty E, Pukkala E, Langmark F, Kaijser M, Andersson M, Joensuu H, Fossa SD, Allan JM, Travis LB (2008)
Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patients
Ann Epidemiol, 18 (5), 416-21
DOI 10.1016/j.annepidem.2008.01.003, PubMed 18433667

Ikdahl T, Josefsen D, Jakobsen E, Delabie J, Fosså SD (2008)
Concurrent mediastinal germ-cell tumour and haematological malignancy: case report and short review of literature
Acta Oncol, 47 (3), 466-9
DOI 10.1080/02841860701636272, PubMed 18348004

Kiserud CE, Magelssen H, Fedorcsak P, Fosså SD (2008)
[Gonadal function after cancer treatment in adult men]
Tidsskr Nor Laegeforen, 128 (4), 461-5
PubMed 18274582

Kvåle R, Møller B, Wahlqvist R, Fosså SD, Berner A, Busch C, Kyrdalen AE, Svindland A, Viset T, Halvorsen OJ (2008)
Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study
BJU Int, 103 (12), 1647-54
DOI 10.1111/j.1464-410X.2008.08255.x, PubMed 19154461

Linger R, Dudakia D, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Stoppa-Lyonnet D, Bonaïti-Pellié C, Heidenreich A, Albers P, Olah E, Geczi L, Bodrogi I, Daly PA, Guilford P, Fosså SD, Heimdal K, Tjulandin SA, Liubchenko L et al. (2008)
Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors
Genes Chromosomes Cancer, 47 (3), 247-52
DOI 10.1002/gcc.20526, PubMed 18069663

Nesvold IL, Dahl AA, Løkkevik E, Marit Mengshoel A, Fosså SD (2008)
Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy
Acta Oncol, 47 (5), 835-42
DOI 10.1080/02841860801961257, PubMed 18568481

Nesvold IL, Fosså SD, Naume B, Dahl AA (2008)
Kwan's arm problem scale: psychometric examination in a sample of stage II breast cancer survivors
Breast Cancer Res Treat, 117 (2), 281-8
DOI 10.1007/s10549-008-0288-7, PubMed 19112616

Oldenburg J, Fosså SD, Ikdahl T (2008)
Genetic variants associated with cisplatin-induced ototoxicity
Pharmacogenomics, 9 (10), 1521-30
DOI 10.2217/14622416.9.10.1521, PubMed 18855538

Oldenburg J, Lehne G, Fosså SD (2008)
[Testicular cancer]
Tidsskr Nor Laegeforen, 128 (4), 457-60
PubMed 18274581

Orre IJ, Fosså SD, Murison R, Bremnes R, Dahl O, Klepp O, Loge JH, Wist E, Dahl AA (2008)
Chronic cancer-related fatigue in long-term survivors of testicular cancer
J Psychosom Res, 64 (4), 363-71
DOI 10.1016/j.jpsychores.2008.01.002, PubMed 18374735

Schröder FH, Kurth KH, Fossa SD, Hoekstra W, Karthaus PP, De Prijck L, Collette L (2008)
Early versus delayed endocrine treatment of T2-T3 pN1-3 M0 prostate cancer without local treatment of the primary tumour: final results of European Organisation for the Research and Treatment of Cancer protocol 30846 after 13 years of follow-up (a randomised controlled trial)
Eur Urol, 55 (1), 14-22
DOI 10.1016/j.eururo.2008.09.008, PubMed 18823693

Steinsvik EA, Fosså SD, Lilleby W, Eilertsen K (2008)
Fertility issues in patients with prostate cancer
BJU Int, 102 (7), 793-5
DOI 10.1111/j.1464-410X.2008.07739.x, PubMed 18489529

Stensheim H, Møller B, van Dijk T, Fosså SD (2008)
Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study
J Clin Oncol, 27 (1), 45-51
DOI 10.1200/JCO.2008.17.4110, PubMed 19029418

Thorsen L, Courneya KS, Stevinson C, Fosså SD (2008)
A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants
Support Care Cancer, 16 (9), 987-97
DOI 10.1007/s00520-008-0411-7, PubMed 18274783

van Andel G, Bottomley A, Fosså SD, Efficace F, Coens C, Guerif S, Kynaston H, Gontero P, Thalmann G, Akdas A, D'Haese S, Aaronson NK (2008)
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer
Eur J Cancer, 44 (16), 2418-24
DOI 10.1016/j.ejca.2008.07.030, PubMed 18774706

Vistad I, Cvancarova M, Fosså SD, Kristensen GB (2008)
Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients?
Int J Radiat Oncol Biol Phys, 71 (5), 1335-42
DOI 10.1016/j.ijrobp.2007.12.030, PubMed 18355976

Vistad I, Kristensen GB, Fosså SD, Dahl AA, Mørkrid L (2008)
Intestinal malabsorption in long-term survivors of cervical cancer treated with radiotherapy
Int J Radiat Oncol Biol Phys, 73 (4), 1141-7
DOI 10.1016/j.ijrobp.2008.05.064, PubMed 18760883

Vågane R, Bruland ØS, Fosså SD, Olsen DR (2008)
Radiological and functional assessment of radiation-induced pulmonary damage following breast irradiation
Acta Oncol, 47 (2), 248-54
DOI 10.1080/02841860701630267, PubMed 18210300

Vågane R, Danielsen T, Fosså SD, Løkkevik E, Olsen DR (2008)
Late regional density changes of the lung after radiotherapy for breast cancer
Radiother Oncol, 90 (1), 148-52
DOI 10.1016/j.radonc.2007.12.031, PubMed 18262670

Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fosså SD, Scandinavian Prostate Cancer Group Study 7, Swedish Association for Urological Oncology 3 (2008)
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
Lancet, 373 (9660), 301-8
DOI 10.1016/S0140-6736(08)61815-2, PubMed 19091394

Publications 2007

Aksnes LH, Hall KS, Jebsen N, Fosså SD, Dahl AA (2007)
Young survivors of malignant bone tumours in the extremities: a comparative study of quality of life, fatigue and mental distress
Support Care Cancer, 15 (9), 1087-96
DOI 10.1007/s00520-007-0227-x, PubMed 17347843

Berg A, Berner A, Lilleby W, Bruland ØS, Fosså SD, Nesland JM, Kvalheim G (2007)
Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy
Int J Cancer, 120 (8), 1603-9
DOI 10.1002/ijc.22488, PubMed 17230512

Berg A, Lilleby W, Bruland OS, Fosså SD (2007)
10-year survival and quality of life in patients with high-risk pN0 prostate cancer following definitive radiotherapy
Int J Radiat Oncol Biol Phys, 69 (4), 1074-83
DOI 10.1016/j.ijrobp.2007.04.031, PubMed 17703896

Brown LM, Chen BE, Pfeiffer RM, Schairer C, Hall P, Storm H, Pukkala E, Langmark F, Kaijser M, Andersson M, Joensuu H, Fosså SD, Travis LB (2007)
Risk of second non-hematological malignancies among 376,825 breast cancer survivors
Breast Cancer Res Treat, 106 (3), 439-51
DOI 10.1007/s10549-007-9509-8, PubMed 17277968

Brydøy M, Fosså SD, Dahl O, Bjøro T (2007)
Gonadal dysfunction and fertility problems in cancer survivors
Acta Oncol, 46 (4), 480-9
DOI 10.1080/02841860601166958, PubMed 17497315

Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fosså SD, Joensuu H, Boice JD, Kleinerman RA, Travis LB (2007)
Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk
J Natl Cancer Inst, 99 (21), 1634-43
DOI 10.1093/jnci/djm201, PubMed 17971527

Dahl AA, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD (2007)
Is the sexual function compromised in long-term testicular cancer survivors?
Eur Urol, 52 (5), 1438-47
DOI 10.1016/j.eururo.2007.02.046, PubMed 17350159

Edvardsen H, Kristensen VN, Grenaker Alnaes GI, Bøhn M, Erikstein B, Helland A, Børresen-Dale AL, Fosså SD (2007)
Germline glutathione S-transferase variants in breast cancer: relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy
Int J Radiat Oncol Biol Phys, 67 (4), 1163-71
DOI 10.1016/j.ijrobp.2006.11.009, PubMed 17336217

Edvardsen H, Tefre T, Jansen L, Vu P, Haffty BG, Fosså SD, Kristensen VN, Børresen-Dale AL (2007)
Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence
Radiat Oncol, 2, 25
DOI 10.1186/1748-717X-2-25, PubMed 17623063

Fizazi K, Oldenburg J, Dunant A, Chen I, Salvioni R, Hartmann JT, De Santis M, Daugaard G, Flechon A, de Giorgi U, Tjulandin S, Schmoll HJ, Bouzy J, Fossa SD, Fromont G (2007)
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study
Ann Oncol, 19 (2), 259-64
DOI 10.1093/annonc/mdm472, PubMed 18042838

Fosså SD, Gilbert E, Dores GM, Chen J, McGlynn KA, Schonfeld S, Storm H, Hall P, Holowaty E, Andersen A, Joensuu H, Andersson M, Kaijser M, Gospodarowicz M, Cohen R, Pukkala E, Travis LB (2007)
Noncancer causes of death in survivors of testicular cancer
J Natl Cancer Inst, 99 (7), 533-44
DOI 10.1093/jnci/djk111, PubMed 17405998

Fosså SD, Hess SL, Dahl AA, Hjermstad MJ, Veenstra M (2007)
Stability of health-related quality of life in the Norwegian general population and impact of chronic morbidity in individuals with and without a cancer diagnosis
Acta Oncol, 46 (4), 452-61
DOI 10.1080/02841860601182641, PubMed 17497312

Fosså SD, Jacobsen AB, Ginman C, Jacobsen IN, Overn S, Iversen JR, Urnes T, Dahl AA, Veenstra M, Sandstad B (2007)
Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study
Eur Urol, 52 (6), 1691-8
DOI 10.1016/j.eururo.2007.01.104, PubMed 17306441

Fosså SD, Vassilopoulou-Sellin R, Dahl AA (2007)
Long term physical sequelae after adult-onset cancer
J Cancer Surviv, 2 (1), 3-11
DOI 10.1007/s11764-007-0039-5, PubMed 18648982

Gudbergsson SB, Fosså SD, Ganz PA, Zebrack BJ, Dahl AA (2007)
The associations between living conditions, demography, and the 'impact of cancer' scale in tumor-free cancer survivors: a NOCWO study
Support Care Cancer, 15 (11), 1309-1318
DOI 10.1007/s00520-007-0251-x, PubMed 17450387

Gudbergsson SB, Fosså SD, Sanne B, Dahl AA (2007)
A controlled study of job strain in primary-treated cancer patients without metastases
Acta Oncol, 46 (4), 534-44
DOI 10.1080/02841860601156132, PubMed 17497321

Hodgson DC, Gilbert ES, Dores GM, Schonfeld SJ, Lynch CF, Storm H, Hall P, Langmark F, Pukkala E, Andersson M, Kaijser M, Joensuu H, Fosså SD, Travis LB (2007)
Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma
J Clin Oncol, 25 (12), 1489-97
DOI 10.1200/JCO.2006.09.0936, PubMed 17372278

Howard RA, Gilbert ES, Chen BE, Hall P, Storm H, Pukkala E, Langmark F, Kaijser M, Andersson M, Joensuu H, Fossa SD, Travis LB (2007)
Leukemia following breast cancer: an international population-based study of 376,825 women
Breast Cancer Res Treat, 105 (3), 359-68
DOI 10.1007/s10549-006-9460-0, PubMed 17221155

Kiserud CE, Fosså A, Holte H, Fosså SD (2007)
Post-treatment parenthood in Hodgkin's lymphoma survivors
Br J Cancer, 96 (9), 1442-9
DOI 10.1038/sj.bjc.6603711, PubMed 17406362

Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Ståhl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K et al. (2007)
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II
Eur Urol, 53 (3), 497-513
DOI 10.1016/j.eururo.2007.12.025, PubMed 18191015

Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Ståhl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K et al. (2007)
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I
Eur Urol, 53 (3), 478-96
DOI 10.1016/j.eururo.2007.12.024, PubMed 18191324

Liavaag AH, Dørum A, Bjøro T, Oksefjell H, Fosså SD, Tropé C, Dahl AA (2007)
A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach
Gynecol Oncol, 108 (2), 348-54
DOI 10.1016/j.ygyno.2007.10.009, PubMed 17996925

Liavaag AH, Dørum A, Fosså SD, Tropé C, Dahl AA (2007)
Controlled study of fatigue, quality of life, and somatic and mental morbidity in epithelial ovarian cancer survivors: how lucky are the lucky ones?
J Clin Oncol, 25 (15), 2049-56
DOI 10.1200/JCO.2006.09.1769, PubMed 17513809

Magelssen H, Melve KK, Skjaerven R, Fosså SD (2007)
Parenthood probability and pregnancy outcome in patients with a cancer diagnosis during adolescence and young adulthood
Hum Reprod, 23 (1), 178-86
DOI 10.1093/humrep/dem362, PubMed 18024486

Nord C, Ganz PA, Aziz N, Fosså SD (2007)
Follow-up of long-term cancer survivors in the Nordic countries
Acta Oncol, 46 (4), 433-40
DOI 10.1080/02841860701203552, PubMed 17497309

Oldenburg J, Kraggerud SM, Brydøy M, Cvancarova M, Lothe RA, Fossa SD (2007)
Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study
J Transl Med, 5, 70
DOI 10.1186/1479-5876-5-70, PubMed 18162130

Oldenburg J, Kraggerud SM, Cvancarova M, Lothe RA, Fossa SD (2007)
Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors
J Clin Oncol, 25 (6), 708-14
DOI 10.1200/JCO.2006.08.9599, PubMed 17228018

Oldervoll LM, Loge JH, Kaasa S, Lydersen S, Hjermstad MJ, Thorsen L, Holte H, Jacobsen AB, Fosså SD (2007)
Physical activity in Hodgkin's lymphoma survivors with and without chronic fatigue compared with the general population - a cross-sectional study
BMC Cancer, 7, 210
DOI 10.1186/1471-2407-7-210, PubMed 17997822

Røtterud R, Fosså SD, Nesland JM (2007)
Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urothelium
Histol Histopathol, 22 (4), 349-63
DOI 10.14670/HH-22.349, PubMed 17290345

Schairer C, Hisada M, Chen BE, Brown LM, Howard R, Fosså SD, Gail M, Travis LB (2007)
Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancers
J Natl Cancer Inst, 99 (16), 1248-56
DOI 10.1093/jnci/djm081, PubMed 17686826

Schlichting E, Nielsen HB, Fosså SD, Aasland OG (2007)
[Women's academic careers in medicine]
Tidsskr Nor Laegeforen, 127 (16), 2109-12
PubMed 17717577

Thorsen L, Dahl AA, Skovlund E, Hornslien K, Fosså SD (2007)
Effectiveness after 1 year of a short-term physical activity intervention on cardiorespiratory fitness in cancer patients
J Clin Oncol, 25 (10), 1301-2
DOI 10.1200/JCO.2007.10.6682, PubMed 17401029

Vistad I, Fosså SD, Kristensen GB, Dahl AA (2007)
Chronic fatigue and its correlates in long-term survivors of cervical cancer treated with radiotherapy
BJOG, 114 (9), 1150-8
DOI 10.1111/j.1471-0528.2007.01445.x, PubMed 17655733

Vistad I, Fosså SD, Kristensen GB, Mykletun A, Dahl AA (2007)
The sexual activity questionnaire: pychometric properties and normative data in a norwegian population sample
J Womens Health (Larchmt), 16 (1), 139-48
DOI 10.1089/jwh.2006.0052, PubMed 17324105

Wethal T, Kjekshus J, Røislien J, Ueland T, Andreassen AK, Wergeland R, Aukrust P, Fosså SD (2007)
Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer
J Cancer Surviv, 1 (1), 8-16
DOI 10.1007/s11764-007-0012-3, PubMed 18648940

Publications 2006

Christophersen AO, Lie AK, Fosså SD (2006)
Unexpected 10 years complete remission after cortisone mono-therapy in metastatic renal cell carcinoma
Acta Oncol, 45 (2), 226-8
DOI 10.1080/02841860500400995, PubMed 16546876

Crockford GP, Linger R, Hockley S, Dudakia D, Johnson L, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Bonaïti-Pellié C, Heidenreich A, Albers P, Olah E, Geczi L, Bodrogi I, Ormiston WJ, Daly PA, Guilford P, Fosså SD et al. (2006)
Genome-wide linkage screen for testicular germ cell tumour susceptibility loci
Hum Mol Genet, 15 (3), 443-51
DOI 10.1093/hmg/ddi459, PubMed 16407372

Fosså SD, Johannesen TB, Lehne G (2006)
Long-term outcome after adult-onset cancer
Ann Oncol, 17 Suppl 10, x293-8
DOI 10.1093/annonc/mdl276, PubMed 17018741

Fosså SD, Karlsen S, Wahlqvist R (2006)
Prostatakreft: til pasienter, pårørende og andre interesserte
In Kreftinfo, Den norske kreftforening, Oslo, 42 s.
BIBSYS 06036579x

Grov EK, Dahl AA, Fosså SD, Wahl AK, Moum T (2006)
Global quality of life in primary caregivers of patients with cancer in palliative phase staying at home
Support Care Cancer, 14 (9), 943-51
DOI 10.1007/s00520-006-0026-9, PubMed 16523266

Grov EK, Fosså SD, Sørebø O, Dahl AA (2006)
Primary caregivers of cancer patients in the palliative phase: a path analysis of variables influencing their burden
Soc Sci Med, 63 (9), 2429-39
DOI 10.1016/j.socscimed.2006.06.008, PubMed 16887247

Grov EK, Fosså SD, Tønnessen A, Dahl AA (2006)
The caregiver reaction assessment: psychometrics, and temporal stability in primary caregivers of Norwegian cancer patients in late palliative phase
Psychooncology, 15 (6), 517-27
DOI 10.1002/pon.987, PubMed 16189843

Gudbergsson SB, Fosså SD, Borgeraas E, Dahl AA (2006)
A comparative study of living conditions in cancer patients who have returned to work after curative treatment
Support Care Cancer, 14 (10), 1020-9
DOI 10.1007/s00520-006-0042-9, PubMed 16572315

Haugnes HS, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Svartberg J, Wilsgaard T, Bremnes RM (2006)
Components of the metabolic syndrome in long-term survivors of testicular cancer
Ann Oncol, 18 (2), 241-8
DOI 10.1093/annonc/mdl372, PubMed 17060482

Haukvik UK, Dieset I, Bjøro T, Holte H, Fosså SD (2006)
Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma
Ann Oncol, 17 (9), 1428-33
DOI 10.1093/annonc/mdl149, PubMed 16831852

Jacobsen KD, Fosså SD, Aamdal S (2006)
[Malignant melanoma--diagnosis and treatment]
Tidsskr Nor Laegeforen, 126 (23), 3094-7
PubMed 17160112

Kvåle R, Skarre E, Tønne A, Kyrdalen AE, Norstein J, Angelsen A, Wahlqvist R, Fosså SD (2006)
[Curative treatment of prostatic cancer in Norway in 1998 and 2001]
Tidsskr Nor Laegeforen, 126 (7), 912-6
PubMed 16554883

Lilleby W, Hernes E, Waehre H, Raabe N, Fosså SD (2006)
[Treatment of hormone-resistant prostate cancer]
Tidsskr Nor Laegeforen, 126 (21), 2798-801
PubMed 17086220

Magelssen H, Brydøy M, Fosså SD (2006)
The effects of cancer and cancer treatments on male reproductive function
Nat Clin Pract Urol, 3 (6), 312-22
DOI 10.1038/ncpuro0508, PubMed 16763643

Mykletun A, Dahl AA, O'Leary MP, Fosså SD (2006)
Assessment of male sexual function by the Brief Sexual Function Inventory
BJU Int, 97 (2), 316-23
DOI 10.1111/j.1464-410X.2005.05904.x, PubMed 16430637

Oldenburg J, Alfsen GC, Waehre H, Fosså SD (2006)
Late recurrences of germ cell malignancies: a population-based experience over three decades
Br J Cancer, 94 (6), 820-7
DOI 10.1038/sj.bjc.6603014, PubMed 16508636

Oldenburg J, Fosså SD, Dahl AA (2006)
Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors
Qual Life Res, 15 (5), 791-800
DOI 10.1007/s11136-005-5370-6, PubMed 16721639

Oldenburg J, Martin JM, Fosså SD (2006)
Late relapses of germ cell malignancies: incidence, management, and prognosis
J Clin Oncol, 24 (35), 5503-11
DOI 10.1200/JCO.2006.08.1836, PubMed 17158535

Schairer C, Brown LM, Chen BE, Howard R, Lynch CF, Hall P, Storm H, Pukkala E, Anderson A, Kaijser M, Andersson M, Joensuu H, Fosså SD, Ganz PA, Travis LB (2006)
Suicide after breast cancer: an international population-based study of 723,810 women
J Natl Cancer Inst, 98 (19), 1416-9
DOI 10.1093/jnci/djj377, PubMed 17018788

Schonfeld SJ, Gilbert ES, Dores GM, Lynch CF, Hodgson DC, Hall P, Storm H, Andersen A, Pukkala E, Holowaty E, Kaijser M, Andersson M, Joensuu H, Fosså SD, Allan JM, Travis LB (2006)
Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients
J Natl Cancer Inst, 98 (3), 215-8
DOI 10.1093/jnci/djj017, PubMed 16449681

Sørlie T, Rosenvinge JH, Bremnes R, Balteskard L, Dahl AA, Klepp O, Fosså SD (2006)
Management satisfaction in survivors of testicular cancer
Anticancer Res, 26 (2B), 1463-9
PubMed 16619559

Thorsen L, Nystad W, Stigum H, Hjermstad M, Oldervoll L, Martinsen EW, Hornslien K, Strømme SB, Dahl AA, Fosså SD (2006)
Cardiorespiratory fitness in relation to self-reported physical function in cancer patients after chemotherapy
J Sports Med Phys Fitness, 46 (1), 122-7
PubMed 16596110

Vergouwe Y, Steyerberg EW, Foster RS, Sleijfer DT, Fosså SD, Gerl A, de Wit R, Roberts JT, Habbema JD (2006)
Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients
Eur Urol, 51 (2), 424-32
DOI 10.1016/j.eururo.2006.06.047, PubMed 16911854

Vistad I, Fosså SD, Dahl AA (2006)
A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer
Gynecol Oncol, 102 (3), 563-72
DOI 10.1016/j.ygyno.2006.03.050, PubMed 16716379

Publications 2005

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O (2005)
Paternity following treatment for testicular cancer
J Natl Cancer Inst, 97 (21), 1580-8
DOI 10.1093/jnci/dji339, PubMed 16264178

Dahl AA, Haaland CF, Mykletun A, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD (2005)
Study of anxiety disorder and depression in long-term survivors of testicular cancer
J Clin Oncol, 23 (10), 2389-95
DOI 10.1200/JCO.2005.05.061, PubMed 15800331

Dahl AA, Mykletun A, Fosså SD (2005)
Quality of life in survivors of testicular cancer
Urol Oncol, 23 (3), 193-200
DOI 10.1016/j.urolonc.2005.03.004, PubMed 15907721

Dearnaley DP, Fossa SD, Kaye SB, Cullen MH, Harland SJ, Sokal MP, Graham JD, Roberts JT, Mead GM, Williams MV, Cook PA, Stenning SP, MRC Testicular Tumour Working Party (2005)
Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)
Br J Cancer, 92 (12), 2107-13
DOI 10.1038/sj.bjc.6602624, PubMed 15928672

Fosså SD (2005)
[Are all LH-RH analogues equally effective in prostate cancer?]
Tidsskr Nor Laegeforen, 125 (18), 2493-5
PubMed 16186869

Fosså SD, Chen J, Schonfeld SJ, McGlynn KA, McMaster ML, Gail MH, Travis LB (2005)
Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men
J Natl Cancer Inst, 97 (14), 1056-66
DOI 10.1093/jnci/dji185, PubMed 16030303

Fosså SD, Holte H, Holmen MM, Bjøro T, Langmark F, Hess SL, Kvaløy S (2005)
[Long-term effects after mantle field radiotherapy for Hodgkin's lymphoma]
Tidsskr Nor Laegeforen, 125 (1), 41-4
PubMed 15643464

Fosså SD, Magelssen H, Melve K, Jacobsen AB, Langmark F, Skjaerven R (2005)
Parenthood in survivors after adulthood cancer and perinatal health in their offspring: a preliminary report
J Natl Cancer Inst Monogr (34), 77-82
DOI 10.1093/jncimonographs/lgi019, PubMed 15784830

Fosså SD, Paluchowska B, Horwich A, Kaiser G, de Mulder PH, Koriakine O, van Oosterom AT, de Prijck L, Collette L, de Wit R, EORTC GU Group (2005)
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)
Br J Cancer, 93 (11), 1209-14
DOI 10.1038/sj.bjc.6602830, PubMed 16251877

Fosså SD, Wahlqvist R (2005)
[Radical treatment of prostatic cancer in Norway]
Tidsskr Nor Laegeforen, 125 (20), 2834; author reply 2834-5
PubMed 16244698

Grov EK, Dahl AA, Moum T, Fosså SD (2005)
Anxiety, depression, and quality of life in caregivers of patients with cancer in late palliative phase
Ann Oncol, 16 (7), 1185-91
DOI 10.1093/annonc/mdi210, PubMed 15849218

Hernes E, Harvei S, Glattre E, Gjertsen F, Fosså SD (2005)
High prostate cancer mortality in Norway: influence of Cancer Registry information?
APMIS, 113 (7-8), 542-9
DOI 10.1111/j.1600-0463.2005.apm_245.x, PubMed 16086825

Hjermstad MJ, Fosså SD, Oldervoll L, Holte H, Jacobsen AB, Loge JH (2005)
Fatigue in long-term Hodgkin's Disease survivors: a follow-up study
J Clin Oncol, 23 (27), 6587-95
DOI 10.1200/JCO.2005.09.936, PubMed 16170166

Hjermstad MJ, Oldervoll L, Fosså SD, Holte H, Jacobsen AB, Loge JH (2005)
Quality of life in long-term Hodgkin's disease survivors with chronic fatigue
Eur J Cancer, 42 (3), 327-33
DOI 10.1016/j.ejca.2005.09.028, PubMed 16377179

Jones WG, Fossa SD, Mead GM, Roberts JT, Sokal M, Horwich A, Stenning SP (2005)
Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328)
J Clin Oncol, 23 (6), 1200-8
DOI 10.1200/JCO.2005.08.003, PubMed 15718317

Josefsen D, Fosså S (2005)
The management strategies for stage I seminoma
Clin Oncol (R Coll Radiol), 17 (7), 539-42
DOI 10.1016/j.clon.2005.07.002, PubMed 16238141

Lilleby W, Fosså SD (2005)
Chemotherapy in metastatic renal cell cancer
World J Urol, 23 (3), 175-9
DOI 10.1007/s00345-004-0469-x, PubMed 15726382

Lilleby W, Sudbø J, Fosså SD (2005)
[Biology and treatment options during the development of prostate cancer]
Tidsskr Nor Laegeforen, 125 (5), 571-4
PubMed 15776028

Magelssen H, Haugen TB, von Düring V, Melve KK, Sandstad B, Fosså SD (2005)
Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it?
Eur Urol, 48 (5), 779-85
DOI 10.1016/j.eururo.2005.05.002, PubMed 15963629

Mykletun A, Dahl AA, Haaland CF, Bremnes R, Dahl O, Klepp O, Wist E, Fosså SD (2005)
Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer
J Clin Oncol, 23 (13), 3061-8
DOI 10.1200/JCO.2005.08.048, PubMed 15860864

Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Bonaïti-Pellié C, Heidenreich A, Olah E, Geczi L, Bodrogi I, Ormiston WJ, Daly PA, Oosterhuis JW, Gillis AJ, Looijenga LH, Guilford P et al. (2005)
The Y deletion gr/gr and susceptibility to testicular germ cell tumor
Am J Hum Genet, 77 (6), 1034-43
DOI 10.1086/498455, PubMed 16380914

Nilsson S, Larsen RH, Fosså SD, Balteskard L, Borch KW, Westlin JE, Salberg G, Bruland OS (2005)
First clinical experience with alpha-emitting radium-223 in the treatment of skeletal metastases
Clin Cancer Res, 11 (12), 4451-9
DOI 10.1158/1078-0432.CCR-04-2244, PubMed 15958630

Nord C, Mykletun A, Thorsen L, Bjøro T, Fosså SD (2005)
Self-reported health and use of health care services in long-term cancer survivors
Int J Cancer, 114 (2), 307-16
DOI 10.1002/ijc.20713, PubMed 15543613

Røtterud R, Nesland JM, Berner A, Fosså SD (2005)
Expression of the epidermal growth factor receptor family in normal and malignant urothelium
BJU Int, 95 (9), 1344-50
DOI 10.1111/j.1464-410X.2005.05497.x, PubMed 15892828

Sagstuen H, Aass N, Fosså SD, Dahl O, Klepp O, Wist EA, Wilsgaard T, Bremnes RM (2005)
Blood pressure and body mass index in long-term survivors of testicular cancer
J Clin Oncol, 23 (22), 4980-90
DOI 10.1200/JCO.2005.06.882, PubMed 16051950

Skarstein J, Bjelland I, Dahl AA, Laading J, Fosså SD (2005)
Is there an association between haemoglobin, depression, and anxiety in cancer patients?
J Psychosom Res, 58 (6), 477-83
DOI 10.1016/j.jpsychores.2005.02.003, PubMed 16125514

Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fosså SD, Duale N, Brunborg G, Kallioniemi O, Andrews PW, Lothe RA (2005)
Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development
Cancer Res, 65 (13), 5588-98
DOI 10.1158/0008-5472.CAN-05-0153, PubMed 15994931

Sternberg CN, de Mulder P, Schornagel JH, Theodore C, Fossa SD, van Oosterom AT, Witjes JA, Spina M, van Groeningen CJ, Duclos B, Roberts JT, de Balincourt C, Collette L, EORTC Genito-Urinary Cancer Group (2005)
Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours
Eur J Cancer, 42 (1), 50-4
DOI 10.1016/j.ejca.2005.08.032, PubMed 16330205

Thorsen L, Nystad W, Stigum H, Dahl O, Klepp O, Bremnes RM, Wist E, Fosså SD (2005)
The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample
Support Care Cancer, 13 (8), 637-46
DOI 10.1007/s00520-004-0769-0, PubMed 15756585

Thorsen L, Skovlund E, Strømme SB, Hornslien K, Dahl AA, Fosså SD (2005)
Effectiveness of physical activity on cardiorespiratory fitness and health-related quality of life in young and middle-aged cancer patients shortly after chemotherapy
J Clin Oncol, 23 (10), 2378-88
DOI 10.1200/JCO.2005.04.106, PubMed 15800330

Torlakovic E, Lilleby W, Berner A, Torlakovic G, Chibbar R, Furre T, Fosså SD (2005)
Differential expression of steroid receptors in prostate tissues before and after radiation therapy for prostatic adenocarcinoma
Int J Cancer, 117 (3), 381-6
DOI 10.1002/ijc.21174, PubMed 15900599

Travis LB, Fosså SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice JD, Dores GM, Gilbert ES (2005)
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors
J Natl Cancer Inst, 97 (18), 1354-65
DOI 10.1093/jnci/dji278, PubMed 16174857

Yri OE, Bjoro T, Fossa SD (2005)
Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer
Eur Urol, 49 (1), 54-8; discussion 58
DOI 10.1016/j.eururo.2005.09.009, PubMed 16314038

Aass N, De Mulder PH, Mickisch GH, Mulders P, van Oosterom AT, van Poppel H, Fossa SD, de Prijck L, Sylvester RJ (2005)
Randomized phase II/III trial of interferon Alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell Carcinoma: the European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951)
J Clin Oncol, 23 (18), 4172-8
DOI 10.1200/JCO.2005.07.114, PubMed 15961764

Publications 2004

Collette L, van Andel G, Bottomley A, Oosterhof GO, Albrecht W, de Reijke TM, Fossà SD (2004)
Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group
J Clin Oncol, 22 (19), 3877-85
DOI 10.1200/JCO.2004.07.089, PubMed 15459209

Fosså A, Berner A, Fosså SD, Hernes E, Gaudernack G, Smeland EB (2004)
NY-ESO-1 protein expression and humoral immune responses in prostate cancer
Prostate, 59 (4), 440-7
DOI 10.1002/pros.20025, PubMed 15065093

Fosså SD (2004)
Long-term sequelae after cancer therapy--survivorship after treatment for testicular cancer
Acta Oncol, 43 (2), 134-41
DOI 10.1080/02841860310023174, PubMed 15163161

Fosså SD, Magelssen H (2004)
Fertility and reproduction after chemotherapy of adult cancer patients: malignant lymphoma and testicular cancer
Ann Oncol, 15 Suppl 4, iv259-65
DOI 10.1093/annonc/mdh936, PubMed 15477318

Fosså SD, Mickisch GH, De Mulder PH, Horenblas S, van Oosterom AT, van Poppel H, Fey M, Croles JJ, de Prijck L, Van Glabbeke M (2004)
Interferon-alpha-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma
Cancer, 101 (3), 533-40
DOI 10.1002/cncr.20307, PubMed 15274066

Fosså SD, Aass N, Harvei S, Tretli S (2004)
Increased mortality rates in young and middle-aged patients with malignant germ cell tumours
Br J Cancer, 90 (3), 607-12
DOI 10.1038/sj.bjc.6601558, PubMed 14760372

Hernes E, Fosså SD, Berner A, Otnes B, Nesland JM (2004)
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence
Br J Cancer, 90 (2), 449-54
DOI 10.1038/sj.bjc.6601536, PubMed 14735192

Kvåle R, Fosså SD, Halvorsen OJ, Kyrdalen AE, Norstein J, Wahlqvist R (2004)
Kurativ behandling av prostatacancer i Norge 1997-2001: en analyse basert på data innsamlet av Kreftregisteret
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2004, Abstrakt 60
BIBSYS 052031810

Kvåle R, Fosså SD, Kyrdalen AE, Norstein J, Halvorsen OJ, Wahlqvist R (2004)
Prostatakreft i Norge. Insidens, dødelighet og behandling: en deskriptiv analyse av data fra Kreftregisteret
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2004, Abstrakt 61
BIBSYS 052031896

Norderhaug IN, Wisløff T, Fosså S, Sandberg S, Malde K, Forland F, Førde OH (2004)
[Dissemination of evidence-based information about PSA test and prostatic cancer to physicians]
Tidsskr Nor Laegeforen, 124 (22), 2893-5
PubMed 15550959

Rapley EA, Hockley S, Warren W, Johnson L, Huddart R, Crockford G, Forman D, Leahy MG, Oliver DT, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Heidenreich A, Geczi L, Bodrogi I, Olah E, Ormiston WJ, Daly PA, Looijenga LH, Guilford P et al. (2004)
Somatic mutations of KIT in familial testicular germ cell tumours
Br J Cancer, 90 (12), 2397-401
DOI 10.1038/sj.bjc.6601880, PubMed 15150569

Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, Fossa SD, Skakkebaek NE, de Wit R, Fizazi K, Droz JP, Pizzocaro G, Daugaard G, de Mulder PH, Horwich A, Oliver T, Huddart R, Rosti G, Paz Ares L, Pont O, Hartmann JT, Aass N, Algaba F, Bamberg M, Bodrogi I et al. (2004)
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
Ann Oncol, 15 (9), 1377-99
DOI 10.1093/annonc/mdh301, PubMed 15319245

Schröder FH, Kurth KH, Fosså SD, Hoekstra W, Karthaus PP, Debois M, Collette L, Members of the European Organisation for the Research and Treatment of Cancer Genito-urinary Group (2004)
Early versus delayed endocrine treatment of pN1-3 M0 prostate cancer without local treatment of the primary tumor: results of European Organisation for the Research and Treatment of Cancer 30846--a phase III study
J Urol, 172 (3), 923-7
DOI 10.1097/01.ju.0000135742.13171.d2, PubMed 15310999

Stensvold E, Aass N, Gladhaug I, Stenwig AE, Claussen OP, Fosså SD (2004)
Erroneous diagnosis of pancreatic cancer after radiotherapy of testicular cancer
Eur J Surg Oncol, 30 (3), 352-5
DOI 10.1016/j.ejso.2003.09.006, PubMed 15028321

Wahlqvist R, Kvåle R, Kyrdalen AE, Halvorsen OJ, Norstein J, Fosså SD (2004)
Utvidet registrering av prostatakreft i Norge
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2004, Abstrakt 53
BIBSYS 05203268x

Aass N, Fosså SD (2004)
Pre- and post-treatment daily life function in patients with hormone resistant prostate carcinoma treated with radiotherapy for spinal cord compression
Radiother Oncol, 74 (3), 259-65
DOI 10.1016/j.radonc.2004.12.001, PubMed 15763306

Publications 2003

Bokemeyer C, Hartmann JT, Fossa SD, Droz JP, Schmol HJ, Horwich A, Gerl A, Beyer J, Pont J, Kanz L, Nichols CR, Einhorn L (2003)
Extragonadal germ cell tumors: relation to testicular neoplasia and management options
APMIS, 111 (1), 49-59; discussion 59-63
DOI 10.1034/j.1600-0463.2003.11101081.x, PubMed 12752235

Christian JA, Huddart RA, Norman A, Mason M, Fossa S, Aass N, Nicholl EJ, Dearnaley DP, Horwich A (2003)
Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors
J Clin Oncol, 21 (5), 871-7
DOI 10.1200/JCO.2003.05.155, PubMed 12610187

Fossa SD, Dahl AA, Loge JH (2003)
Fatigue, anxiety and depression in long-term survivors oftesticular cancer
In Journal of clinical oncology, The Society, Alexandria VA, 21(2003)7, s.1249-54
BIBSYS 041709357

Fosså SD, Dahl AA, Loge JH (2003)
Fatigue, anxiety, and depression in long-term survivors of testicular cancer
J Clin Oncol, 21 (7), 1249-54
DOI 10.1200/JCO.2003.08.163, PubMed 12663711

Fosså SD, de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, Cook P, de Prijck L, Stenning S, Aaronson NK, Bottomley A, Collette L, European Organization for Research and Treatment of Cancer Genitourinary Group 30941, Medical Research Council Testicular Cancer Study Group TE20 (2003)
Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20)
J Clin Oncol, 21 (6), 1107-18
DOI 10.1200/JCO.2003.02.075, PubMed 12637478

Fosså SD, Lilleby W, Waehre H, Berner A, Torlakovic G, Paus E, Olsen DR (2003)
Definitive radiotherapy of prostate cancer: the possible role of staging lymphadenectomy
Int J Radiat Oncol Biol Phys, 57 (1), 33-41
DOI 10.1016/s0360-3016(03)00428-0, PubMed 12909213

Fosså SD, Aass N, Heilo A, Daugaard G, E Skakkebaek N, Stenwig AE, Nesland JM, Looijenga LH, Oosterhuis JW (2003)
Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: the clinical role of pretreatment biopsy
Ann Oncol, 14 (9), 1412-8
DOI 10.1093/annonc/mdg373, PubMed 12954581

Guren MG, Dueland S, Skovlund E, Fosså SD, Poulsen JP, Tveit KM (2003)
Quality of life during radiotherapy for rectal cancer
Eur J Cancer, 39 (5), 587-94
DOI 10.1016/s0959-8049(02)00741-4, PubMed 12628837

Hernes E, Fosså SD, Skovlund E (2003)
Androgen-independent prostate cancer--the clinical problem of a growing pelvic tumour
Acta Oncol, 42 (7), 749-55
DOI 10.1080/02841860310014624, PubMed 14690161

Hvamstad T, Jordal A, Hekmat N, Paus E, Fosså SD (2003)
Neuroendocrine serum tumour markers in hormone-resistant prostate cancer
Eur Urol, 44 (2), 215-21
DOI 10.1016/s0302-2838(03)00257-4, PubMed 12875941

Kraggerud SM, Lee MP, Skotheim RI, Stenwig AE, Fosså SD, Feinberg AP, Lothe RA (2003)
Lack of parental origin specificity of altered alleles at 11p15 in testicular germ cell tumors
Cancer Genet Cytogenet, 147 (1), 1-8
DOI 10.1016/s0165-4608(03)00160-2, PubMed 14580764

Lilleby W, Dale E, Olsen DR, Gude U, Fosså SD (2003)
Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose
Acta Oncol, 42 (1), 10-4
DOI 10.1080/0891060310002177, PubMed 12665325

Lilleby W, Nesland JM, Fosså SD, Torlakovic G, Waehre H, Kvalheim G (2003)
The prognostic impact of cytokeratin-positive cells in bone marrow of patients with localized prostate cancer
Int J Cancer, 103 (1), 91-6
DOI 10.1002/ijc.10780, PubMed 12455058

Looijenga LH, de Leeuw H, van Oorschot M, van Gurp RJ, Stoop H, Gillis AJ, de Gouveia Brazao CA, Weber RF, Kirkels WJ, van Dijk T, von Lindern M, Valk P, Lajos G, Olah E, Nesland JM, Fosså SD, Oosterhuis JW (2003)
Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors
Cancer Res, 63 (22), 7674-8
PubMed 14633689

Nord C, Bjøro T, Ellingsen D, Mykletun A, Dahl O, Klepp O, Bremnes RM, Wist E, Fosså SD (2003)
Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer
Eur Urol, 44 (3), 322-8
DOI 10.1016/s0302-2838(03)00263-x, PubMed 12932930

Nord C, Fosså SD, Egeland T (2003)
Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer
Br J Cancer, 88 (1), 36-41
DOI 10.1038/sj.bjc.6600714, PubMed 12556956

Nord C, Mykletun A, Fosså SD (2003)
Cancer patients' awareness about their diagnosis: a population-based study
J Public Health Med, 25 (4), 313-7
DOI 10.1093/pubmed/fdg076, PubMed 14747590

Norderhaug IN, Sandberg S, Fosså SD, Forland F, Malde K, Kvinnsland S, Traaholt I, Rossiné BK, Førde OH (2003)
Health technology assessment and implications for clinical practice: the case of prostate cancer screening
Scand J Clin Lab Invest, 63 (5), 331-8
DOI 10.1080/00365510310002022, PubMed 14599155

Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD (2003)
Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses
J Clin Oncol, 21 (17), 3310-7
DOI 10.1200/JCO.2003.03.184, PubMed 12947067

Rustøen T, Fosså SD, Skarstein J, Moum T (2003)
The impact of demographic and disease-specific variables on pain in cancer patients
J Pain Symptom Manage, 26 (2), 696-704
DOI 10.1016/s0885-3924(03)00239-2, PubMed 12906954

Skotheim RI, Abeler VM, Nesland JM, Fosså SD, Holm R, Wagner U, Flørenes VA, Aass N, Kallioniemi OP, Lothe RA (2003)
Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays
Neoplasia, 5 (5), 397-404
DOI 10.1016/s1476-5586(03)80042-8, PubMed 14670177

Skotheim RI, Korkmaz KS, Klokk TI, Abeler VM, Korkmaz CG, Nesland JM, Fosså SD, Lothe RA, Saatcioglu F (2003)
NKX3.1 expression is lost in testicular germ cell tumors
Am J Pathol, 163 (6), 2149-54
DOI 10.1016/S0002-9440(10)63571-7, PubMed 14633588

Smeland S, Erikstein B, Aas M, Skovlund E, Hess SL, Fosså SD (2003)
Role of strontium-89 as adjuvant to palliative external beam radiotherapy is questionable: results of a double-blind randomized study
Int J Radiat Oncol Biol Phys, 56 (5), 1397-404
DOI 10.1016/s0360-3016(03)00274-8, PubMed 12873686

Thorsen L, Nystad W, Dahl O, Klepp O, Bremnes RM, Wist E, Fosså SD (2003)
The level of physical activity in long-term survivors of testicular cancer
Eur J Cancer, 39 (9), 1216-21
DOI 10.1016/s0959-8049(03)00151-5, PubMed 12763208

Wahlqvist R, Fosså SD, Kyrdalen AE, Strand TE, Skarre E, Norstein J (2003)
Nasjonalt program for prostatacancer (NPPC): målsetting, oppstart og de første erfaringer
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2003, Abstrakt 47
BIBSYS 041735668

Widmark A, Fosså SD, Lundmo P, Damber JE, Vaage S, Damber L, Wiklund F, Klepp O (2003)
Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3
Urology, 61 (1), 145-51
DOI 10.1016/s0090-4295(02)02107-6, PubMed 12559286

Publications 2002

Beyer J, Stenning S, Gerl A, Fossa S, Siegert W (2002)
High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis
Ann Oncol, 13 (4), 599-605
DOI 10.1093/annonc/mdf112, PubMed 12056711

Bokemeyer C, Nichols CR, Droz JP, Schmoll HJ, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Kanz L, Einhorn L, Hartmann JT (2002)
Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis
J Clin Oncol, 20 (7), 1864-73
DOI 10.1200/JCO.2002.07.062, PubMed 11919246

Curran D, Molenberghs G, Aaronson NK, Fossa SD, Sylvester RJ (2002)
Analysing longitudinal continuous quality of life data with dropout
Stat Methods Med Res, 11 (1), 5-23
DOI 10.1191/0962280202sm270ra, PubMed 11923994

Fodstad P, Bjøro T, Torlakovic G, Fossa SD (2002)
No association of serum gonadal or pituitary hormones with prognostic parameters in stages T1 to T3 PN0M0 prostate cancer
J Urol, 168 (3), 1188-92
DOI 10.1016/S0022-5347(05)64623-X, PubMed 12187265

Fosså A, Lilleby W, Fosså SD, Gaudernack G, Torlakovic G, Berner A (2002)
Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy
Int J Cancer, 99 (1), 100-5
DOI 10.1002/ijc.10286, PubMed 11948499

Fosså SD (2002)
Kreft og seksualitet: informasjon til pasienter og andre interesserte
In Kreftinfo, Den norske kreftforening, Oslo, 1/2002 (5. oppl.), 32 s.
BIBSYS 02249751x

Fosså SD, Dahl AA (2002)
Short Form 36 and Hospital Anxiety and Depression Scale. A comparison based on patients with testicular cancer
J Psychosom Res, 52 (2), 79-87
DOI 10.1016/s0022-3999(01)00308-7, PubMed 11832253

Fosså SD, Dahl AA (2002)
Short Form 36 and Hospital Anxiety and Depression Scale: a comparison based on patients with testicular cancer
In Journal of psychosomatic research, Elsevier, New York, 52(2002)nr 2, s. 79-87
BIBSYS 03128129x

Fosså SD, Skovlund E (2002)
Selection of patients may limit the generalizability of results from cancer trials
Acta Oncol, 41 (2), 131-7
DOI 10.1080/028418602753669490, PubMed 12102156

Fosså SD, Vaage S, Letocha H, Iversen J, Risberg T, Johannessen DC, Paus E, Smedsrud T, Norwegian Urological Cancer Group (2002)
Liposomal doxorubicin (Caelyx) in symptomatic androgen-independent prostate cancer (AIPC)--delayed response and flare phenomenon should be considered
Scand J Urol Nephrol, 36 (1), 34-9
DOI 10.1080/003655902317259346, PubMed 12002355

Fosså SD, Aass N (2002)
Testikkelkreft: informasjon til pasienter, pårørende og andre interesserte
In Kreftinfo, Den norske kreftforening, Oslo, 3/2002, 33 s.
BIBSYS 022497250

Fosså SD, Aass N, Winderen M, Börmer OP, Olsen DR (2002)
Long-term renal function after treatment for malignant germ-cell tumours
Ann Oncol, 13 (2), 222-8
DOI 10.1093/annonc/mdf048, PubMed 11885998

Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Kanz L, Einhorn L, Bokemeyer C (2002)
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors
Ann Oncol, 13 (7), 1017-28
DOI 10.1093/annonc/mdf176, PubMed 12176779

Jacobsen KD, Fosså SD, Bjøro TP, Aass N, Heilo A, Stenwig AE (2002)
Gonadal function and fertility in patients with bilateral testicular germ cell malignancy
Eur Urol, 42 (3), 229-38; discussion 237-8
DOI 10.1016/s0302-2838(02)00274-9, PubMed 12234507

Kraggerud SM, Aman P, Holm R, Stenwig AE, Fosså SD, Nesland JM, Lothe RA (2002)
Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis
Cancer Res, 62 (2), 512-7
PubMed 11809703

Kraggerud SM, Skotheim RI, Szymanska J, Eknaes M, Fosså SD, Stenwig AE, Peltomäki P, Lothe RA (2002)
Genome profiles of familial/bilateral and sporadic testicular germ cell tumors
Genes Chromosomes Cancer, 34 (2), 168-74
DOI 10.1002/gcc.10058, PubMed 11979550

Kvarstein B, Fosså SD, Harvei S (2002)
[Diagnosis and treatment of penile cancer]
Tidsskr Nor Laegeforen, 122 (12), 1194-7
PubMed 12089846

Nesvold IL, Fosså SD (2002)
[Lymphedema after surgical treatment of cervical and vulvar cancer]
Tidsskr Nor Laegeforen, 122 (26), 2531-3
PubMed 12522877

Røtterud R, Pettersen EO, Berner A, Holm R, Olsen DR, Fosså SD (2002)
Cell cycle inhibitors and outcome after radiotherapy in bladder cancer patients
Acta Oncol, 41 (5), 463-70
DOI 10.1080/028418602320405069, PubMed 12442923

Skarstein J, Dahl AA, Laading J, Fosså SD (2002)
'Patient satisfaction' in hospitalized cancer patients
Acta Oncol, 41 (7-8), 639-45
DOI 10.1080/028418602321028256, PubMed 14651208

Skarstein J, Dahl AA, Laading J, Fosså SD (2002)
"Patient satisfaction" in Hospitalized Cancer Patients
In Acta oncologica, Taylor & Francis, Basingstoke, 41(2002)nr 7, s. 639-645
BIBSYS 031282660

Skotheim RI, Monni O, Mousses S, Fosså SD, Kallioniemi OP, Lothe RA, Kallioniemi A (2002)
New insights into testicular germ cell tumorigenesis from gene expression profiling
Cancer Res, 62 (8), 2359-64
PubMed 11956097

Smith-Sørensen B, Lind GE, Skotheim RI, Fosså SD, Fodstad Ø, Stenwig AE, Jakobsen KS, Lothe RA (2002)
Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer
Oncogene, 21 (57), 8878-84
DOI 10.1038/sj.onc.1205978, PubMed 12483540

Torlakovic E, Lilleby W, Torlakovic G, Fosså SD, Chibbar R (2002)
Prostate carcinoma expression of estrogen receptor-beta as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score
Hum Pathol, 33 (6), 646-51
DOI 10.1053/hupa.2002.124033, PubMed 12152165

Ustün M, Heilo A, Fosså S, Aass N, Berner A (2002)
Ultrasound-guided fine needle cytology of retroperitoneal masses in patients with malignant germ cell tumours: diagnosis and therapeutic impact
Eur Urol, 42 (3), 221-8; discussion 228
DOI 10.1016/s0302-2838(02)00310-x, PubMed 12234506

Publications 2001

Bokemeyer C, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Schmoll HJ, Kanz L, Einhorn L, Nichols CR, Hartmann JT (2001)
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome
Cancer, 91 (7), 1394-401
PubMed 11283942

de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, Fosså SD, Cook P, de Prijck L, Stenning S, Collette L (2001)
Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council
J Clin Oncol, 19 (6), 1629-40
DOI 10.1200/JCO.2001.19.6.1629, PubMed 11250991

Fosså SD, Eri LM, Skovlund E, Tveter K, Vatten L, Norwegian Urological Cancer Group (2001)
No randomised trial of prostate-cancer screening in Norway
Lancet Oncol, 2 (12), 741-5; discussion 746-9
DOI 10.1016/S1470-2045(01)00588-5, PubMed 11902516

Fosså SD, Slee PH, Brausi M, Horenblas S, Hall RR, Hetherington JW, Aaronson N, de Prijck L, Collette L (2001)
Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group
J Clin Oncol, 19 (1), 62-71
DOI 10.1200/JCO.2001.19.1.62, PubMed 11134196

Guren MG, Wiig JN, Dueland S, Tveit KM, Fosså SD, Waehre H, Giercksky KE (2001)
Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer
Eur J Surg Oncol, 27 (7), 645-51
DOI 10.1053/ejso.2001.1195, PubMed 11669593

Hartmann JT, Einhorn L, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Schmoll HJ, Kanz L, Bokemeyer C (2001)
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis
J Clin Oncol, 19 (6), 1641-8
DOI 10.1200/JCO.2001.19.6.1641, PubMed 11250992

Hartmann JT, Fossa SD, Nichols CR, Droz JP, Horwich A, Gerl A, Beyer J, Pont J, Fizazi K, Hecker H, Kanz L, Einhorn L, Bokemeyer C (2001)
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors
J Natl Cancer Inst, 93 (22), 1733-8
DOI 10.1093/jnci/93.22.1733, PubMed 11717334

Jacobsen KD, Theodorsen L, Fossa SD (2001)
Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy
J Urol, 165 (1), 93-6
DOI 10.1097/00005392-200101000-00023, PubMed 11125372

Lilleby W, Paus E, Skovlund E, Fosså SD (2001)
Prognostic value of neuroendocrine serum markers and PSA in irradiated patients with pN0 localized prostate cancer
Prostate, 46 (2), 126-33
DOI 10.1002/1097-0045(20010201)46:2<126::aid-pros1016>3.0.co;2-7, PubMed 11170140

Lilleby W, Torlakovic G, Torlakovic E, Skovlund E, Fosså SD (2001)
Prognostic significance of histologic grading in patients with prostate carcinoma who are assessed by the Gleason and World Health Organization grading systems in needle biopsies obtained prior to radiotherapy
Cancer, 92 (2), 311-9
DOI 10.1002/1097-0142(20010715)92:2<311::aid-cncr1324>3.0.co;2-h, PubMed 11466684

Røtterud R, Berner A, Holm R, Skovlund E, Fosså SD (2001)
p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder
BJU Int, 88 (3), 202-8
DOI 10.1046/j.1464-410x.2001.02268.x, PubMed 11488730

Røtterud R, Skomedal H, Berner A, Danielsen HE, Skovlund E, Fosså SD (2001)
TP53 and p21WAF1/CIP1 behave differently in euploid versus aneuploid bladder tumours treated with radiotherapy
Acta Oncol, 40 (5), 644-52
DOI 10.1080/028418601750444213, PubMed 11669339

Skotheim RI, Kraggerud SM, Fosså SD, Stenwig AE, Gedde-Dahl T, Danielsen HE, Jakobsen KS, Lothe RA (2001)
Familial/bilateral and sporadic testicular germ cell tumors show frequent genetic changes at loci with suggestive linkage evidence
Neoplasia, 3 (3), 196-203
DOI 10.1038/sj.neo.7900153, PubMed 11494113

Sternberg CN, de Mulder PH, Schornagel JH, Théodore C, Fossa SD, van Oosterom AT, Witjes F, Spina M, van Groeningen CJ, de Balincourt C, Collette L, European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group (2001)
Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924
J Clin Oncol, 19 (10), 2638-46
DOI 10.1200/JCO.2001.19.10.2638, PubMed 11352955

Publications 2000

Cappelen T, Fosså SD, Stenwig AE, Aass N (2000)
False-negative biopsy for testicular intraepithelial neoplasia and high-risk features for testicular cancer
Acta Oncol, 39 (1), 105-9
DOI 10.1080/028418600431067, PubMed 10752663

Clobes H, Fossâ SD, Waehre H, Jocham D, Berner A (2000)
The immunohistochemical assessment of occult regional lymph node metastases in patients with T3pN0M0 prostate cancer before definitive radiotherapy
BJU Int, 85 (3), 270-5
DOI 10.1046/j.1464-410x.2000.00406.x, PubMed 10671880

Duchesne GM, Bolger JJ, Griffiths GO, Trevor Roberts J, Graham JD, Hoskin PJ, Fossâ SD, Uscinska BM, Parmar MK (2000)
A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09
Int J Radiat Oncol Biol Phys, 47 (2), 379-88
DOI 10.1016/s0360-3016(00)00430-2, PubMed 10802363

Fossâ SD, Skovlund E (2000)
Interim analyses in clinical trials: why do we plan them?
J Clin Oncol, 18 (24), 4007-8
DOI 10.1200/JCO.2000.18.24.4007, PubMed 11118460

Fosså A, Siebert R, Aasheim HC, Maelandsmo GM, Berner A, Fosså SD, Paus E, Smeland EB, Gaudernack G (2000)
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer
Br J Cancer, 83 (6), 743-9
DOI 10.1054/bjoc.2000.1365, PubMed 10952778

Fosså SD (2000)
Interferon in metastatic renal cell carcinoma
Semin Oncol, 27 (2), 187-93
PubMed 10768597

Fosså SD, Curran D, Aaronson NK, Keuppens F, Kliment J, Robinson MR, DeReijke TM, Hetherington J, Kil PJ, Rea LA (2000)
Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C. Results from the EORTC Phase-III trial 30893
Eur Urol, 37 (5), 541-51
DOI 10.1159/000020191, PubMed 10765092

Fosså SD, Kravdal O (2000)
Fertility in Norwegian testicular cancer patients
Br J Cancer, 82 (3), 737-41
DOI 10.1054/bjoc.1999.0989, PubMed 10682691

Fosså SD, Aass N, Tveter K, Dahl O (2000)
[Treatment of renal carcinoma with distant metastases]
Tidsskr Nor Laegeforen, 120 (19), 2274-8
PubMed 10997087

Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Einhorn L, Kanz L, Bokemeyer C (2000)
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors
Cancer, 88 (11), 2629-35
DOI 10.1002/1097-0142(20000601)88:11<2629::AID-CNCR27>3.3.CO;2-6, PubMed 10861442

Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Fizazi K, Einhorn L, Kanz L, Bokemeyer C (2000)
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors
J Natl Cancer Inst, 92 (1), 54-61
DOI 10.1093/jnci/92.1.54, PubMed 10620634

Hernandez AM, Fosså SD, Brøgger A, Kat A, Skovlund E (2000)
Chromosome aberrations after etoposide containing cisplatin-based chemotherapy for malignant germ-cell tumours
Ann Oncol, 11 (7), 897-8
DOI 10.1023/a:1008311532043, PubMed 10997823

Hernes EH, Linja M, Fosså SD, Visakorpi T, Berner A, Winderen M, Koivisto PA (2000)
Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors
BJU Int, 86 (3), 240-7
DOI 10.1046/j.1464-410x.2000.00767.x, PubMed 10930923

Horwich A, Oliver RT, Wilkinson PM, Mead GM, Harland SJ, Cullen MH, Roberts JT, Fossa SD, Dearnaley DP, Lallemand E, Stenning SP, MRC Testicular Tumour Working Party (2000)
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party
Br J Cancer, 83 (12), 1623-9
DOI 10.1054/bjoc.2000.1498, PubMed 11104556

Jacobsen KD, Fosså SD (2000)
Fatherhood in testicular cancer patients with carcinoma in situ in the contralateral testicle
Eur Urol, 38 (6), 725-6;discussion 727
DOI 10.1159/000020369, PubMed 11111191

Lilleby W, Fosså SD, Knutsen BH, Abildgaard A, Skovlund E, Lien HH (2000)
Computed tomography/magnetic resonance based volume changes of the primary tumour in patients with prostate cancer with or without androgen deprivation
Radiother Oncol, 57 (2), 195-200
DOI 10.1016/s0167-8140(00)00219-x, PubMed 11054523

Nord C, Fosså SD, Giercksky KE (2000)
Gastrointestinal presentation of germ cell malignancy
Eur Urol, 38 (6), 721-4
DOI 10.1159/000020368, PubMed 11111190

Rapley EA, Crockford GP, Teare D, Biggs P, Seal S, Barfoot R, Edwards S, Hamoudi R, Heimdal K, Fossâ SD, Tucker K, Donald J, Collins F, Friedlander M, Hogg D, Goss P, Heidenreich A, Ormiston W, Daly PA, Forman D, Oliver TD, Leahy M, Huddart R, Cooper CS, Bodmer JG et al. (2000)
Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours
Nat Genet, 24 (2), 197-200
DOI 10.1038/72877, PubMed 10655070

Rørth M, Rajpert-De Meyts E, Andersson L, Dieckmann KP, Fosså SD, Grigor KM, Hendry WF, Herr HW, Looijenga LH, Oosterhuis JW, Skakkebaek NE (2000)
Carcinoma in situ in the testis
Scand J Urol Nephrol Suppl (205), 166-86
DOI 10.1080/00365590050509896, PubMed 11144894

Skarstein J, Aass N, Fosså SD, Skovlund E, Dahl AA (2000)
Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire
J Psychosom Res, 49 (1), 27-34
DOI 10.1016/s0022-3999(00)00080-5, PubMed 11053601

Skarstein J, Aass N, Fosså SD, Skovlund E, Dahl AA (2000)
Anxiety and depression in cancer patients : relation between the hospital anxiety and depression scale and the european organization for research and treatment of cancer core quality of life questionnaire
In Journal of psychosomatic research, Elsevier, New York, s. 27-34
BIBSYS 01070535x

Skovlund E, Fosså SD (2000)
[PSA analyses in three Norwegian counties in 1999]
Tidsskr Nor Laegeforen, 120 (21), 2539-41
PubMed 11070992

Steyerberg EW, Keizer HJ, Sleijfer DT, Fossâ SD, Bajorin DF, Gerl A, de Wit R, Kirkels WJ, Koops HS, Habbema JD (2000)
Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy
Radiology, 215 (2), 437-44
DOI 10.1148/radiology.215.2.r00ma02437, PubMed 10796922

Publications 1999

Collette L, Sylvester RJ, Stenning SP, Fossa SD, Mead GM, de Wit R, de Mulder PH, Neymark N, Lallemand E, Kaye SB (1999)
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party
J Natl Cancer Inst, 91 (10), 839-46
DOI 10.1093/jnci/91.10.839, PubMed 10340903

Dale E, Olsen DR, Fosså SD (1999)
Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy
Int J Radiat Oncol Biol Phys, 43 (2), 385-91
DOI 10.1016/s0360-3016(98)00400-3, PubMed 10030266

Fossa S, Horwich A (1999)
Is "optimal" radiation for stage I seminoma yet defined? In reply
J. Clin. Oncol., 17 (9), 3005

Fosså SD (1999)
Good quality of life in prostate cancer patients: how can it be obtained?
Scand J Urol Nephrol Suppl, 203, 51-2
DOI 10.1080/003655999750169385-1, PubMed 10636571

Fosså SD, Bokemeyer C, Gerl A, Culine S, Jones WG, Mead GM, Germa-Luch JR, Pont J, Schmoll HJ, Tjulandin S (1999)
Treatment outcome of patients with brain metastases from malignant germ cell tumors
Cancer, 85 (4), 988-97
DOI 10.1002/(sici)1097-0142(19990215)85:4<988::aid-cncr29>3.0.co;2-r, PubMed 10091779

Fosså SD, Dahl AA, Haaland CF (1999)
Health-related quality of life in patients treated for testicular cancer
Curr Opin Urol, 9 (5), 425-9
DOI 10.1097/00042307-199909000-00010, PubMed 10579081

Fosså SD, Eri LM (1999)
[Timely screening routines for prostatic cancer by Norwegian physicians]
Tidsskr Nor Laegeforen, 119 (24), 3572-6
PubMed 10563174

Fosså SD, Horwich A, Russell JM, Roberts JT, Cullen MH, Hodson NJ, Jones WG, Yosef H, Duchesne GM, Owen JR, Grosch EJ, Chetiyawardana AD, Reed NS, Widmer B, Stenning SP (1999)
Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group
J Clin Oncol, 17 (4), 1146
DOI 10.1200/JCO.1999.17.4.1146, PubMed 10561173

Fosså SD, Opjordsmoen S, Haug E (1999)
Androgen replacement and quality of life in patients treated for bilateral testicular cancer
Eur J Cancer, 35 (8), 1220-5
DOI 10.1016/s0959-8049(99)00123-9, PubMed 10615233

Fosså SD, Stenning SP, Gerl A, Horwich A, Clark PI, Wilkinson PM, Jones WG, Williams MV, Oliver RT, Newlands ES, Mead GM, Cullen MH, Kaye SB, Rustin GJ, Cook PA (1999)
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
Br J Cancer, 80 (9), 1392-9
DOI 10.1038/sj.bjc.6690534, PubMed 10424741

Jacobsen KD, Ous S, Waehre H, Trasti H, Stenwig AE, Lien HH, Aass N, Fosså SD (1999)
Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection
Br J Cancer, 80 (1-2), 249-55
DOI 10.1038/sj.bjc.6690347, PubMed 10390004

Kraggerud SM, Berner A, Bryne M, Pettersen EO, Fossa SD (1999)
Spermatocytic seminoma as compared to classical seminoma: an immunohistochemical and DNA flow cytometric study
APMIS, 107 (3), 297-302
DOI 10.1111/j.1699-0463.1999.tb01557.x, PubMed 10223302

Lilleby W, Fosså SD, Waehre HR, Olsen DR (1999)
Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy
Int J Radiat Oncol Biol Phys, 43 (4), 735-43
DOI 10.1016/s0360-3016(98)00475-1, PubMed 10098428

Litwin MS, Fitzpatrick JM, Fossa SD, Newling DW (1999)
Defining an international research agenda for quality of life in men with prostate cancer
Prostate, 41 (1), 58-67
DOI 10.1002/(sici)1097-0045(19990915)41:1<58::aid-pros8>3.0.co;2-3, PubMed 10440876

Ogreid P, Berner A, Dahl O, Rettedal E, Fosså SD (1999)
Tissue prostate-specific antigen and androgen receptor immunoreactivity in prostate cancer biopsies before, during and after neo-adjuvant androgen deprivation followed by radiotherapy
Eur Urol, 36 (2), 116-22
DOI 10.1159/000067982, PubMed 10420032

Raabe NK, Sauer T, Erichsen A, Nesland JM, Fossaa SD (1999)
Breast cancer in the contralateral breast: incidence and histopathology after unilateral radical treatment of the first breast cancer
Oncol Rep, 6 (5), 1001-7
DOI 10.3892/or.6.5.1001, PubMed 10425294

Publications 1998

Avizienyte E, Roth S, Loukola A, Hemminki A, Lothe RA, Stenwig AE, Fosså SD, Salovaara R, Aaltonen LA (1998)
Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors
Cancer Res, 58 (10), 2087-90
PubMed 9605748

Boffetta P, Fichtinger-Schepman AM, Weiderpass E, van Dijk-Knijnenburg HC, Stoter G, van Oosterom AT, Keizer HJ, Fosså SD, Kaldor J, Roy P (1998)
Cisplatin-DNA adducts and protein-bound platinum in blood of testicular cancer patients
Anticancer Drugs, 9 (2), 125-9
DOI 10.1097/00001813-199802000-00002, PubMed 9510497

Dueland S, Stenwig AE, Heilo A, Høie J, Ous S, Fosså SD (1998)
Treatment and outcome of patients with extragonadal germ cell tumours--the Norwegian Radium Hospital's experience 1979-94
Br J Cancer, 77 (2), 329-35
DOI 10.1038/bjc.1998.51, PubMed 9461006

Fosså SD, Kaye SB, Mead GM, Cullen M, de Wit R, Bodrogi I, van Groeningen CJ, De Mulder PH, Stenning S, Lallemand E, De Prijck L, Collette L (1998)
Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom
J Clin Oncol, 16 (2), 716-24
DOI 10.1200/JCO.1998.16.2.716, PubMed 9469362

Fosså SD, Aass N, Parö G (1998)
A phase II study of DaunoXome in advanced urothelial transitional cell carcinoma
Eur J Cancer, 34 (7), 1131-2
DOI 10.1016/s0959-8049(97)10156-3, PubMed 9849467

Harland SJ, Cook PA, Fossa SD, Horwich A, Mead GM, Parkinson MC, Roberts JT, Stenning SP (1998)
Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group
J Urol, 160 (4), 1353-7
PubMed 9751353

Ilner K, Blomlie V, Fosså SD (1998)
Radiation-induced insufficiency fractures after definitive prostate cancer radiotherapy
Acta Oncol, 37 (2), 201-2
DOI 10.1080/028418698429775, PubMed 9636016

Kaye SB, Mead GM, Fossa S, Cullen M, deWit R, Bodrogi I, van Groeningen C, Sylvester R, Collette L, Stenning S, De Prijck L, Lallemand E, deMulder P (1998)
Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study
J Clin Oncol, 16 (2), 692-701
DOI 10.1200/JCO.1998.16.2.692, PubMed 9469359

Osen I, Fosså SD, Majak B, Røtterud R, Berner A (1998)
Prognostic factors in muscle-invasive bladder cancer treated with radiotherapy: an immunohistochemical study
Br J Urol, 81 (6), 862-9
DOI 10.1046/j.1464-410x.1998.00657.x, PubMed 9666772

Otnes B, Hernes E, Fosså SD (1998)
[Prostate-specific antigen in the follow-up of conservatively treated prostatic cancer]
Tidsskr Nor Laegeforen, 118 (22), 3401-5
PubMed 9800488

Paus E, Nilsson O, Børmer OP, Fosså SD, Otnes B, Skovlund E (1998)
Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia
J Urol, 159 (5), 1599-605
DOI 10.1097/00005392-199805000-00051, PubMed 9554362

Raabe NK, Hagen S, Haug E, Fossaa SD (1998)
Hormone receptor measurements and survival in 1335 consecutive patients with primary invasive breast carcinoma
Int J Oncol, 12 (5), 1091-6
DOI 10.3892/ijo.12.5.1091, PubMed 9538134

Stenning SP, Parkinson MC, Fisher C, Mead GM, Cook PA, Fossa SD, Horwich A, Jones WG, Newlands ES, Oliver RT, Stenwig AE, Wilkinson PM (1998)
Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party
Cancer, 83 (7), 1409-19
DOI 10.1002/(SICI)1097-0142(19981001)83:7<1409::AID-CNCR19>3.3.CO;2-1, PubMed 9762943

Steyerberg EW, Gerl A, Fossá SD, Sleijfer DT, de Wit R, Kirkels WJ, Schmeller N, Clemm C, Habbema JD, Keizer HJ (1998)
Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer
J Clin Oncol, 16 (1), 269-74
DOI 10.1200/JCO.1998.16.1.269, PubMed 9440752

Wanderås EH, Grotmol T, Fosså SD, Tretli S (1998)
Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective population- and register-based study on Norwegian males born between 1967 and 1995
Cancer Causes Control, 9 (5), 475-86
DOI 10.1023/a:1008857702380, PubMed 9934714

Aass N, Fosså SD, Dahl AA, Moe TJ (1998)
[Occurrence of anxiety and depression in cancer patients. An investigation at the Norwegian Radium Hospital]
Tidsskr Nor Laegeforen, 118 (5), 698-703
PubMed 9528365

Publications 1997

Altwein J, Ekman P, Barry M, Biermann C, Carlsson P, Fosså S, Kiebert G, Küchler T, McLeod D, Porter A, Steineck G (1997)
How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium
Urology, 49 (4A Suppl), 66-76
DOI 10.1016/s0090-4295(99)80325-2, PubMed 9111616

Curran D, Fossa S, Aaronson N, Kiebert G, Keuppens F, Hall R (1997)
Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG)
Eur J Cancer, 33 (11), 1809-14
DOI 10.1016/s0959-8049(97)00187-1, PubMed 9470838

de Wit R, Pawinsky A, Stoter G, van Oosterom AT, Fosså SD, Paridaens R, Svedberg A, de Mulder PH (1997)
EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factors
Eur J Cancer, 33 (3), 493-5
DOI 10.1016/s0959-8049(97)89027-2, PubMed 9155537

Duchesne GM, Stenning SP, Aass N, Mead GM, Fosså SD, Oliver RT, Horwich A, Read G, Roberts IT, Rustin G, Cullen MH, Kaye SB, Harland SJ, Cook PA (1997)
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party
Eur J Cancer, 33 (6), 829-35
DOI 10.1016/s0959-8049(97)00033-6, PubMed 9291801

Fosså SD (1997)
Residual androgen depending in hormone-resistant prostate cancer
Acta Oncol, 36 (1), 81-2
DOI 10.3109/02841869709100739, PubMed 9090973

Fosså SD, De Angelis P, Kraggerud SM, Evenson D, Theodorsen L, Clausen OP (1997)
Prediction of posttreatment spermatogenesis in patients with testicular cancer by flow cytometric sperm chromatin structure assay
Cytometry, 30 (4), 192-6
PubMed 9298838

Fosså SD, Horwich A (1997)
Current status of chemotherapy in advanced seminoma
Eur J Cancer, 33 (2), 181-3
DOI 10.1016/s0959-8049(96)00281-x, PubMed 9135484

Fosså SD, Oliver RT, Stenning SP, Horwich A, Wilkinson P, Read G, Mead GM, Roberts JT, Rustin G, Cullen MH, Kaye SB, Harland SJ, Cook P (1997)
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy
Eur J Cancer, 33 (9), 1380-7
DOI 10.1016/s0959-8049(96)00425-x, PubMed 9337678

Fosså SD, Woehre H, Kurth KH, Hetherington J, Bakke H, Rustad DA, Skånvik R (1997)
Influence of urological morbidity on quality of life in patients with prostate cancer
Eur Urol, 31 Suppl 3, 3-8
DOI 10.1159/000474553, PubMed 9101208

Heimdal K, Olsson H, Tretli S, Fosså SD, Børresen AL, Bishop DT (1997)
A segregation analysis of testicular cancer based on Norwegian and Swedish families
Br J Cancer, 75 (7), 1084-7
DOI 10.1038/bjc.1997.185, PubMed 9083348

Herlofson BB, Norman-Pedersen K, Redfors M, Fosså SD (1997)
Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study
Eur J Oral Sci, 105 (5 Pt 2), 523-6
DOI 10.1111/j.1600-0722.1997.tb00239.x, PubMed 9395118

Hernes EH, Fosså SD, Vaage S, Ogreid P, Heilo A, Paus E (1997)
Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study
Br J Cancer, 76 (1), 93-9
DOI 10.1038/bjc.1997.342, PubMed 9218739

Hollender A, Stenwig EA, Ous S, Fosså SD (1997)
Survival of patients with viable malignant non-seminomatous germ cell tumour persistent after cisplatin-based induction chemotherapy
Eur Urol, 31 (2), 141-7
DOI 10.1159/000474439, PubMed 9076455

Horwich A, Sleijfer DT, Fosså SD, Kaye SB, Oliver RT, Cullen MH, Mead GM, de Wit R, de Mulder PH, Dearnaley DP, Cook PA, Sylvester RJ, Stenning SP (1997)
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial
J Clin Oncol, 15 (5), 1844-52
DOI 10.1200/JCO.1997.15.5.1844, PubMed 9164194

Jacobsen KD, Olsen DR, Fosså K, Fosså SD (1997)
External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis
Int J Radiat Oncol Biol Phys, 38 (1), 95-102
DOI 10.1016/s0360-3016(96)00597-4, PubMed 9212009

Kraggerud SM, Jacobsen KD, Berner A, Stokke T, Holm R, Smedshammer L, Børresen-Dale AL, Fosså SD (1997)
A comparison of different modes for the detection of p53 protein accumulation. A study of bladder cancer
Pathol Res Pract, 193 (7), 471-8
DOI 10.1016/s0344-0338(97)80099-4, PubMed 9342752

Newling D, Fosså SD, Andersson L, Abrahamsson PA, Aso Y, Eisenberger MA, Khoury S, Kozlowski JS, Kelly K, Scher H, Hartley-Asp B (1997)
Assessment of hormone refractory prostate cancer
Urology, 49 (4A Suppl), 46-53
DOI 10.1016/s0090-4295(99)80323-9, PubMed 9111614

Pawinski A, van Oosterom AT, de Wit R, Fosså S, Croles J, Svedberg A, Lentz MA, de Mulder PH (1997)
An EORTC phase II study of the efficacy and safety of linomide in the treatment of advanced renal cell carcinoma
Eur J Cancer, 33 (3), 496-9
DOI 10.1016/s0959-8049(97)89028-4, PubMed 9155538

Raabe NK, Fosså SD, Kåresen R (1997)
[Primary invasive breast cancer in Oslo 1980-89. A population based study of 1942 unselected patients treated by radical surgery]
Tidsskr Nor Laegeforen, 117 (26), 3778-83
PubMed 9417680

Raabe NK, Kaaresen R, Fossaa SD (1997)
Hospital-related differences in breast cancer management. Analysis of an unselected population-based series of 1353 radically operated patients
Breast Cancer Res Treat, 43 (3), 225-35
DOI 10.1023/a:1005730327487, PubMed 9150902

Raabe NK, Kaaresen R, Fosså SD (1997)
Analysis of adjuvant treatment in postmenopausal patients with stage II invasive breast carcinoma--a pattern of care study and quality assurance of 431 consecutive patients in Oslo 1980-1989
Acta Oncol, 36 (3), 255-60
DOI 10.3109/02841869709001259, PubMed 9208893

Raabe NK, Schistad O, Sauer T, Bofin A, Kaaresen R, Fossaa SD (1997)
Prognosis of radically operated breast carcinoma patients. A retrospective study of 167 consecutive patients with emphasis on histopathological grading, reproducibility and mean nuclear area
APMIS, 105 (5), 363-70
DOI 10.1111/j.1699-0463.1997.tb00582.x, PubMed 9201237

Sternberg CN, de Mulder P, Fossa S, Kaye S, Roberts T, Pawinsky A, Daamen S (1997)
Lobaplatin in advanced urothelial tract tumors. The Genitourinary Group of the European Organization for Research and Treatment of Cancer (EORTC)
Ann Oncol, 8 (7), 695-6
DOI 10.1023/a:1008269432176, PubMed 9296225

Steyerberg EW, Donohue JP, Gerl A, Toner GC, Schraffordt Koops H, Fosså SD, Keizer HJ (1997)
Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group
J Urol, 158 (2), 474-8
DOI 10.1016/s0022-5347(01)64506-3, PubMed 9224327

Steyerberg EW, Keizer HJ, Messemer JE, Toner GC, Schraffordt Koops H, Fosså SD, Gerl A, Sleijfer DT, Donohue JP, Habbema JD (1997)
Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group
Cancer, 79 (2), 345-55
PubMed 9010108

Tallaksen CM, Jetne V, Fosså S (1997)
Postradiation lower motor neuron syndrome--a case report and brief literature review
Acta Oncol, 36 (3), 345-7
DOI 10.3109/02841869709001276, PubMed 9208910

Wanderås EH, Fosså SD, Tretli S (1997)
Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients
Eur J Cancer, 33 (2), 244-52
DOI 10.1016/s0959-8049(96)00459-5, PubMed 9135496

Wanderås EH, Fosså SD, Tretli S (1997)
Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients
Eur J Cancer, 33 (2), 253-62
DOI 10.1016/s0959-8049(96)00458-3, PubMed 9135497

Aass N, Fosså SD, Dahl AA, Moe TJ (1997)
Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital
Eur J Cancer, 33 (10), 1597-604
DOI 10.1016/s0959-8049(97)00054-3, PubMed 9389921

Aass N, Håtun DE, Thoresen M, Fosså SD (1997)
Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients
Radiother Oncol, 45 (2), 125-8
DOI 10.1016/s0167-8140(97)00099-6, PubMed 9424001

Publications 1996

Berner A, Skjørten FJ, Fossà SD (1996)
Follow-up of prostatic intraepithelial neoplasia
Eur Urol, 30 (2), 256-60
DOI 10.1159/000474177, PubMed 8875208

Braendengen M, Winderen M, Fosså SD (1996)
Clinical significance of routine pre-cystectomy bone scans in patients with muscle-invasive bladder cancer
Br J Urol, 77 (1), 36-40
DOI 10.1046/j.1464-410x.1996.08467.x, PubMed 8653315

Cullen MH, Stenning SP, Parkinson MC, Fossa SD, Kaye SB, Horwich AH, Harland SJ, Williams MV, Jakes R (1996)
Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report
J Clin Oncol, 14 (4), 1106-13
DOI 10.1200/JCO.1996.14.4.1106, PubMed 8648364

da Silva FC, Fossa SD, Aaronson NK, Serbouti S, Denis L, Casselman J, Whelan P, Hetherington J, Fava C, Richards B, Robinson MR (1996)
The quality of life of patients with newly diagnosed M1 prostate cancer: experience with EORTC clinical trial 30853
Eur J Cancer, 32A (1), 72-7
DOI 10.1016/0959-8049(95)00402-5, PubMed 8695246

Fossa SD, Aass N, Ous S, Waehre H, Ilner K, Hannisdal E (1996)
Survival after curative treatment of muscle-invasive bladder cancer
Acta Oncol, 35 Suppl 8, 59-65
DOI 10.3109/02841869609098521, PubMed 9073049

Fosså SD (1996)
Quality of life in prostate cancer: what are the issues and how are they measured?
Eur Urol, 29 Suppl 2, 121-3
DOI 10.1159/000473852, PubMed 8717474

Fosså SD (1996)
Quality of life in advanced prostate cancer
Semin Oncol, 23 (6 Suppl 14), 32-4
PubMed 8996583

Fosså SD, Hjermstad MJ, Mørk IH, Hjortdahl P (1996)
Does the service at a large oncologic out-patient clinic satisfy the patients' perceived need?
Int J Health Care Qual Assur, 9 (4), 24-9
DOI 10.1108/09526869610124209, PubMed 10159575

Fosså SD, Moynihan C, Serbouti S (1996)
Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I. A descriptive pilot study
Support Care Cancer, 4 (2), 118-28
DOI 10.1007/BF01845761, PubMed 8673349

Fosså SD, Sternberg C, Scher HI, Theodore CH, Mead B, Dearnaley D, Roberts JT, Skovlund E (1996)
Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy
Br J Cancer, 74 (10), 1655-9
DOI 10.1038/bjc.1996.605, PubMed 8932351

Heimdal K, Olsson H, Tretli S, Flodgren P, Børresen AL, Fossa SD (1996)
Familial testicular cancer in Norway and southern Sweden
Br J Cancer, 73 (7), 964-9
DOI 10.1038/bjc.1996.173, PubMed 8611416

Heimdal K, Olsson H, Tretli S, Flodgren P, Børresen AL, Fossa SD (1996)
Risk of cancer in relatives of testicular cancer patients
Br J Cancer, 73 (7), 970-3
DOI 10.1038/bjc.1996.174, PubMed 8611417

Loraas A, Fosså SD, Franzen S, Saeter G, Rode L (1996)
Skin lesions and G-CSF in patients with malignant diseases. Malignancy or cutaneous side-effect?
Eur J Cancer, 32A (3), 554-5
DOI 10.1016/0959-8049(95)00595-1, PubMed 8814708

Otnes B, Harvei S, Fosså SD (1996)
[Increased incidence of prostatic cancer. The significance of prostate-specific antigen]
Tidsskr Nor Laegeforen, 116 (15), 1795-9
PubMed 8693464

Raabe NK, Fossaa SD (1996)
Primary invasive breast carcinoma in Oslo 1980-1989. Incidence and delay
Acta Oncol, 35 (1), 9-15
DOI 10.3109/02841869609098473, PubMed 8619947

Semb KA, Aamdal S, Fosså SD, Oian P (1996)
Transcapillary forces of the subcutaneous tissue in patients treated with interleukin-2 and alpha-interferon: no capillary protein leak syndrome?
J Exp Ther Oncol, 1 (3), 155-61
PubMed 9414399

Steyerberg EW, Keizer HJ, Fosså SD, Sleijfer DT, Bajorin DF, Donohue JP, Habbema JD (1996)
Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer
Br J Cancer, 74 (9), 1492-8
DOI 10.1038/bjc.1996.571, PubMed 8912551

Publications 1995

Berner A, Geitvik G, Karlsen F, Fosså SD, Nesland JM, Børresen AL (1995)
TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue
J Pathol, 176 (3), 299-308
DOI 10.1002/path.1711760312, PubMed 7674092

Berner A, Waere H, Nesland JM, Paus E, Danielsen HE, Fosså SD (1995)
DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma
Br J Urol, 75 (1), 26-32
DOI 10.1111/j.1464-410x.1995.tb07227.x, PubMed 7531589

Brausi M, Jones WG, Fosså SD, de Mulder PH, Droz JP, Lentz MA, van Glabbeke M, Pawinski A (1995)
High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary Group
Eur J Cancer, 31A (10), 1622-6
DOI 10.1016/0959-8049(95)00193-m, PubMed 7488412

Davidson PJ, Hop W, Kurth KH, Fossa SD, Waehre H, Schröder FH (1995)
Progression in untreated carcinoma of the prostate metastatic to regional lymph nodes (stage t0 to 4,N1 to 3.M0,D1). European Organization for Research and Treatment of Cancer Genitourinary Group
J Urol, 154 (6), 2118-22
DOI 10.1016/S0022-5347(01)66711-9, PubMed 7500472

Fossa S, Jones M, Johnson P, Joffe J, Holdener E, Elson P, Ritchie A, Selby P (1995)
Interferon-alpha and survival in renal cell cancer
Br J Urol, 76 (3), 286-90
DOI 10.1111/j.1464-410x.1995.tb07702.x, PubMed 7551834

Fosså SD (1995)
[Treatment of testicular cancer in regional health care]
Tidsskr Nor Laegeforen, 115 (19), 2435-7
PubMed 7667865

Fosså SD (1995)
[Tumor cells in peripheral blood and bone marrow in patients with prostatic cancer. Many unanswered questions]
Tidsskr Nor Laegeforen, 115 (29), 3599-600
PubMed 8539709

Fosså SD, Droz JP, Stoter G, Kaye SB, Vermeylen K, Sylvester R (1995)
Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group
Br J Cancer, 71 (3), 619-24
DOI 10.1038/bjc.1995.121, PubMed 7880748

Fosså SD, Lehne G, Heimdal K, Theodorsen L (1995)
Clinical and biochemical long-term toxicity after postoperative cisplatin-based chemotherapy in patients with low-stage testicular cancer
Oncology, 52 (4), 300-5
DOI 10.1159/000227478, PubMed 7539902

Fosså SD, Aamdal S, Naume B, Gallati H (1995)
Serum levels of cytokines and soluble cytokine receptors in patients with metastatic renal cell carcinoma or malignant melanoma receiving IL-2/interferon-alpha combination therapy
Acta Oncol, 34 (5), 599-603
DOI 10.3109/02841869509094034, PubMed 7546824

Gospodarowicz MK, Quilty PM, Scalliet P, Tsujii H, Fossa SD, Horenblas S, Isaka S, Prout GR, Shipley WU, Wijnmaalen AJ (1995)
The place of radiation therapy as definitive treatment of bladder cancer
Int J Urol, 2 Suppl 2, 41-8
DOI 10.1111/j.1442-2042.1995.tb00478.x, PubMed 7553304

Heimdal K, Andersen TI, Skrede M, Fosså SD, Berg K, Børresen AL (1995)
Association studies of estrogen receptor polymorphisms in a Norwegian testicular cancer population
Cancer Epidemiol Biomarkers Prev, 4 (2), 123-6
PubMed 7742719

Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995)
Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire
J Clin Oncol, 13 (5), 1249-54
DOI 10.1200/JCO.1995.13.5.1249, PubMed 7738629

Josefsen D, Waehre H, Paus E, Fosså SD (1995)
Increase of serum prostatic specific antigen and clinical progression in pN + MO prostate cancer
Br J Urol, 75 (4), 502-6
DOI 10.1111/j.1464-410x.1995.tb07273.x, PubMed 7540482

Lothe RA, Peltomäki P, Tommerup N, Fosså SD, Stenwig AE, Børresen AL, Nesland JM (1995)
Molecular genetic changes in human male germ cell tumors
Lab Invest, 73 (5), 606-14
PubMed 7474934

Otnes B, Harvei S, Fosså SD (1995)
The burden of prostate cancer from diagnosis until death
Br J Urol, 76 (5), 587-94
DOI 10.1111/j.1464-410x.1995.tb07783.x, PubMed 8535677

Scher HI, Fossa S (1995)
Prostate cancer in the era of prostate-specific antigen
Curr Opin Oncol, 7 (3), 281-91
DOI 10.1097/00001622-199505000-00014, PubMed 7544627

Steyerberg EW, Keizer HJ, Fosså SD, Sleijfer DT, Toner GC, Schraffordt Koops H, Mulders PF, Messemer JE, Ney K, Donohue JP (1995)
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups
J Clin Oncol, 13 (5), 1177-87
DOI 10.1200/JCO.1995.13.5.1177, PubMed 7537801

Wanderås EH, Tretli S, Fosså SD (1995)
Trends in incidence of testicular cancer in Norway 1955-1992
Eur J Cancer, 31A (12), 2044-8
DOI 10.1016/0959-8049(95)00321-5, PubMed 8562163

Publications 1994

Berner A, Harvei S, Tretli S, Fosså SD, Nesland JM (1994)
Prostatic carcinoma: a multivariate analysis of prognostic factors
Br J Cancer, 69 (5), 924-30
DOI 10.1038/bjc.1994.179, PubMed 7514029

Bjerkehagen B, Fosså SD, Raabe N, Holm R, Nesland JM (1994)
Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV
Eur Urol, 26 (4), 334-9
DOI 10.1159/000475410, PubMed 7713133

de Mulder PH, Sternberg CN, van Oosterom AT, Fossa SD (1994)
The application of hematopoietic growth factors in advanced transitional cell carcinoma of the urinary tract
Semin Oncol, 21 (1 Suppl 1), 65-9
PubMed 7512278

Fossa S (1994)
Quality-of-life assessment in unselected oncologic out-patients - a pilot-study
Int J Oncol, 4 (6), 1393-7
DOI 10.3892/ijo.4.6.1393, PubMed 21567068

Fosså SD (1994)
Management of hormone resistant prostate cancer
Acta Urol Belg, 62 (1), 73-6
PubMed 7515211

Fosså SD (1994)
Quality of life after palliative radiotherapy in patients with hormone-resistant prostate cancer: single institution experience
Br J Urol, 74 (3), 345-51
DOI 10.1111/j.1464-410x.1994.tb16625.x, PubMed 7524999

Fosså SD, Jacobsen AB, Aass N, Heilo A, Stenwig AE, Kummen O, Johannessen NB, Waaler G, Ogreid P, Borge L (1994)
How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?
Br J Cancer, 70 (6), 1156-60
DOI 10.1038/bjc.1994.464, PubMed 7981068

Fosså SD, Kramar A, Droz JP (1994)
Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-alpha
Eur J Cancer, 30A (9), 1310-4
DOI 10.1016/0959-8049(94)90179-1, PubMed 7999419

Fosså SD, Paus E (1994)
Reduction of serum prostate-specific antigen during endocrine or cytotoxic treatment of hormone-resistant cancer of the prostate. A preliminary report
Eur Urol, 26 (1), 29-34
DOI 10.1159/000475338, PubMed 7523131

Fosså SD, Silde J, Theodorsen L, Pettersen EO (1994)
Pre-treatment DNA ploidy of sperm cells as a predictive parameter of post-treatment spermatogenesis in patients with testicular cancer
Br J Urol, 74 (3), 359-65
DOI 10.1111/j.1464-410x.1994.tb16627.x, PubMed 7953268

Fosså SD, Wanderås EH, Heimdal K (1994)
Second cancer after treatment of malignant germ-cell tumors
World J Urol, 12 (3), 151-4
DOI 10.1007/BF00192277, PubMed 7951342

Fosså SD, Aass N, Opjordsmoen S (1994)
Assessment of quality of life in patients with prostate cancer
Semin Oncol, 21 (5), 657-61
PubMed 7524156

Hall K, Nordal K, Brekke I, Fossa S (1994)
Pharmacokinetics of Carboplatin in a patient with both testicular cancer and hemodialysis-requiring kidney failure
Int J Oncol, 4 (2), 359-62
DOI 10.3892/ijo.4.2.359, PubMed 21566932

Heimdal K, Fosså SD (1994)
Genetic factors in malignant germ-cell tumors
World J Urol, 12 (4), 178-81
DOI 10.1007/BF00185667, PubMed 7820137

Heimdal KR, Lothe RA, Fosså SD, Børresen AL (1994)
Association studies of a polymorphism in the Wilms' tumor 1 locus in Norwegian patients with testicular cancer
Int J Cancer, 58 (4), 523-6
DOI 10.1002/ijc.2910580412, PubMed 8056449

Haarstad H, Jacobsen AB, Schjølseth SA, Risberg T, Fosså SD (1994)
Interferon-alpha, 5-FU and prednisone in metastatic renal cell carcinoma: a phase II study
Ann Oncol, 5 (3), 245-8
DOI 10.1093/oxfordjournals.annonc.a058801, PubMed 8186172

Jacobsen KD, Follerås G, Fosså SD (1994)
Metastases from renal cell carcinoma to the humerus or the shoulder girdle
Br J Urol, 73 (2), 124-8
DOI 10.1111/j.1464-410x.1994.tb07478.x, PubMed 8131012

Møller P, Fosså SD, Heimdal K, Kvinnsland S, Giercksky KE, Woehre H (1994)
[Screening for early diagnosis of prostatic cancer]
Tidsskr Nor Laegeforen, 114 (9), 1104-5
PubMed 8009529

Opjordsmoen S, Fosså SD (1994)
Quality of life in patients treated for penile cancer. A follow-up study
Br J Urol, 74 (5), 652-7
DOI 10.1111/j.1464-410x.1994.tb09200.x, PubMed 7827818

Opjordsmoen S, Waehre H, Aass N, Fossa SD (1994)
Sexuality in patients treated for penile cancer: patients' experience and doctors' judgement
Br J Urol, 73 (5), 554-60
DOI 10.1111/j.1464-410x.1994.tb07643.x, PubMed 8012779

Wanderas E, Fossa S, Tretli S, Klepp O (1994)
Toxicity in long-term survivors after adriamycin containing chemotherapy of malignant germ-cell tumors
Int J Oncol, 4 (3), 681-8
DOI 10.3892/ijo.4.3.681, PubMed 21566977

Yao WQ, Fosså SD, Dearnaley DP, Horwich A (1994)
Combined single course carboplatin with radiotherapy in treatment of stage IIA,B seminoma--a preliminary report
Radiother Oncol, 33 (1), 88-90
DOI 10.1016/0167-8140(94)90092-2, PubMed 7878216

Aass N, Fosså SD (1994)
Aims and results of palliative radiotherapy in urological cancer
Curr Opin Oncol, 6 (3), 308-12
DOI 10.1097/00001622-199405000-00014, PubMed 7521671

Publications 1993

Berner A, Danielsen HE, Juul NO, Juul ME, Pettersen EO, Reith A, Nesland JM, Fosså SD (1993)
Caveats in the estimation of DNA-ploidy in paraffin embedded specimens of primary prostate cancer and lymph node metastases by flow and image cytometry
Anal Cell Pathol, 5 (6), 339-52
PubMed 8305330

Berner A, Danielsen HE, Pettersen EO, Fosså SD, Reith A, Nesland JM (1993)
DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas
Anal Quant Cytol Histol, 15 (4), 247-52
PubMed 7691062

Berner A, Jacobsen AB, Fosså SD, Nesland JM (1993)
Expression of c-erbB-2 protein, neuron-specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder
Histopathology, 22 (4), 327-33
DOI 10.1111/j.1365-2559.1993.tb00131.x, PubMed 8099896

Berner A, Nesland JM, Waehre H, Silde J, Fosså SD (1993)
Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens
Br J Cancer, 68 (2), 380-4
DOI 10.1038/bjc.1993.344, PubMed 7688548

Blomlie V, Lehne G, Lien HH, Winderen M, Fosså SD (1993)
Meningeal tumour infiltration in hormone resistant prostate cancer demonstrated with magnetic resonance
Eur J Cancer, 29A (9), 1357
DOI 10.1016/0959-8049(93)90094-v, PubMed 8343288

Fosså SD, Aune H, Baggerud E, Granerud T, Heilo A, Theodorsen L (1993)
Continuous intravenous interleukin-2 infusion and subcutaneous interferon-alpha in metastatic renal cell carcinoma
Eur J Cancer, 29A (9), 1313-5
DOI 10.1016/0959-8049(93)90080-y, PubMed 8343275

Fosså SD, Berner AA, Jacobsen AB, Waehre H, Kvarstein B, Urnes T, Ogreid P, Johansen TE, Silde J, Nesland JM (1993)
Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer
Br J Cancer, 68 (3), 572-8
DOI 10.1038/bjc.1993.388, PubMed 8102536

Fosså SD, Heilo A, Sövik E (1993)
Quality control of computed tomograms in testicular tumours
Lancet, 341 (8861), 1666
DOI 10.1016/0140-6736(93)90806-r, PubMed 8100034

Fosså SD, Waehre H, Aass N, Jacobsen AB, Olsen DR, Ous S (1993)
Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients
Cancer, 72 (10), 3036-43
DOI 10.1002/1097-0142(19931115)72:10<3036::aid-cncr2820721028>3.0.co;2-b, PubMed 8221571

Fosså SD, Winderen M (1993)
Does decreased skeletal uptake of 99mTc-methylene bisphosphonate in irradiated bone indicate the absence of bone metastases?
Radiother Oncol, 27 (1), 63-5
DOI 10.1016/0167-8140(93)90046-b, PubMed 8327735

Fosså SD, Aabyholm T, Vespestad S, Norman N, Ous S (1993)
Semen quality after treatment for testicular cancer
Eur Urol, 23 (1), 172-6
DOI 10.1159/000474589, PubMed 8477777

Hannisdal E, Fosså SD, Høst H (1993)
Blood tests and prognosis in bladder carcinomas treated with definitive radiotherapy
Radiother Oncol, 27 (2), 117-22
DOI 10.1016/0167-8140(93)90131-q, PubMed 8356221

Harland SJ, Cook PA, Fosså SD, Horwich A, Parkinson MC, Roberts JT, Stenning SP (1993)
Risk factors for carcinoma in situ of the contralateral testis in patients with testicular cancer. An interim report
Eur Urol, 23 (1), 115-8; discussion 119
DOI 10.1159/000474578, PubMed 8477771

Heikkilä R, Heilo A, Stenwig AE, Fosså SD (1993)
Testicular ultrasonography and 18G biopty biopsy for clinically undetected cancer or carcinoma in situ in patients with germ cell tumours
Br J Urol, 71 (2), 214-6
DOI 10.1111/j.1464-410x.1993.tb15921.x, PubMed 8384915

Heimdal K, Fosså SD (1993)
Urologic cancer in elderly patients
Curr Opin Oncol, 5 (3), 568-73
DOI 10.1097/00001622-199305000-00019, PubMed 8494916

Heimdal K, Lothe RA, Lystad S, Holm R, Fosså SD, Børresen AL (1993)
No germline TP53 mutations detected in familial and bilateral testicular cancer
Genes Chromosomes Cancer, 6 (2), 92-7
DOI 10.1002/gcc.2870060205, PubMed 7680893

Josefsen D, Ous S, Høie J, Stenwig AE, Fosså SD (1993)
Salvage treatment in male patients with germ cell tumours
Br J Cancer, 67 (3), 568-72
DOI 10.1038/bjc.1993.104, PubMed 8382512

Kelly WK, Scher HI, Mazumdar M, Vlamis V, Schwartz M, Fossa SD (1993)
Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer
J Clin Oncol, 11 (4), 607-15
DOI 10.1200/JCO.1993.11.4.607, PubMed 7683043

Lehne G, Johansen B, Fosså SD (1993)
Long-term follow-up of pulmonary function in patients cured from testicular cancer with combination chemotherapy including bleomycin
Br J Cancer, 68 (3), 555-8
DOI 10.1038/bjc.1993.385, PubMed 7688978

Lothe RA, Hastie N, Heimdal K, Fosså SD, Stenwig AE, Børresen AL (1993)
Frequent loss of 11p13 and 11p15 loci in male germ cell tumours
Genes Chromosomes Cancer, 7 (2), 96-101
DOI 10.1002/gcc.2870070206, PubMed 7687459

Newling DW, Fossa SD, Tunn UW, Kurth KH, de Pauw M, Sylvester R (1993)
Mitomycin C versus estramustine in the treatment of hormone resistant metastatic prostate cancer: the final analysis of the European Organization for Research and Treatment of Cancer, genitourinary group prospective randomized phase III study (30865)
J Urol, 150 (6), 1840-4
DOI 10.1016/s0022-5347(17)35911-6, PubMed 8230517

Ottestad L, Pettersen EO, Nesland JM, Hannisdal E, Fosså SD, Tveit KM (1993)
Flow cytometric DNA analysis as prognostic factor in human breast carcinoma
Pathol Res Pract, 189 (4), 405-10
DOI 10.1016/S0344-0338(11)80327-4, PubMed 8351241

Ridanpää M, Lothe RA, Onfelt A, Fosså S, Børresen AL, Husgafvel-Pursiainen K (1993)
K-ras oncogene codon 12 point mutations in testicular cancer
Environ Health Perspect, 101 Suppl 3 (Suppl 3), 185-7
DOI 10.1289/ehp.101-1521158, PubMed 8143614

Rintala E, Hannisdahl E, Fosså SD, Hellsten S, Sander S (1993)
Neoadjuvant chemotherapy in bladder cancer: a randomized study. Nordic Cystectomy Trial I
Scand J Urol Nephrol, 27 (3), 355-62
DOI 10.3109/00365599309180447, PubMed 8290916

Ryberg D, Heimdal K, Fosså SD, Børresen AL, Haugen A (1993)
Rare Ha-ras1 alleles and predisposition to testicular cancer
Int J Cancer, 53 (6), 938-40
DOI 10.1002/ijc.2910530612, PubMed 8097187

Räth U, Upadhyaya BK, Arechavala E, Böckmann H, Dearnaley D, Droz JP, Fosså SD, Henriksson R, Aulitzky WE, Jones WG (1993)
Role of ondansetron plus dexamethasone in fractionated chemotherapy
Oncology, 50 (3), 168-72
DOI 10.1159/000227172, PubMed 8459987

Sternberg CN, de Mulder PH, van Oosterom AT, Fossa SD, Giannarelli D, Soedirman JR (1993)
Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumors
Ann Oncol, 4 (5), 403-7
DOI 10.1093/oxfordjournals.annonc.a058520, PubMed 8353075

van den Ouden D, Tribukait B, Blom JH, Fossa SD, Kurth KH, ten Kate FJ, Heiden T, Wang N, Schroder FH (1993)
Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: impact on time to progression. The European Organization for Research and Treatment of Cancer Genitourinary Group
J Urol, 150 (2 Pt 1), 400-6
DOI 10.1016/s0022-5347(17)35493-9, PubMed 8326563

Waehre H, Ous S, Klevmark B, Kvarstein B, Urnes T, Ogreid P, Johansen TE, Fosså SD (1993)
A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer
Cancer, 72 (10), 3044-51
DOI 10.1002/1097-0142(19931115)72:10<3044::aid-cncr2820721029>3.0.co;2-d, PubMed 8221572

Aaserud A, Thomle S, Fosså SD (1993)
[Treatment of threatened spinal cord lesions in patients with prostatic cancer]
Tidsskr Nor Laegeforen, 113 (17), 2141
PubMed 8337680

Aass N, Grünfeld B, Kaalhus O, Fosså SD (1993)
Pre- and post-treatment sexual life in testicular cancer patients: a descriptive investigation
Br J Cancer, 67 (5), 1113-7
DOI 10.1038/bjc.1993.204, PubMed 8494708

Publications 1992

Clavel M, Monfardini S, Fosså S, Smyth J, Renard J, Kaye SB (1992)
5-Aza-2'-deoxycytidine (NSC 127716) in non-seminomatous testicular cancer. Phase II from the EORTC Early Clinical Trials Cooperative Group and Genito-Urinary Group
Ann Oncol, 3 (5), 399-400
DOI 10.1093/oxfordjournals.annonc.a058216, PubMed 1377488

DENIS L, PEELING WB, NARAYAN P, COONER WH, HENRIKX AJM, POLLACK HM, DEMOURA JC, FOSSA S, TORPPEDERSEN S (1992)
PROSTATE-CANCER - IMAGING, MANAGEMENT, AND SCREENING - PROCEEDINGS OF THE PROSTATE SESSIONS AT THE 1ST INTERNATIONAL-CONGRESS OF THE DUTCH-UROLOGICAL-ASSOCIATION (NVU) HELD IN ROTTERDAM, THE NETHERLANDS OCTOBER 9-13, 1991 - ROUND-TABLE DISCUSSION
Prostate (4), 59-62

Fossa SD, Mason M (1992)
Determination of pre-orchiectomy serum levels of alpha-fetoprotein and human choriogonadotrophin in testicular cancer
Br J Urol, 69 (1), 108
PubMed 1371085

Fosså S (1992)
Rare and unusual tumors of the genitourinary tract
Curr Opin Oncol, 4 (3), 463-8
DOI 10.1097/00001622-199206000-00006, PubMed 1323334

Fosså SD, Berner A, Waehre H, Heiden T, Juul ME, van den Ouden D, Pettersen EO, Wang N, Tribukait B (1992)
DNA ploidy in cell nuclei from paraffin-embedded material--comparison of results from two laboratories
Cytometry, 13 (4), 395-403
DOI 10.1002/cyto.990130410, PubMed 1526198

Fosså SD, Dearnaley DP, Law M, Gad J, Newling DW, Tveter K (1992)
Prognostic factors in hormone-resistant progressing cancer of the prostate
Ann Oncol, 3 (5), 361-6
DOI 10.1093/oxfordjournals.annonc.a058207, PubMed 1616889

Fosså SD, Droz JP, Pavone-Macaluso MM, Debruyne FJ, Vermeylen K, Sylvester R (1992)
Vinblastine in metastatic renal cell carcinoma: EORTC phase II trial 30882. The EORTC Genitourinary Group
Eur J Cancer, 28A (4-5), 878-80
DOI 10.1016/0959-8049(92)90139-s, PubMed 1524914

Fosså SD, Harland SJ, Kaye SB, Raghavan D, Russell JM, Parmar MK, Uscinska BM, Wood R (1992)
Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party)
Br J Urol, 70 (2), 161-8
DOI 10.1111/j.1464-410x.1992.tb15696.x, PubMed 1393439

Fosså SD, Klepp O, Paus E (1992)
Neuron-specific enolase--a serum tumour marker in seminoma?
Br J Cancer, 65 (2), 297-9
DOI 10.1038/bjc.1992.59, PubMed 1739633

Fosså SD, Kaasa S, da Silva FC, Suciu S, Hengeveld MW (1992)
Quality of life in prostate cancer patients
Prostate Suppl, 4, 145-8
DOI 10.1002/pros.2990210523, PubMed 1574455

Fosså SD, Lehne G, Gunderson R, Hjelmaas U, Holdener EE (1992)
Recombinant interferon alpha-2A combined with prednisone in metastatic renal-cell carcinoma: treatment results, serum interferon levels and the development of antibodies
Int J Cancer, 50 (6), 868-70
DOI 10.1002/ijc.2910500606, PubMed 1372881

Fosså SD, Martinelli G, Otto U, Schneider G, Wander H, Oberling F, Bauer HW, Achtnicht U, Holdener EE (1992)
Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III study
Ann Oncol, 3 (4), 301-5
DOI 10.1093/oxfordjournals.annonc.a058185, PubMed 1390305

Fosså SD, Ous S, Espetveit S, Langmark F (1992)
Patterns of primary care and survival in 336 consecutive unselected Norwegian patients with bladder cancer
Scand J Urol Nephrol, 26 (2), 131-8
DOI 10.1080/00365599.1992.11690444, PubMed 1626202

Fosså SD, Paus E, Lindegaard M, Newling DW (1992)
Prostate-specific antigen and other prognostic factors in patients with hormone-resistant prostatic cancer undergoing experimental treatment
Br J Urol, 69 (2), 175-9
DOI 10.1111/j.1464-410x.1992.tb15491.x, PubMed 1371425

Fosså SD, Paus E, Lochoff M, Backe SM, Aas M (1992)
89Strontium in bone metastases from hormone resistant prostate cancer: palliation effect and biochemical changes
Br J Cancer, 66 (1), 177-80
DOI 10.1038/bjc.1992.238, PubMed 1379058

Fosså SD, Poulsen JP, Aaserud A (1992)
Alkaline phosphatase and lactate dehydrogenase changes during leucocytosis induced by G-CSF in testicular cancer
Lancet, 340 (8834-8835), 1544
DOI 10.1016/0140-6736(92)92794-g, PubMed 1281904

Fosså SD, Qvist H, Stenwig AE, Lien HH, Ous S, Giercksky KE (1992)
Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
J Clin Oncol, 10 (4), 569-73
DOI 10.1200/JCO.1992.10.4.569, PubMed 1312586

Fosså SD, Waehre H, Paus E (1992)
The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer
Br J Cancer, 66 (1), 181-4
DOI 10.1038/bjc.1992.239, PubMed 1379059

Heier MS, Aass N, Ous S, Fosså SD (1992)
Asymmetrical autonomic dysfunction of the feet after retroperitoneal surgery in patients with testicular cancer: 2 case reports
J Urol, 147 (2), 470-1
DOI 10.1016/s0022-5347(17)37278-6, PubMed 1732625

Heimdal K, Fosså SD, Brøgger A, Møller P (1992)
No evidence for constitutional chromosome instability in testicular cancer
Hum Genet, 89 (3), 338-40
DOI 10.1007/BF00220554, PubMed 1318262

Jacobsen AB, Berner A, Juul M, Ous S, Pettersen EO, Fosså SD (1992)
DNA flow cytometry and neo-adjuvant chemotherapy/radiotherapy in operable muscle-invasive bladder carcinoma. A preliminary report
Eur Urol, 22 (4), 316-22
DOI 10.1159/000474779, PubMed 1490510

Jacobsen AB, Pettersen EO, Amellem O, Berner A, Ous S, Fosså SD (1992)
The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy
J Urol, 147 (1), 34-7
DOI 10.1016/s0022-5347(17)37127-6, PubMed 1729547

Lothe RA, Heimdal K, Lier ME, Fosså SD, Møller P, Brøgger A (1992)
High resolution chromosome banding in search of germ line mutations applied on testicular cancer patients
Cancer Genet Cytogenet, 59 (1), 62-7
DOI 10.1016/0165-4608(92)90160-a, PubMed 1555193

Mead GM, Stenning SP, Parkinson MC, Horwich A, Fossa SD, Wilkinson PM, Kaye SB, Newlands ES, Cook PA (1992)
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party
J Clin Oncol, 10 (1), 85-94
DOI 10.1200/JCO.1992.10.1.85, PubMed 1309383

Peltomäki P, Lothe RA, Børresen AL, Fosså SD, Brøgger A, de la Chapelle A (1992)
Chromosome 12 in human testicular cancer: dosage changes and their parental origin
Cancer Genet Cytogenet, 64 (1), 21-6
DOI 10.1016/0165-4608(92)90316-z, PubMed 1458445

Qvist H, Fosså SD, Ous S, Lien HH, Stenwig AE, Giercksky KE (1992)
Retroperitoneal surgery in patients with nonseminomatous testicular cancer and minimal residual tumor
J Surg Oncol, 50 (4), 220-3
DOI 10.1002/jso.2930500404, PubMed 1640703

Raabe NK, Fosså SD, Bjerkehagen B (1992)
Carcinoma of the renal pelvis. Experience of 80 cases
Scand J Urol Nephrol, 26 (4), 357-61
DOI 10.3109/00365599209181226, PubMed 1292073

Shammas FV, Ous S, Fossa SD (1992)
Cisplatin and 5-fluorouracil in advanced cancer of the penis
J Urol, 147 (3), 630-2
DOI 10.1016/s0022-5347(17)37327-5, PubMed 1538445

Stoter G, Akdas A, Fosså SD, Kaye SB, van Groeningen CJ, Renard J, van Glabbeke M (1992)
High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: a phase II study. EORTC Genito-Urinary Tract Cancer Co-operative Group. EORTC Early Clinical Trials Group
Ann Oncol, 3 (7), 577-8
DOI 10.1093/oxfordjournals.annonc.a058266, PubMed 1323325

Waehre H, Amellem O, Stenwig AE, Tverå K, Juul M, Pettersen EO, Fosså SD (1992)
Deoxyribonucleic acid cytometry and histological findings before and after 125iodine implantation of primary prostate cancer
J Urol, 148 (3), 838-41; discussion 841-2
DOI 10.1016/s0022-5347(17)36737-x, PubMed 1512835

Waehre H, Wanderaas EH, Paus E, Fosså SD (1992)
Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer
Eur Urol, 22 (1), 33-8
DOI 10.1159/000474718, PubMed 1385143

Aass N, Fosså SD, Høst H (1992)
Acute and subacute side effects due to infra-diaphragmatic radiotherapy for testicular cancer: a prospective study
Int J Radiat Oncol Biol Phys, 22 (5), 1057-64
DOI 10.1016/0360-3016(92)90808-u, PubMed 1555953

Publications 1991

Blomlie V, Lien HH, Fosså SD, Jacobsen AB, Stenwig AE (1991)
CT in primary malignant germ cell tumors of the retroperitoneum
Acta Radiol, 32 (2), 155-8
DOI 10.3109/02841859109177536, PubMed 1851626

Fosså SD (1991)
Pelvic palliation radiotherapy of advanced bladder cancer
Int J Radiat Oncol Biol Phys, 20 (6), 1379
DOI 10.1016/0360-3016(91)90254-2, PubMed 1710614

Fosså SD (1991)
Penile and adrenal cancer
Curr Opin Oncol, 3 (3), 565-7
DOI 10.1097/00001622-199106000-00020, PubMed 1892924

Fosså SD, Hosbach G (1991)
Short-term moderate-dose pelvic radiotherapy of advanced bladder carcinoma. A questionnaire-based evaluation of its symptomatic effect
Acta Oncol, 30 (6), 735-8
DOI 10.3109/02841869109092449, PubMed 1958395

Fosså SD, Lien HH, Lindegaard M (1991)
Effect of recombinant interferon alfa on bone metastases of renal-cell carcinoma
N Engl J Med, 324 (9), 633-4
DOI 10.1056/NEJM199102283240913, PubMed 1992326

Fosså SD, Melvik JE, Juul NO, Pettersen EO, Amellem O, Theodorsen L (1991)
DNA flow cytometry in sperm cells from testicular cancer patients. Impact of different treatment modalities on spermatogenesis
Eur Urol, 19 (2), 125-31
DOI 10.1159/000473600, PubMed 2022215

Fosså SD, Nesland JM, Pettersen EO, Amellem O, Waehre H, Heimdal K (1991)
DNA ploidy in primary testicular cancer
Br J Cancer, 64 (5), 948-52
DOI 10.1038/bjc.1991.432, PubMed 1931622

Fosså SD, Nesland JM, Waehre H, Amellem O, Pettersen EO (1991)
DNA ploidy in the primary tumor from patients with nonseminomatous testicular germ cell tumors clinical stage I
Cancer, 67 (7), 1874-7
DOI 10.1002/1097-0142(19910401)67:7<1874::aid-cncr2820670710>3.0.co;2-6, PubMed 1848470

Fosså SD, Ous S, Berner A (1991)
Clinical significance of the "palpable mass" in patients with muscle-infiltrating bladder cancer undergoing cystectomy after pre-operative radiotherapy
Br J Urol, 67 (1), 54-60
DOI 10.1111/j.1464-410x.1991.tb15070.x, PubMed 1993277

Fosså SD, Aass N, Ous S, Waehre H (1991)
Long-term morbidity and quality of life in testicular cancer patients
Scand J Urol Nephrol Suppl, 138, 241-6
PubMed 1785014

Heier MS, Nilsen T, Graver V, Aass N, Fosså SD (1991)
Raynaud's phenomenon after combination chemotherapy of testicular cancer, measured by laser Doppler flowmetry. A pilot study
Br J Cancer, 63 (4), 550-2
DOI 10.1038/bjc.1991.129, PubMed 1850610

Heimdal K, Evensen SA, Fosså SD, Hirscberg H, Langholm R, Brøgger A, Møller P (1991)
Karyotyping of a hematologic neoplasia developing shortly after treatment for cerebral extragonadal germ cell tumor
Cancer Genet Cytogenet, 57 (1), 41-6
DOI 10.1016/0165-4608(91)90187-y, PubMed 1756483

Jacobsen AB, Tveit KM, Pettersen EO, Fossa SD, Ous S (1991)
Colony formation in urinary bladder carcinoma. Relationship to DNA flow cytometry, stage and histopathology
Anticancer Res, 11 (2), 777-81
PubMed 2064333

Kaasa S, Aass N, Mastekaasa A, Lund E, Fosså SD (1991)
Psychosocial well-being in testicular cancer patients
Eur J Cancer, 27 (9), 1091-5
DOI 10.1016/0277-5379(91)90299-s, PubMed 1683558

Lewis CR, Fossà SD, Mead G, ten Bokkel Huinink W, Harding MJ, Mill L, Paul J, Jones WG, Rodenburg CJ, Cantwell B (1991)
BOP/VIP--a new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours
Ann Oncol, 2 (3), 203-11
DOI 10.1093/oxfordjournals.annonc.a057906, PubMed 1710482

Lien HH, Blomlie V, Saeter G, Solheim O, Fosså SD (1991)
Osteogenic sarcoma: MR signal abnormalities of the brain in asymptomatic patients treated with high-dose methotrexate
Radiology, 179 (2), 547-50
DOI 10.1148/radiology.179.2.2014309, PubMed 2014309

Lindegaard MW, Aass N, Bue ES, Theodorsen L, Fosså SD (1991)
Glomerular filtration rate, 131I-hippuran clearance and estimated creatinine clearance in cancer patients
Br J Cancer, 64 (2), 401-5
DOI 10.1038/bjc.1991.317, PubMed 1892774

Peltomäki P, Lothe R, Børresen AL, Fosså SD, Brøgger A, de la Chapelle A (1991)
Altered dosage of the sex chromosomes in human testicular cancer: a molecular genetic study
Int J Cancer, 47 (4), 518-22
DOI 10.1002/ijc.2910470408, PubMed 1995482

Qvist HL, Fosså SD, Ous S, Høie J, Stenwig AE, Giercksky KE (1991)
Post-chemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses?
J Urol, 145 (2), 300-2; discussion 302-3
DOI 10.1016/s0022-5347(17)38321-0, PubMed 1988722

Roberts JT, Fossa SD, Richards B, Kaye SB, White EF, Robinson MC, Uscinska B, Parmar MK (1991)
Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinoma of the bladder
Br J Urol, 68 (2), 162-8
DOI 10.1111/j.1464-410x.1991.tb15287.x, PubMed 1884143

von der Maase H, Geertsen P, Thatcher N, Jasmin C, Mercatello A, Fosså SD, Symann M, Stoter G, Nagel G, Israel L (1991)
Recombinant interleukin-2 in metastatic renal cell carcinoma--a European multicentre phase II study
Eur J Cancer, 27 (12), 1583-9
DOI 10.1016/0277-5379(91)90419-e, PubMed 1782066

Aass N, Fosså SD, Theodorsen L, Norman N (1991)
Prediction of long-term gonadal toxicity after standard treatment for testicular cancer
Eur J Cancer, 27 (9), 1087-91
DOI 10.1016/0277-5379(91)90298-r, PubMed 1720322

Aass N, Klepp O, Cavallin-Stahl E, Dahl O, Wicklund H, Unsgaard B, Baldetorp L, Ahlström S, Fosså SD (1991)
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience
J Clin Oncol, 9 (5), 818-26
DOI 10.1200/JCO.1991.9.5.818, PubMed 1707957

Publications 1990

Abrahamsen JF, Fosså SD (1990)
Long-term morbidity after curative radiotherapy for carcinoma of the bladder. A retrospective study
Strahlenther Onkol, 166 (9), 580-3
PubMed 2120783

Borge N, Fosså SD, Stenwig AE (1990)
Metastatic testicular cancer and extragonadal germ cell tumor presenting with neurological symptoms
J Neurooncol, 8 (2), 145-8
DOI 10.1007/BF00177837, PubMed 2162914

Fosså SD (1990)
Penile and adrenal cancer
Curr Opin Oncol, 2 (3), 533-6
PubMed 2092771

Fosså SD, Gunderson R, Moe B (1990)
Recombinant interferon-alpha combined with prednisone in metastatic renal cell carcinoma. Reduced toxicity without reduction of the response rate--a phase II study
Cancer, 65 (11), 2451-4
DOI 10.1002/1097-0142(19900601)65:11<2451::aid-cncr2820651108>3.0.co;2-3, PubMed 2337859

Fosså SD, Haug E (1990)
Serum levels of sex hormone binding globulin and oestradiol in patients with testicular cancer
Br J Urol, 66 (5), 518-22
DOI 10.1111/j.1464-410x.1990.tb15001.x, PubMed 2249122

Fosså SD, Heilo A, Børmer O (1990)
Unexpectedly high serum methotrexate levels in cystectomized bladder cancer patients with an ileal conduit treated with intermediate doses of the drug
J Urol, 143 (3), 498-501
DOI 10.1016/s0022-5347(17)40001-2, PubMed 2304161

Fosså SD, Hosbach G, Paus E (1990)
Flutamide in hormone-resistant prostatic cancer
J Urol, 144 (6), 1411-4
DOI 10.1016/s0022-5347(17)39756-2, PubMed 1700154

Fosså SD, Jones WG, Hamers HP, van den Bogaert W (1990)
[Penile cancer]
Tidsskr Nor Laegeforen, 110 (11), 1354-6
PubMed 1692641

Fosså SD, Kreuser ED, Roth GJ, Raghavan D (1990)
Long-term side effects after treatment of testicular cancer
Prog Clin Biol Res, 357, 321-30
PubMed 2217475

Fosså SD, Langmark F, Aass N, Andersen A, Lothe R, Børresen AL (1990)
Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy
Br J Cancer, 61 (4), 639-43
DOI 10.1038/bjc.1990.142, PubMed 2109999

Fosså SD, Nesland JM, Melvik JE, Jacobsen AB, Moe B (1990)
Prediction of objective response to recombinant interferon-alpha with or without vinblastine in metastatic renal cell carcinoma
Acta Oncol, 29 (3), 303-6
DOI 10.3109/02841869009090002, PubMed 2363942

Fosså SD, Ous S, Stenwig AE, Lien HH, Aass N, Kaalhus O (1990)
Distribution of retroperitoneal lymph node metastases in patients with non-seminomatous testicular cancer in clinical stage I
Eur Urol, 17 (2), 107-12
DOI 10.1159/000464016, PubMed 2155789

Fosså SD, Saeter G, Aass N, Ous S, Stenwig AE, Blomlie V (1990)
Management of patients with poor-prognosis nonseminomatous germ cell cancer
Oncology, 47 (3), 234-40
DOI 10.1159/000226822, PubMed 1692984

Fosså SD, Sager EM, Hosbach G, Waehre H, Ous S (1990)
Cisplatin and medium dose methotrexate in advanced transitional cell carcinoma of the urinary tract
Scand J Urol Nephrol, 24 (3), 199-204
DOI 10.3109/00365599009180858, PubMed 2237296

Fosså SD, Theodorsen L, Norman N, Aabyholm T (1990)
Recovery of impaired pretreatment spermatogenesis in testicular cancer
Fertil Steril, 54 (3), 493-6
DOI 10.1016/s0015-0282(16)53768-6, PubMed 2118861

Fosså SD, Aaronson N, de Voogt HJ, da Silva FC (1990)
Assessment of quality of life and subjective response criteria in patients with prostatic cancer
Prog Clin Biol Res, 357, 199-202
PubMed 2217464

Fosså SD, Aaronson NK, Newling D, van Cangh PJ, Denis L, Kurth KH, de Pauw M (1990)
Quality of life and treatment of hormone resistant metastatic prostatic cancer. The EORTC Genito-Urinary Group
Eur J Cancer, 26 (11-12), 1133-6
DOI 10.1016/0277-5379(90)90269-y, PubMed 2149995

Freedman LS, Javadpour N, Sylvester R, Aso Y, Debruyne FM, Fosså SD, Geller N, Horwich A, Levine L, Mostofi FK (1990)
Basic principles of clinical trials as applied to testicular cancer
Prog Clin Biol Res, 357, 255-66
PubMed 2217470

Heimdal K, Fosså SD, Johansen A (1990)
Increasing incidence and changing stage distribution of testicular carcinoma in Norway 1970-1987
Br J Cancer, 62 (2), 277-8
DOI 10.1038/bjc.1990.277, PubMed 2386743

Jacobsen AB, Nesland JM, Fosså SD, Pettersen EO (1990)
Human chorionic gonadotropin, neuron specific enolase and deoxyribonucleic acid flow cytometry in patients with high grade bladder carcinoma
J Urol, 143 (4), 706-9
DOI 10.1016/s0022-5347(17)40066-8, PubMed 2313795

Jones WG, Fosså SD, Verbaeys AC, Droz JP, Klijn JG, Boven E, de Pauw M, Sylvester R (1990)
Low-dose fortnightly methotrexate in advanced prostate cancer. The EORTC Genito-Urinary Tract Cancer Cooperative Group
Eur J Cancer, 26 (5), 646
DOI 10.1016/0277-5379(90)90099-f, PubMed 2144757

Klepp O, Flodgren P, Maartman-Moe H, Lindholm CE, Unsgaard B, Teigum H, Fosså SD, Paus E (1990)
Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA)
Ann Oncol, 1 (4), 281-8
DOI 10.1093/oxfordjournals.annonc.a057749, PubMed 1702312

Klepp O, Olsson AM, Henrikson H, Aass N, Dahl O, Stenwig AE, Persson BE, Cavallin-Ståhl E, Fosså SD, Wahlqvist L (1990)
Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group
J Clin Oncol, 8 (3), 509-18
DOI 10.1200/JCO.1990.8.3.509, PubMed 1689773

Melsom H, Monge OR, Fosså SD, Gundersen S (1990)
[Locally advanced breast cancer--primary treatment with tamoxifen]
Tidsskr Nor Laegeforen, 110 (14), 1815-6
PubMed 2363143

Newling DW, Fossa S, Tunn U, Kurth KH, De Pauw M, Sylvester R (1990)
Comparison of the effects of high dose Estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: an interim analysis of EORTC-GU Group study no. 30865
J Steroid Biochem Mol Biol, 37 (6), 971-5
DOI 10.1016/0960-0760(90)90452-q, PubMed 2126739

Sager EM, Fossa SD, Ous S (1990)
Sensitivity to short-term chemotherapy in patients with bladder cancer evaluated by computed tomography of the primary tumor
Prog Clin Biol Res, 353, 203-12
PubMed 2217420

Sager EM, Fosså SD, Kaalhus O, Tveit KM (1990)
Computed tomography of the urinary bladder shortly after radiation therapy for rectal carcinoma
Acta Radiol, 31 (6), 585-8
PubMed 2278782

Stoter G, Bosl GJ, Droz JP, Fossa SD, Freedman LS, Geller NL, Horwich A, Jones WG, Kaye SB, Mead GM (1990)
Prognostic factors in metastatic germ cell tumors
Prog Clin Biol Res, 357, 313-9
PubMed 2170996

Wanderas EH, Fosså SD, Heilo A, Stenwig AE, Norman N (1990)
Serum follicle stimulating hormone--predictor of cancer in the remaining testis in patients with unilateral testicular cancer
Br J Urol, 66 (3), 315-7
DOI 10.1111/j.1464-410x.1990.tb14935.x, PubMed 2119845

Aass N, Fosså SD, Ous S, Lien HH, Stenwig AE, Paus E, Kaalhus O (1990)
Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage non-seminomatous testicular cancer?
Br J Urol, 65 (4), 385-90
DOI 10.1111/j.1464-410x.1990.tb14762.x, PubMed 2340372

Aass N, Fosså SD, Ous S, Stenwig AE, Lien HH, Paus E, Kaalhus O (1990)
Prognosis in patients with metastatic non-seminomatous testicular cancer
Radiother Oncol, 17 (4), 285-92
DOI 10.1016/0167-8140(90)90002-e, PubMed 1693003

Aass N, Fosså SD, Aas M, Lindegaard MW (1990)
Renal function related to different treatment modalities for malignant germ cell tumours
Br J Cancer, 62 (5), 842-6
DOI 10.1038/bjc.1990.391, PubMed 2173944

Aass N, Kaasa S, Lund E, Kaalhus O, Heier MS, Fosså SD (1990)
Long-term somatic side-effects and morbidity in testicular cancer patients
Br J Cancer, 61 (1), 151-5
DOI 10.1038/bjc.1990.31, PubMed 2297486

Publications 1989

Abildgaard A, Lien HH, Fosså SD, Høie J, Langholm R (1989)
Enlargement of the thymus following chemotherapy for non-seminomatous testicular cancer
Acta Radiol, 30 (3), 259-62
PubMed 2472163

Fosså A, Fosså SD (1989)
Serum lactate dehydrogenase and human choriogonadotrophin in seminoma
Br J Urol, 63 (4), 408-15
DOI 10.1111/j.1464-410x.1989.tb05228.x, PubMed 2653557

Fosså SD, Kullmann G, Lien HH, Stenwig AE, Ous S (1989)
Chemotherapy of advanced seminoma: clinical significance of radiological findings before and after treatment
Br J Urol, 64 (5), 530-4
DOI 10.1111/j.1464-410x.1989.tb05293.x, PubMed 2611626

Fosså SD, Melvik JE, Juul NO, Pettersen EO, Theodorsen L (1989)
DNA flow cytometry in sperm cells from unilaterally orchiectomized patients with testicular cancer before further treatment
Cytometry, 10 (3), 345-50
DOI 10.1002/cyto.990100315, PubMed 2714118

Fosså SD, Ous S, Lien HH, Stenwig AE (1989)
Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer
J Urol, 141 (3), 557-9
DOI 10.1016/s0022-5347(17)40892-5, PubMed 2918591

Fosså SD, Raabe N, Moe B (1989)
Recombinant interferon-alpha with or without vinblastine in metastatic renal carcinoma. Results of a randomised phase II study
Br J Urol, 64 (5), 468-71
DOI 10.1111/j.1464-410x.1989.tb05278.x, PubMed 2611615

Fosså SD, Splinter T, Roozendaal KJ, Veenhof KH, Pavone-Macaluso M, Calciati A, de Pauw M, Sylvester R (1989)
A phase II study of 4-epi-adriamycin in advanced urothelial transitional cell cancer. EORTC-GU Group protocol 30867
Eur J Cancer Clin Oncol, 25 (2), 389-90
DOI 10.1016/0277-5379(89)90035-7, PubMed 2702991

Fosså SD, Stenwig AE, Lien HH, Ous S, Kaalhus O (1989)
Non-seminomatous testicular cancer clinical stage I: prediction of outcome by histopathological parameters. A multivariate analysis
Oncology, 46 (5), 297-300
DOI 10.1159/000226736, PubMed 2779945

Fosså SD, Aagedal H (1989)
The introduction of personal computers into clinical cancer research in Norway
Acta Oncol, 28 (4), 543-5
DOI 10.3109/02841868909092266, PubMed 2789833

Fosså SD, Aaronson N, Calais da Silva F, Denis L, Newling D, Hosbach G, Kaalhus O (1989)
Quality of life in patients with muscle-infiltrating bladder cancer and hormone-resistant prostatic cancer
Eur Urol, 16 (5), 335-9
DOI 10.1159/000471611, PubMed 2476317

Fosså SD, Aass N (1989)
Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer
Br J Urol, 63 (5), 531-4
DOI 10.1111/j.1464-410x.1989.tb05951.x, PubMed 2543475

Fosså SD, Aass N, Kaalhus O (1989)
Long-term morbidity after infradiaphragmatic radiotherapy in young men with testicular cancer
Cancer, 64 (2), 404-8
DOI 10.1002/1097-0142(19890715)64:2<404::aid-cncr2820640211>3.0.co;2-7, PubMed 2736486

Fosså SD, Aass N, Kaalhus O (1989)
Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients
Int J Radiat Oncol Biol Phys, 16 (2), 383-8
DOI 10.1016/0360-3016(89)90334-9, PubMed 2921142

Fosså SD, Aass N, Molne K (1989)
Is routine pre-treatment cryopreservation of semen worthwhile in the management of patients with testicular cancer?
Br J Urol, 64 (5), 524-9
DOI 10.1111/j.1464-410x.1989.tb05292.x, PubMed 2611625

Fosså SD, Aass N, Molne K (1989)
Can we cure testicular cancer and retain fertility?
Prog Clin Biol Res, 303, 769-77
PubMed 2780672

Fosså SD, Aass N, Ous S (1989)
[Testicular cancer. A challenge to the health services taking care of young males]
Tidsskr Nor Laegeforen, 109 (3), 337-40
PubMed 2916218

Fosså SD, Aass N, Ous S, Høie J, Stenwig AE, Lien HH, Paus E, Kaalhus O (1989)
Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer
J Urol, 142 (5), 1239-42
DOI 10.1016/s0022-5347(17)39044-4, PubMed 2478726

Jacobsen AB, Lunde S, Ous S, Melvik JE, Pettersen EO, Kaalhus O, Fosså SD (1989)
T2/T3 bladder carcinomas treated with definitive radiotherapy with emphasis on flow cytometric DNA ploidy values
Int J Radiat Oncol Biol Phys, 17 (5), 923-9
DOI 10.1016/0360-3016(89)90137-5, PubMed 2808053

Jones WG, Fosså SD, Hamers H, Van den Bogaert W (1989)
Penis cancer: a review by the Joint Radiotherapy Committee of the European Organisation for Research and Treatment of Cancer (EORTC) Genitourinary and Radiotherapy Groups
J Surg Oncol, 40 (4), 227-31
DOI 10.1002/jso.2930400405, PubMed 2648076

Lothe RA, Fosså SD, Stenwig AE, Nakamura Y, White R, Børresen AL, Brøgger A (1989)
Loss of 3p or 11p alleles is associated with testicular cancer tumors
Genomics, 5 (1), 134-8
DOI 10.1016/0888-7543(89)90097-9, PubMed 2767683

Negrier S, Philip T, Stoter G, Fossa SD, Janssen S, Iacone A, Cleton FS, Eremin O, Israel L, Jasmin C (1989)
Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre study
Eur J Cancer Clin Oncol, 25 Suppl 3, S21-8
PubMed 2697575

Omland H, Fosså SD (1989)
Spontaneous regression of cerebral and pulmonary metastases in renal cell carcinoma
Scand J Urol Nephrol, 23 (2), 159-60
DOI 10.3109/00365598909180834, PubMed 2756362

Raabe NK, Fossa SD, Parø G (1989)
Phase II study of carboplatin in locally advanced and metastatic transitional cell carcinoma of the urinary bladder
Br J Urol, 64 (6), 604-7
DOI 10.1111/j.1464-410x.1989.tb05318.x, PubMed 2697452

Stoter G, Fosså SD, Rugarli C, Symann M, Jasmin C, Israel L, Bijman JT, Palmer P, Franks CR, Philip T (1989)
Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre study
Cancer Treat Rev, 16 Suppl A, 111-3
DOI 10.1016/0305-7372(89)90030-3, PubMed 2670207

Tveit KM, Karlsen KO, Fosså SD, Flokkmann A, Guldvog I, Haffner J (1989)
Primary treatment of carcinoma of the anus by combined radiotherapy and chemotherapy
Scand J Gastroenterol, 24 (10), 1243-7
DOI 10.3109/00365528909090794, PubMed 2513640

van Oosterom AT, Stoter G, Bono AV, Splinter TA, Fossa SD, Verbaeys AJ, de Mulder PH, de Pauw M, Sylvester R (1989)
Mitozolomide in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group
Eur J Cancer Clin Oncol, 25 (8), 1249-50
DOI 10.1016/0277-5379(89)90422-7, PubMed 2767112

Aass N, Fosså SD, Otto F, Ose T (1989)
Acute subjective morbidity after cisplatin-based combination chemotherapy in patients with testicular cancer: a prospective study
Radiother Oncol, 14 (1), 27-33
DOI 10.1016/0167-8140(89)90005-4, PubMed 2467328

Publications 1988

Andersson L, Esposti PL, Fosså SD, Sander S (1988)
Induction chemotherapy in association with preoperative radiotherapy and cystectomy in bladder carcinoma--a preliminary report
Prog Clin Biol Res, 260, 621-3
PubMed 3362910

Blomlie V, Lien HH, Fosså SD, Jacobsen AB, Stenwig AE (1988)
Computed tomography in primary non-seminomatous germ cell tumors of the mediastinum
Acta Radiol, 29 (3), 289-92
PubMed 2838064

Borge N, Fosså SD, Ous S, Stenwig AE, Lien HH (1988)
Late recurrence of testicular cancer
J Clin Oncol, 6 (8), 1248-53
DOI 10.1200/JCO.1988.6.8.1248, PubMed 2842463

Fosså SD (1988)
Is interferon with or without vinblastine the "treatment of choice" in metastatic renal cell carcinoma? The Norwegian Radium Hospital's experience 1983-1986
Semin Surg Oncol, 4 (3), 178-83
DOI 10.1002/ssu.2980040308, PubMed 3055161

Fosså SD, Arnesen A, Granerud T (1988)
[Application for basic financial support and special allowance by cancer patients with colostomies]
Tidsskr Nor Laegeforen, 108 (27), 2264-6
PubMed 3206433

Fosså SD, Klepp O, Norman N (1988)
Lack of gonadal protection by medroxyprogesterone acetate-induced transient medical castration during chemotherapy for testicular cancer
Br J Urol, 62 (5), 449-53
DOI 10.1111/j.1464-410x.1988.tb04395.x, PubMed 2850071

Fosså SD, Miller A, Ous S, Poppe E, Host H, Kaalhus O (1988)
Treatment of muscle-infiltrating bladder cancer: the Norwegian Radium Hospital's experience 1966-1982
Prog Clin Biol Res, 260, 525-41
PubMed 3129737

Fosså SD, Tveit K, Börmer O, Moxnes A, Jørgensen NP, Orjaseter H, Kristoffersen DT (1988)
Relative bioavailability of oral low dose methotrexate. A comparison of 2 different formulations
Eur J Clin Pharmacol, 34 (5), 517-9
DOI 10.1007/BF01046713, PubMed 3203714

Fosså SD, Aass N, Kaalhus O (1988)
Testicular cancer in young Norwegians
J Surg Oncol, 39 (1), 43-63
DOI 10.1002/jso.2930390110, PubMed 3047500

Heimdal K, Hannisdal E, Fosså SD (1988)
Survival after palliative radiotherapy of liver metastases. A search for prognostic factors
Acta Oncol, 27 (1), 63-5
DOI 10.3109/02841868809090320, PubMed 2452647

Jacobsen AB, Fosså SD, Thorud E, Lunde S, Melvik JE, Pettersen EO (1988)
DNA flow cytometric values in bladder carcinoma biopsies obtained from fresh and paraffin-embedded material
APMIS, 96 (1), 25-9
DOI 10.1111/j.1699-0463.1988.tb05263.x, PubMed 3278720

Jacobsen AB, Thorud E, Fosså SD, Lunde S, Shoaib MC, Juul NO, Pettersen EO (1988)
DNA flow cytometry in metastases and a recurrency of malignant melanomas. A comparison of results from fresh and paraffin embedded material
Virchows Arch B Cell Pathol Incl Mol Pathol, 54 (5), 273-7
DOI 10.1007/BF02899223, PubMed 2895539

Lien HH, Lindsköld L, Fosså SD, Aass N (1988)
Computed tomography and conventional radiography in intrathoracic metastases from non-seminomatous testicular tumor
Acta Radiol, 29 (5), 547-9
PubMed 3166874

Paus E, Fosså A, Fosså SD, Nustad K (1988)
High frequency of incomplete human chorionic gonadotropin in patients with testicular seminoma
J Urol, 139 (3), 542-4
DOI 10.1016/s0022-5347(17)42515-8, PubMed 2449547

Sager EM, Fosså SD, Ous S, Johannessen N (1988)
Evaluation of response by CT in patients with advanced bladder cancer treated with cisplatinum/methotrexate
Prog Clin Biol Res, 260, 499-510
PubMed 3362903

Sager EM, Talle K, Lindsköld L, Fosså SD, Kaalhus O, Johannessen NB, Ous S (1988)
Computed tomography of invasive bladder carcinoma after diagnostic transurethral resection
Acta Radiol, 29 (4), 435-9
PubMed 3408604

Svare A, Fosså SD, Heier MS (1988)
Cranial nerve dysfunction in metastatic cancer of the prostate
Br J Urol, 61 (5), 441-4
DOI 10.1111/j.1464-410x.1988.tb06594.x, PubMed 3395804

Aass N, Fosså SD (1988)
Paternity in young patients with testicular cancer--expectations and experience
Prog Clin Biol Res, 269, 481-91
PubMed 2839852

Publications 1987

Evensen JF, Fosså SD, Kjellevold K, Lien HH (1987)
Testicular seminoma: histological findings and their prognostic significance for stage II disease
J Surg Oncol, 36 (3), 166-9
DOI 10.1002/jso.2930360304, PubMed 3682835

Flokkmann A, Fosså SD, Karlsen KO (1987)
[Radiotherapy and chemotherapy in anal carcinoma]
Tidsskr Nor Laegeforen, 107 (1), 50-2, 61
PubMed 3103254

Fossa SD (1987)
Improved subjective tolerability of interferon by combination with prednisolone
Eur J Cancer Clin Oncol, 23 (6), 875-6
DOI 10.1016/0277-5379(87)90295-1, PubMed 3653205

Fosså SD (1987)
To meet spiritual needs of the cancer patient--a responsibility for the oncologist?
Acta Oncol, 26 (1), 75-6
DOI 10.3109/02841868709092982, PubMed 2439109

Fosså SD (1987)
Palliative pelvic radiotherapy in patients with hormone-resistant prostatic cancer
Prog Clin Biol Res, 243B, 479-85
PubMed 2443925

Fosså SD, Borge L, Aass N, Johannessen NB, Stenwig AE, Kaalhus O (1987)
The treatment of advanced metastatic seminoma: experience in 55 cases
J Clin Oncol, 5 (7), 1071-7
DOI 10.1200/JCO.1987.5.7.1071, PubMed 2439660

Fosså SD, De Garis ST (1987)
Further experience with recombinant interferon alfa-2a with vinblastine in metastatic renal cell carcinoma: a progress report
Int J Cancer Suppl, 1, 36-40
DOI 10.1002/ijc.2910390708, PubMed 3476476

Fosså SD, Dingsør E, Johannessen NB, Kvarstein B, Stenwig AE, Urnes T, Waehre H, Ogreid P (1987)
Pre-cystectomy chemotherapy in patients with muscle infiltrating bladder carcinoma. A multicentre feasibility study
Scand J Urol Nephrol, 21 (1), 39-42
DOI 10.3109/00365598709180288, PubMed 3589522

Fosså SD, Hall KS, Johannessen NB, Urnes T, Kaalhus O (1987)
Cancer of the penis. Experience at the Norwegian Radium Hospital 1974-1985
Eur Urol, 13 (6), 372-7
PubMed 3428320

Fosså SD, Reitan JB, Ous S, Kaalhus O (1987)
Life with an ileal conduit in cystectomized bladder cancer patients: expectations and experience
Scand J Urol Nephrol, 21 (2), 97-101
DOI 10.3109/00365598709180301, PubMed 3616512

Fosså SD, Urnes T, Kaalhus O (1987)
Weekly low-dose adriamycin in hormone-resistant metastatic cancer of the prostate
Scand J Urol Nephrol, 21 (1), 13-6
DOI 10.3109/00365598709180283, PubMed 2438753

Jacobsen AB, Fosså SD, Lunde S, Melvik JE, Pettersen EO (1987)
Flow cytometric DNA measurements in paraffin-embedded bladder carcinoma tissue before and after precystectomy radiotherapy
Radiother Oncol, 10 (2), 149-55
DOI 10.1016/s0167-8140(87)80057-9, PubMed 3423304

Jones WG, Fosså SD, Bono AV, Klijn JG, De Pauw M, Sylvester R (1987)
European Organization for Research and Treatment of Cancer (EORTC) phase II study of low-dose weekly epirubicin in metastatic prostate cancer
Cancer Treat Rep, 71 (12), 1317-8
PubMed 3480046

Kvale D, Rognum TO, Thorud E, Fosså SD, Rø JS, Brandtzaeg P (1987)
Circulating secretory component in breast neoplasms
J Clin Pathol, 40 (6), 621-5
DOI 10.1136/jcp.40.6.621, PubMed 3301907

Lien HH, Lindsköld L, Stenwig AE, Ous S, Fosså SD (1987)
Shape of retroperitoneal lymph nodes at computed tomography does not correlate to metastatic disease in early stage non-seminomatous testicular tumors
Acta Radiol, 28 (3), 271-3
PubMed 2820452

Lien HH, Stenwig AE, Ous S, Fosså SD (1987)
Influence of section spacing on reliability of abdominal computed tomography in early stage non-seminomatous testicular tumor
Acta Radiol, 28 (2), 169-71
PubMed 2953371

Paus E, Fosså SD, Risberg T, Nustad K (1987)
The diagnostic value of human chorionic gonadotrophin in patients with testicular seminoma
Br J Urol, 59 (6), 572-7
DOI 10.1111/j.1464-410x.1987.tb04880.x, PubMed 3690188

Saeter G, Fosså SD, Norman N (1987)
Gynaecomastia following cytotoxic therapy for testicular cancer
Br J Urol, 59 (4), 348-52
DOI 10.1111/j.1464-410x.1987.tb04647.x, PubMed 3107651

Sager EM, Fossä SD, Kaalhus O, Talle K (1987)
Contrast-enhanced computed tomography in carcinoma of the urinary bladder. The use of different injection methods
Acta Radiol, 28 (1), 67-70
PubMed 2952145

Sager EM, Talle K, Fosså SD, Ous S, Stenwig AE (1987)
Contrast-enhanced computed tomography to show perivesical extension in bladder carcinoma
Acta Radiol, 28 (3), 307-11
PubMed 2958038

Stoter G, Splinter TA, Child JA, Fosså SD, Denis L, van Oosterom AT, de Pauw M, Sylvester R (1987)
Combination chemotherapy with cisplatin and methotrexate in advanced transitional cell cancer of the bladder
J Urol, 137 (4), 663-7
DOI 10.1016/s0022-5347(17)44168-1, PubMed 3560318

Telhaug R, Fosså SD, Ous S (1987)
Definitive radiotherapy of prostatic cancer: the Norwegian Radium Hospital's experience (1976-1982)
Prostate, 11 (1), 77-86
DOI 10.1002/pros.2990110110, PubMed 3658830

Wanderås EH, Fosså SD, Tveit KM, Flokkmann A (1987)
Sequential 5-fluorouracil and methotrexate. Negative experience in metastatic colorectal cancer
Acta Oncol, 26 (4), 289-93
DOI 10.3109/02841868709089977, PubMed 3500730

Publications 1986

Abrahamsen AF, Klepp O, Fosså SD, Sønstevold A (1986)
Transient vinblastine-induced thrombocytopenia during chemotherapy with vinblastine, cis-platinum and bleomycin
Scand J Haematol, 37 (1), 44-9
DOI 10.1111/j.1600-0609.1986.tb01770.x, PubMed 2429363

Fosså SD, Abyholm T, Normann N, Jetne V (1986)
Post-treatment fertility in patients with testicular cancer. III. Influence of radiotherapy in seminoma patients
Br J Urol, 58 (3), 315-9
DOI 10.1111/j.1464-410x.1986.tb09062.x, PubMed 3087451

Fosså SD, Almaas B, Jetne V, Bjerkedal T (1986)
Paternity after irradiation for testicular cancer
Acta Radiol Oncol, 25 (1), 33-6
DOI 10.3109/02841868609136374, PubMed 3010648

Fosså SD, de Garis ST, Heier MS, Flokkmann A, Lien HH, Salveson A, Moe B (1986)
Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma
Cancer, 57 (8 Suppl), 1700-4
DOI 10.1002/1097-0142(19860415)57:8+<1700::aid-cncr2820571313>3.0.co;2-b, PubMed 3948141

Fosså SD, Flokkmann A, Heier M, Aas M, Moe B, Heintz R, Linder-Ciccolunghi S (1986)
Phase I/II tolerability/pharmacokinetic study with one-hour intravenous infusion of doxifluiridine (5'-dFUrd) 3 g/m2 VS 5 g/m2 QD x 5 per month
Cancer Chemother Pharmacol, 18 (3), 252-6
DOI 10.1007/BF00273397, PubMed 2948731

Fosså SD, Melsom H, Loeb M (1986)
[Metastases from an unknown primary tumor. Diagnostic and prognostic aspects]
Tidsskr Nor Laegeforen, 106 (1), 3-5
PubMed 3952694

Fosså SD, Ous S, Tveter K, Otnes B, Igesund A, Dingsør E, Aunan O, Taksdahl S, Scott-Knudsen O, Lund E (1986)
Treatment of T2/T3 bladder carcinoma: total cystectomy with and without preoperative irradiation
Eur Urol, 12 (3), 158-63
PubMed 3709583

Fosså SD, Thorud E, Pettersen EO, Shoaib MC, Scott-Knudsen O, Ous S (1986)
DNA flow cytometry in human bladder carcinoma
Pathol Res Pract, 181 (3), 291-5
DOI 10.1016/S0344-0338(86)80105-4, PubMed 3748875

Fosså SD, Thorud E, Shoaib MC, Pettersen EO (1986)
DNA flow cytometry of cells obtained from old paraffin-embedded specimens. A comparison with results of scanning absorption cytometry (a methodological study)
Pathol Res Pract, 181 (2), 200-5
DOI 10.1016/S0344-0338(86)80011-5, PubMed 3526304

Fosså SD, Urnes T (1986)
Flare reaction during the initial treatment period with medroxyprogesterone acetate in patients with hormone-resistant prostatic cancer
Eur Urol, 12 (4), 257-9
DOI 10.1159/000472631, PubMed 3743595

Fosså SD, Aass N, Kaalhus O, Klepp O, Tveter K (1986)
Long-term survival and morbidity in patients with metastatic malignant germ cell tumors treated with cisplatin-based combination chemotherapy
Cancer, 58 (12), 2600-5
DOI 10.1002/1097-0142(19861215)58:12<2600::aid-cncr2820581208>3.0.co;2-d, PubMed 3022908

Hall KS, Fosså SD, Aas M (1986)
High-dose cis-platinum combination chemotherapy in advanced nonseminomatous malignant germ cell tumours with emphasis on nephrotoxicity
Cancer Chemother Pharmacol, 18 (1), 74-7
DOI 10.1007/BF00253069, PubMed 2428537

Heier MS, Fosså SD (1986)
Wernicke-Korsakoff-like syndrome in patients with colorectal carcinoma treated with high-dose doxifluridine (5'-dFUrd)
Acta Neurol Scand, 73 (5), 449-57
DOI 10.1111/j.1600-0404.1986.tb04583.x, PubMed 2941966

Heier MS, Heintz R, Fosså SD (1986)
Passage of 5'-dFUrd and its metabolites 5-FU and 5-FUH2 to CSF in a clinical phase 1 study
Acta Neurol Scand, 74 (3), 240-4
DOI 10.1111/j.1600-0404.1986.tb07862.x, PubMed 2947416

Kristianslund S, Fosså SD, Kjellevold K (1986)
Bilateral malignant testicular germ cell cancer
Br J Urol, 58 (1), 60-3
DOI 10.1111/j.1464-410x.1986.tb05429.x, PubMed 2868770

Lien HH, Stenwig AE, Ous S, Fosså SD (1986)
Influence of different criteria for abnormal lymph node size on reliability of computed tomography in patients with non-seminomatous testicular tumor
Acta Radiol Diagn (Stockh), 27 (2), 199-203
DOI 10.1177/028418518602700212, PubMed 3716866

Nesland JM, Pettersen EO, Fosså SD, Høie J, Johannessen JV (1986)
Nuclear DNA content in breast carcinomas with neuroendocrine differentiation
J Pathol, 150 (3), 181-5
DOI 10.1002/path.1711500306, PubMed 3027292

Richards B, Aso Y, Bollack C, Fossa S, Koontz W, Matsuda M, Matsumoto K, Prout G, Van der Werf-Messing B, Wolf H (1986)
Prognostic factors in infiltrating bladder cancer
Prog Clin Biol Res, 221, 271-86
PubMed 3543944

Thorud E, Fosså SD, Vaage S, Kaalhus O, Knudsen OS, Børmer O, Shoaib MC (1986)
Primary breast cancer. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics
Cancer, 57 (4), 808-11
DOI 10.1002/1097-0142(19860215)57:4<808::aid-cncr2820570421>3.0.co;2-#, PubMed 3943014

van Oosterom AT, Bono AV, Kaye SB, Splinter TA, Calciati A, Fosså SD, de Pauw M, Sylvester R (1986)
4'Deoxydoxorubicin in advanced renal cancer. A phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group
Eur J Cancer Clin Oncol, 22 (12), 1531-2
DOI 10.1016/0277-5379(86)90091-x, PubMed 3595678

Aaronson NK, Calais da Silva F, Yoshida O, van Dam FS, Fosså SD, Miyakawa M, Raghavan D, Riedl H, Robinson MR, Worden JW (1986)
Quality of life assessment in bladder cancer clinical trials: conceptual, methodological and practical issues
Prog Clin Biol Res, 221, 149-70
PubMed 3543941

Publications 1985

Evensen JF, Fossa SD, Kjellevold K, Lien HH (1985)
Testicular seminoma: analysis of treatment and failure for stage II disease
Radiother Oncol, 4 (1), 55-61
DOI 10.1016/s0167-8140(85)80062-1, PubMed 4035002

Fossa SD (1985)
The need for long-term follow-up studies after treatment of superficial bladder cancer (Tis/Ta/T1), especially after intravesical chemotherapy
Prog Clin Biol Res, 185B, 31-7
PubMed 4034589

Fossa SD, Ous S (1985)
Primary unilateral retroperitoneal lymph node dissection (RLND) in non-seminomatous testicular cancer
Prog Clin Biol Res, 203, 319
PubMed 3832089

Fossa SD, Paus E (1985)
Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer
Prog Clin Biol Res, 203, 121
PubMed 2421325

Fossa SD, Risberg T (1985)
beta-HCG producing seminoma
Prog Clin Biol Res, 203, 105-6
PubMed 2421322

Fosså SD (1985)
Influence of lymph node dissection and/or chemotherapy on fertility in patients with testicular cancer
Prog Clin Biol Res, 203, 687-701
PubMed 3832117

Fosså SD (1985)
Fertility after radiotherapy for testicular cancer
Prog Clin Biol Res, 203, 703-12
PubMed 3938547

Fosså SD, Abeler V, Marton PF, Lien HH, Høie J (1985)
Sarcoid reaction of hilar and paratracheal lymph nodes in patients treated for testicular cancer
Cancer, 56 (9), 2212-6
DOI 10.1002/1097-0142(19851101)56:9<2212::aid-cncr2820560913>3.0.co;2-n, PubMed 4052967

Fosså SD, Dahl O, Hoel R, Heier M, Loeb M (1985)
Doxifluridine (5'-dFUrd) in patients with advanced colorectal carcinoma. A phase II study
Cancer Chemother Pharmacol, 15 (2), 161-3
DOI 10.1007/BF00257528, PubMed 2990750

Fosså SD, Høst H, Johannessen JV (1985)
Viktig å vite om testikkelkreft
Landsforeningen mot kreft, [Oslo], 11 s.
BIBSYS 865003491

Fosså SD, Jahnsen JU, Karlsen S, Ogreid P, Haveland H, Trovåg A (1985)
High-dose medroxyprogesterone acetate versus prednisolone in hormone-resistant prostatic cancer. A pilot study
Eur Urol, 11 (1), 11-6
DOI 10.1159/000472441, PubMed 3157571

Fosså SD, Kaalhus O (1985)
The prognostic relevance of nuclear Feulgen DNA in transitional cell carcinoma of the urinary bladder. A long-term follow-up study
Eur Urol, 11 (6), 418-21
DOI 10.1159/000472553, PubMed 2417858

Fosså SD, Kaalhus O (1985)
[Radiotherapy. Locally advanced colorectal cancer with and without 5-fluorouracil]
Tidsskr Nor Laegeforen, 105 (6), 423-6
PubMed 3983943

Fosså SD, Ous S, Abyholm T, Loeb M (1985)
Post-treatment fertility in patients with testicular cancer. I. Influence of retroperitoneal lymph node dissection on ejaculatory potency
Br J Urol, 57 (2), 204-9
DOI 10.1111/j.1464-410x.1985.tb06425.x, PubMed 2580586

Fosså SD, Ous S, Abyholm T, Norman N, Loeb M (1985)
Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production
Br J Urol, 57 (2), 210-4
DOI 10.1111/j.1464-410x.1985.tb06426.x, PubMed 2580587

Fosså SD, Ous S, Knudsen OS (1985)
Radical irradiation of T2 and T3 bladder carcinoma. A retrospective investigation
Acta Radiol Oncol, 24 (6), 497-501
DOI 10.3109/02841868509134423, PubMed 3006439

Fosså SD, Pettersen EO, Thorud E, Melvik JE, Ous S (1985)
DNA flow cytometry in human testicular cancer
Cancer Lett, 28 (1), 55-60
DOI 10.1016/0304-3835(85)90092-8, PubMed 4027957

Fosså SD, Reitan JB, Ous S, Odegaard A, Loeb M (1985)
Prediction of tumour progression in superficial bladder carcinoma
Eur Urol, 11 (1), 1-5
DOI 10.1159/000472438, PubMed 3987745

Fosså SD, Urnes T, Ous S (1985)
Short-term and long-term effect of prophylactic treatment of superficial bladder cancer with intravesical adriamycin
Eur Urol, 11 (6), 382-5
DOI 10.1159/000472545, PubMed 4085529

Gedde-Dahl T, Hannisdal E, Klepp OH, Grøttum KA, Waksvik H, Fosså SD, Stenwig AE, Brøogger A (1985)
Testicular neoplasms occurring in four brothers. A search for a genetic predisposition
Cancer, 55 (9), 2005-9
DOI 10.1002/1097-0142(19850501)55:9<2005::aid-cncr2820550930>3.0.co;2-l, PubMed 2983872

Heier MS, Fosså SD (1985)
Neurological manifestations in a phase 2 study of 13 patients treated with doxyfluridine
Acta Neurol Scand, 72 (2), 171-5
DOI 10.1111/j.1600-0404.1985.tb00859.x, PubMed 2996281

Lien HH, Brodahl U, Telhaug R, Holthe H, Fosså SD (1985)
Pulmonary changes at computed tomography in patients with testicular carcinoma treated with cis-platinum, vinblastine and bleomycin
Acta Radiol Diagn (Stockh), 26 (5), 507-10
DOI 10.1177/028418518502600502, PubMed 2416191

Sommer HH, Fosså SD, Lien HH (1985)
Combination chemotherapy of advanced renal cell cancer with CCNU and vinblastine
Cancer Chemother Pharmacol, 14 (3), 277-8
DOI 10.1007/BF00258134, PubMed 3995687

Tveit KM, Pettersen EO, Fosså SD, Pihl A (1985)
Selection of tumour cell subpopulations occurs during cultivation of human tumours in soft agar. A DNA flow cytometric study
Br J Cancer, 52 (5), 701-5
DOI 10.1038/bjc.1985.246, PubMed 4063145

van Oosterom AT, Fosså SD, Mulder JH, Calciati A, de Pauw M, Sylvester R (1985)
Mitoxantrone in advanced bladder carcinoma. A phase II study of the EORTC Genito-urinary Tract Cancer Cooperative Group
Eur J Cancer Clin Oncol, 21 (9), 1013-4
DOI 10.1016/0277-5379(85)90284-6, PubMed 4065174

von Krogh J, Lien HH, Ous S, Fosså SD (1985)
Alterations in the CT image following retroperitoneal lymphadenectomy in early stage non-seminomatous testicular tumor
Acta Radiol Diagn (Stockh), 26 (2), 187-91
DOI 10.1177/028418518502600211, PubMed 3993423

Publications 1984

Fosså SD (1984)
Intravesical treatment with thiotepa: an update review
Prog Clin Biol Res, 162B, 163-8
PubMed 6438640

Fosså SD, Abyholm T, Aakvaag A (1984)
Spermatogenesis and hormonal status after orchiectomy for cancer and before supplementary treatment
Eur Urol, 10 (3), 173-7
DOI 10.1159/000463782, PubMed 6426966

Fosså SD, Hovind OB, Hillestad B (1984)
[The use of estramustine phosphate (estramustine, Estracyt) in Norway 1972-1981. An example of the irrational use of an expensive treatment]
Tidsskr Nor Laegeforen, 104 (7), 482-4
PubMed 6729780

Fosså SD, Klepp O, Ous S, Lien H, Stenwig JT, Abeler V, Eliassen G, Høst H (1984)
Multi-modality treatment in males with advanced malignant germ cell tumours. II. Experience with surgery and radiotherapy following cis-platinum-based chemotherapy
Scand J Urol Nephrol, 18 (1), 21-6
DOI 10.3109/00365598409182159, PubMed 6326253

Fosså SD, Klepp O, Ous S, Lien HH, Stenwig AE, Abyholm T, Kaalhus O (1984)
Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I
Eur Urol, 10 (1), 17-23
DOI 10.1159/000463504, PubMed 6698081

Fosså SD, Kaalhus O, Sauer T, Hager B, Lund G (1984)
Radiotherapy of T4 bladder carcinoma
Radiother Oncol, 1 (4), 291-8
DOI 10.1016/s0167-8140(84)80016-x, PubMed 6209751

Fosså SD, Telhaug R, Wahlqvist R (1984)
[Spontaneous remission of metastases from renal cancer]
Tidsskr Nor Laegeforen, 104 (8), 583-5
PubMed 6719422

Fosså SD, Thorud E, Shoaib MC, Pettersen EO, Høie J, Knudsen OS (1984)
DNA flow cytometry in primary breast carcinoma
Acta Pathol Microbiol Immunol Scand A, 92 (6), 475-80
DOI 10.1111/j.1699-0463.1984.tb04430.x, PubMed 6516845

Klepp O, Fosså SD, Ous S, Lien H, Stenwig JT, Abeler V, Eliassen G, Høst H (1984)
Multi-modality treatment of advanced malignant germ cell tumours in males. I. Experience with cis-platinum-based combination chemotherapy
Scand J Urol Nephrol, 18 (1), 13-9
DOI 10.3109/00365598409182158, PubMed 6201998

Saeter G, Fosså SD, Ous S, Blom GP, Kaalhus O (1984)
Carcinoma of the prostate with soft tissue or non-regional lymphatic metastases at the time of diagnosis: a review of 47 cases
Br J Urol, 56 (4), 385-90
DOI 10.1111/j.1464-410x.1984.tb05827.x, PubMed 6534426

Stoter G, van Oosterom AT, Mulder JH, de Pauw M, Fosså SD (1984)
Combination chemotherapy with cisplatin and VM-26 in advanced transitional cell carcinoma of the bladder
Eur J Cancer Clin Oncol, 20 (3), 315-7
DOI 10.1016/0277-5379(84)90075-0, PubMed 6538494

Stridsklev IC, Fosså SD, Kaalhus O (1984)
[Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)]
Tidsskr Nor Laegeforen, 104 (28), 1977-80
PubMed 6388019

van Oosterom AT, Fosså SD, Pizzocaro G, Bergerat JP, Bono AV, De Pauw M, Sylvester R (1984)
Mitoxantrone in advanced renal cancer: a phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group
Eur J Cancer Clin Oncol, 20 (10), 1239-41
DOI 10.1016/0277-5379(84)90253-0, PubMed 6541582

Publications 1983

Alfthan O, Andersson L, Esposti PL, Fosså SD, Gammelgaard PA, Gjöres JE, Isacson S, Rasmussen F, Ruutu M, von Schreeb T, Setterberg G, Strandell P, Strindberg B (1983)
Cisobitan in treatment of prostatic cancer. A prospective controlled multicentre study
Scand J Urol Nephrol, 17 (1), 37-43
DOI 10.3109/00365598309179778, PubMed 6346476

Fossà SD, Skinningsrud A, Kaalhus O, Engeset A (1983)
Prostatic acid phosphatase in serum and bone marrow in patients with prostatic carcinoma
Br J Urol, 55 (3), 306-11
DOI 10.1111/j.1464-410x.1983.tb03305.x, PubMed 6850249

Fosså SD (1983)
[Preoperative radiotherapy of locally advanced colo-rectal-anal cancer]
Tidsskr Nor Laegeforen, 103 (22), 1523-4
PubMed 6636063

Fosså SD, Denis L, van Oosterom AT, de Pauw M, Stoter G (1983)
Vindesine in advanced renal cancer. A study of the EORTC Genito-urinary Tract Cancer Cooperative Group
Eur J Cancer Clin Oncol, 19 (4), 473-5
DOI 10.1016/0277-5379(83)90109-8, PubMed 6305668

Fosså SD, Heilo A, Lindegaard M, Skinningrud A, Ous S (1983)
Clinical significance of routine follow-up examinations in patients with metastatic cancer of the prostate under hormone treatment
Eur Urol, 9 (5), 262-6
DOI 10.1159/000474099, PubMed 6628467

Fosså SD, Miller A, Stenwig AE (1983)
Intravesical thiotepa prophylaxis of superficial bladder cancer. A follow-up study
Eur Urol, 9 (4), 207-10
DOI 10.1159/000474084, PubMed 6409615

Fosså SD, Nordbø O, Gundersen S, Skilshagen SJ, Otto F (1983)
[Cooling of the scalp as a preventive measure for alopecia during cytostatic therapy]
Tidsskr Nor Laegeforen, 103 (15), 1263-6
PubMed 6879559

Fosså SD, Thorud E, Vaage S, Shoaib MC (1983)
DNA cytometry of primary breast cancer. Comparison of microspectrophotometry and flow cytometry, and different preparation methods for flow cytometric measurements
Acta Pathol Microbiol Immunol Scand A, 91 (4), 235-43
PubMed 6869008

Gundersen S, Kvaløy S, Fosså SD, Høst H (1983)
[Ovarian irridation and prednisone versus tamoxifen (Nolvadex) in advanced breast cancer]
Tidsskr Nor Laegeforen, 103 (27), 1873-5
PubMed 6359581

Jones WG, Fosså SD, Denis L, Coninx P, Glashan RW, Akdas A, De Pauw M (1983)
An EORTC phase II study of vindesine in advanced prostate cancer
Eur J Cancer Clin Oncol, 19 (5), 583-8
DOI 10.1016/0277-5379(83)90172-4, PubMed 6683629

Lien HH, Fosså SD, Ous S, Stenwig AE (1983)
Lymphography in retroperitoneal metastases in non-seminoma testicular tumor patients with a normal CT scan
Acta Radiol Diagn (Stockh), 24 (4), 319-22
DOI 10.1177/028418518302400408, PubMed 6637571

Lien HH, Kolbenstvedt A, Talle K, Fosså SD, Klepp O, Ous S (1983)
Comparison of computed tomography, lymphography, and phlebography in 200 consecutive patients with regard to retroperitoneal metastases from testicular tumor
Radiology, 146 (1), 129-32
DOI 10.1148/radiology.146.1.6849033, PubMed 6849033

Richards B, Newling D, Fossa S, Bastable JR, Denis L, Jones WB, de Pauw M (1983)
Vincristine in advanced bladder cancer: a European organization for research on treatment of cancer (EORTC) phase II study
Cancer Treat Rep, 67 (6), 575-7
PubMed 6861163

Sager EM, Talle K, Fosså S, Ous S, Stenwig AE (1983)
The role of CT in demonstrating perivesical tumor growth in the preoperative staging of carcinoma of the urinary bladder
Radiology, 146 (2), 443-6
DOI 10.1148/radiology.146.2.6849091, PubMed 6849091

von Eyben FE, Skude G, Fosså SD, Klepp O, Børmer O (1983)
Serum lactate dehydrogenase (S-LDH) and S-LDH isoenzymes in patients with testicular germ cell tumors
Mol Gen Genet, 189 (2), 326-33
DOI 10.1007/BF00337825, PubMed 6190072

Publications 1982

Child JA, Bono AV, Fossa SD, Ten Bokkel Huinink WW, De Pauw M, Stoter G (1982)
An EORTC phase II study of methyl-glyoxal bis-guanylhydrazone in advanced renal cell cancer
Eur J Cancer Clin Oncol, 18 (1), 85-7
DOI 10.1016/0277-5379(82)90030-x, PubMed 7200896

Fosså SD (1982)
[A Swedish-Norwegian project for the diagnosis and treatment of non-seminomatous testicular cancer]
Tidsskr Nor Laegeforen, 102 (6), 371-4
PubMed 7157290

Fosså SD, Kjølseth I, Lund G (1982)
Radiotherapy of metastases from renal cancer
Eur Urol, 8 (6), 340-2
DOI 10.1159/000473553, PubMed 6183119

Fosså SD, Klepp O, Molne K, Aakvaag A (1982)
Testicular function after unilateral orchiectomy for cancer and before further treatment
Int J Androl, 5 (2), 179-84
DOI 10.1111/j.1365-2605.1982.tb00245.x, PubMed 7107033

Fosså SD, Kaalhus O, Gjersvik T, Segadal E (1982)
[Treatment of muscle-infiltrating bladder cancer (P2/P3) with partial cystectomy]
Tidsskr Nor Laegeforen, 102 (11), 627-9
PubMed 7157240

Fosså SD, Marton PF, Knudsen OS, Kaalhus O, Børmer O, Vaage S (1982)
Nuclear feulgen DNA content and nuclear size in human breast carcinoma
Hum Pathol, 13 (7), 626-30
DOI 10.1016/s0046-8177(82)80004-x, PubMed 7084938

Fosså SD, Wik B, Bae E, Lien HH (1982)
Phase II study of 4'-epi-doxorubicin in metastatic renal cancer
Cancer Treat Rep, 66 (5), 1219-21
PubMed 6952962

Kjølseth I, Fosså SD, Lund G (1982)
[Radiotherapy of metastasis from renal cancer]
Tidsskr Nor Laegeforen, 102 (19-21), 1012-4
PubMed 6187085

Mulder JH, Fossa SD, De Pauw M, Van Oosterom AT (1982)
Cyclophosphamide, adriamycin and cisplatin combination chemotherapy in advanced bladder carcinoma: an EORTC phase II study
Eur J Cancer Clin Oncol, 18 (1), 111-2
DOI 10.1016/0277-5379(82)90034-7, PubMed 7200890

Telhaug R, Fosså SD, Lund G, Børmer O (1982)
[Hormonal treatment of breast cancer in men. Experiences with antiestrogen Tamoxifen]
Tidsskr Nor Laegeforen, 102 (34-36), 1849-51
PubMed 7170693

Publications 1981

Fossa SD, Klepp O, Elgjo RF, Eliassen G, Melsom H, Urnes T, Wang M (1981)
The effect of patient's delay and doctor's delay in patients with malignant germ cell tumours
Int J Androl, 4 Suppl s4, 134-144
DOI 10.1111/j.1365-2605.1981.tb00664.x, PubMed 29112237

Fosså SD, Gudmundsen TE (1981)
Single-drug chemotherapy with 5-FU and adriamycin in metastatic bladder cancer
Br J Urol, 53 (4), 320-3
DOI 10.1111/j.1464-410x.1981.tb03188.x, PubMed 7260546

Fosså SD, Høst H, Aakvaag A (1981)
[Serum testosterone level in patients with advanced prostatic cancer during androgen suppressive treatment]
Tidsskr Nor Laegeforen, 101 (28), 1570-3
PubMed 7339933

Fosså SD, Odegaard A, Kaalhus O (1981)
Partial cystectomy followed by postoperative irradiation in treatment of bladder carcinoma (P2/P3)
Eur Urol, 7 (3), 150-6
DOI 10.1159/000473206, PubMed 7202452

Tveter KJ, Fosså SD, Odegaard A (1981)
[Carcinoma in situ of the urinary bladder. A review]
Tidsskr Nor Laegeforen, 101 (25), 1378-80
PubMed 7339923

Publications 1980

Fosså SD, Høst H (1980)
[Treatment of muscle-infiltrating bladder cancer by preoperative irradiation and total cystectomy]
Tidsskr Nor Laegeforen, 100 (30), 1773-5
PubMed 7456028

Fosså SD, Klepp O, Barth E, Aakvaag A, Kaalhus O (1980)
Endocrinological studies in patients with metastatic malignant testicular germ cell tumours
Int J Androl, 3 (5), 487-501
DOI 10.1111/j.1365-2605.1980.tb00137.x, PubMed 7192265

Fosså SD, Klepp O, Aakvaag A (1980)
Serum hormone levels in patients with malignant testicular germ cell tumours without clinical and/or radiological signs of tumour
Br J Urol, 52 (2), 151-7
DOI 10.1111/j.1464-410x.1980.tb02946.x, PubMed 6775725

Fosså SD, Klepp O, Aakvaag A, Molne K (1980)
Testicular function after combined chemotherapy for metastatic testicular cancer
Int J Androl, 3 (1), 59-65
DOI 10.1111/j.1365-2605.1980.tb00095.x, PubMed 6773888

Fosså SD, Talle K (1980)
Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation
Cancer Treat Rep, 64 (10-11), 1103-8
PubMed 6780190

Jacobsen AB, Fosså SD, Odegaard A (1980)
[Radiotherapy of prostatic carcinoma]
Tidsskr Nor Laegeforen, 100 (19-21), 1230-3
PubMed 7423453

Lotsberg J, Fosså SD, Klepp O, Orjasaeter H, Torjesen PA (1980)
[Biological markers in cancer of the testis]
Tidsskr Nor Laegeforen, 100 (12), 688-90
PubMed 6158120

Reitan JB, Pape E, Fosså SD, Julsrud OJ, Slettnes ON, Solheim OP (1980)
Osteosclerotic myeloma with polyneuropathy
Acta Med Scand, 208 (1-2), 137-44
DOI 10.1111/j.0954-6820.1980.tb01167.x, PubMed 6254342

Publications 1978

Fosså SD, Sokolowski J, Theodorsen L (1978)
The significance of bone marrow acid phosphatase in patients with prostatic carcinoma
Br J Urol, 50 (3), 185-9
DOI 10.1111/j.1464-410x.1978.tb02800.x, PubMed 753458

Fosså SD, Solheim O, Fosså J (1978)
[Cyklokapron (tranexamic acid) in the treatment of patients with advanced neoplasms]
Tidsskr Nor Laegeforen, 98 (28), 1368-70
PubMed 360480

Orjasaeter H, Fosså SD, Schjølseth SA, Fjaestad K (1978)
Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of the bladder/urethra
Cancer, 42 (1), 287-95
DOI 10.1002/1097-0142(197807)42:1<287::aid-cncr2820420143>3.0.co;2-l, PubMed 667800

Publications 1977

Fossa SD, Kaalhus O, Scott-Knudsen O (1977)
The clinical and histopathological significance of Feulgen DNA-values in transitional cell carcinoma of the human urinary bladder
Eur J Cancer (1965), 13 (10), 1155-62
DOI 10.1016/0014-2964(77)90015-9, PubMed 72669

Fosså SD (1977)
Scanning absorption DNA cytophotometry in human bladder carcinoma
forfatteren, Oslo, (flere pagineringer)
BIBSYS 970779054

Fosså SD, Fosså J, Aakvaag A (1977)
Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate
J Urol, 118 (6), 1013-8
DOI 10.1016/s0022-5347(17)58281-6, PubMed 926240

Fosså SD, Kaalhus O (1977)
Computer assisted image analysis of Feulgen-stained cell nuclei from transitional cell carcinoma of the human urinary bladder
Acta Pathol Microbiol Scand A, 85 (5), 590-602
DOI 10.1111/j.1699-0463.1977.tb00450.x, PubMed 72487

Fosså SD, Schjolseth SA, Miller A (1977)
Multiple urothelial tumours with metastases to uterus and left ovary. A case report
Scand J Urol Nephrol, 11 (1), 81-4
DOI 10.3109/00365597709179697, PubMed 847413

Publications 1976

Fossa SD, Kaalhus O (1976)
Nuclear size and chromatin concentration in transitional cell carcinoma of the human urinary bladder
Beitr Pathol, 157 (2), 109-25
DOI 10.1016/s0005-8165(76)80098-4, PubMed 1275858

Fosså SD, Haveland H, Miller A, Urianstad MK, Aakvaag A (1976)
External high-voltage radiotherapy of carcinoma of the prostate and the regional lymph nodes
Strahlentherapie, 152 (4), 338-44
PubMed 824763

Fosså SD, Kaalhus O (1976)
"Non-condensed" and "condensed" chromain in transitional cell carcinoma of the human urinary bladder
Beitr Pathol, 158 (3), 241-54
DOI 10.1016/s0005-8165(76)80117-5, PubMed 971257

Fosså SD, Miller A (1976)
Treatment of advanced carcinoma of the prostate with estramustine phosphate
J Urol, 115 (4), 406-8
DOI 10.1016/s0022-5347(17)59220-4, PubMed 1263316

Publications 1975

Fossä SD (1975)
Feulgen-DNA-values in transitional cell carcinoma of the human urinary bladder
Beitr Pathol, 155 (1), 44-55
PubMed 1156320

Fosså S, Urianstad MK, Talle K (1975)
[Treatment of advanced kidney adenocarcinoma]
Tidsskr Nor Laegeforen, 95 (13), 806-9
PubMed 1135804

Fosså SD, Miller A (1975)
[Treatment of advanced cancer of the bladder]
Tidsskr Nor Laegeforen, 95 (13), 809-11
PubMed 49090

Fosså SD, Miller A (1975)
[Treatment of advanced prostatic cancer]
Tidsskr Nor Laegeforen, 95 (13), 811-4
PubMed 1135805

Publications 1974

Fossa SD (1974)
[Carcinoma of the male breast]
Tidsskr Nor Laegeforen, 94 (1), 35-7
PubMed 4821256

Publications 1973

Fosså SD (1973)
[Adamantinoma of the tibia. Report of a case]
Acta Chir Scand, 139 (1), 100-3
PubMed 4693433